sentence_id,words,labels
0,Number,O
0,of,O
0,glucocorticoid,B-protein
0,receptors,I-protein
0,in,O
0,lymphocytes,B-cell_type
0,and,O
0,their,O
0,sensitivity,O
0,to,O
0,hormone,O
0,action,O
0,.,O
,,
1,The,O
1,study,O
1,demonstrated,O
1,a,O
1,decreased,O
1,level,O
1,of,O
1,glucocorticoid,B-protein
1,receptors,I-protein
1,(,O
1,GR,B-protein
1,),O
1,in,O
1,peripheral,B-cell_type
1,blood,I-cell_type
1,lymphocytes,I-cell_type
1,from,O
1,hypercholesterolemic,O
1,subjects,O
1,",",O
1,and,O
1,an,O
1,elevated,O
1,level,O
1,in,O
1,patients,O
1,with,O
1,acute,O
1,myocardial,O
1,infarction,O
1,.,O
,,
2,In,O
2,the,O
2,lymphocytes,B-cell_type
2,with,O
2,a,O
2,high,O
2,GR,B-protein
2,number,O
2,",",O
2,dexamethasone,O
2,inhibited,O
2,[,O
2,3H,O
2,],O
2,thymidine,O
2,and,O
2,[,O
2,3H,O
2,],O
2,acetate,O
2,incorporation,O
2,into,O
2,DNA,O
2,and,O
2,cholesterol,O
2,",",O
2,respectively,O
2,",",O
2,in,O
2,the,O
2,same,O
2,manner,O
2,as,O
2,in,O
2,the,O
2,control,B-cell_type
2,cells,I-cell_type
2,.,O
,,
3,On,O
3,the,O
3,other,O
3,hand,O
3,",",O
3,a,O
3,decreased,O
3,GR,B-protein
3,number,O
3,resulted,O
3,in,O
3,a,O
3,less,O
3,efficient,O
3,dexamethasone,O
3,inhibition,O
3,of,O
3,the,O
3,incorporation,O
3,of,O
3,labeled,O
3,compounds,O
3,.,O
,,
4,These,O
4,data,O
4,showed,O
4,that,O
4,the,O
4,sensitivity,O
4,of,O
4,lymphocytes,B-cell_type
4,to,O
4,glucocorticoids,O
4,changed,O
4,only,O
4,with,O
4,a,O
4,decrease,O
4,of,O
4,GR,B-protein
4,level,O
4,.,O
,,
5,[,O
5,1,B-protein
5,",",I-protein
5,25-Dihydroxyvitamin,I-protein
5,D3,I-protein
5,receptors,I-protein
5,in,O
5,lymphocytes,B-cell_type
5,and,O
5,T-,B-cell_type
5,and,I-cell_type
5,B-lymphocyte,I-cell_type
5,count,O
5,in,O
5,patients,O
5,with,O
5,glomerulonephritis,O
5,],O
,,
6,Content,O
6,of,O
6,receptors,O
6,to,O
6,hormonal,O
6,form,O
6,of,O
6,vitamin,O
6,D3,O
6,",",O
6,1.25,O
6,(,O
6,OH,O
6,),O
6,2D3,O
6,",",O
6,constituted,O
6,27.3,O
6,fmole/mg,O
6,of,O
6,protein,O
6,in,O
6,lymphocytes,B-cell_type
6,of,O
6,peripheric,O
6,blood,O
6,of,O
6,children,O
6,with,O
6,glomerulonephritis,O
6,.,O
,,
7,In,O
7,the,O
7,patients,O
7,concentration,O
7,of,O
7,total,O
7,and,O
7,ionized,O
7,form,O
7,of,O
7,Ca2+,O
7,was,O
7,decreased,O
7,down,O
7,to,O
7,2.04,O
7,mmole/L,O
7,and,O
7,1.09,O
7,mmole/L,O
7,",",O
7,respectively,O
7,",",O
7,while,O
7,an,O
7,increase,O
7,in,O
7,parathormone,O
7,(,O
7,PTH,O
7,),O
7,by,O
7,36,O
7,%,O
7,and,O
7,a,O
7,distinct,O
7,decrease,O
7,in,O
7,25,O
7,(,O
7,OH,O
7,),O
7,D,O
7,concentration,O
7,(,O
7,lower,O
7,than,O
7,1.25,O
7,ng/ml,O
7,),O
7,was,O
7,found,O
7,in,O
7,blood,O
7,;,O
7,content,O
7,of,O
7,cAMP,O
7,was,O
7,also,O
7,decreased,O
7,in,O
7,lymphocytes,O
7,by,O
7,33,O
7,%,O
7,.,O
,,
8,At,O
8,the,O
8,same,O
8,time,O
8,",",O
8,total,O
8,content,O
8,of,O
8,T,B-cell_type
8,lymphocytes,I-cell_type
8,was,O
8,decreased,O
8,1.5-fold,O
8,in,O
8,peripheric,O
8,blood,O
8,.,O
,,
9,Treatment,O
9,with,O
9,I-hydroxyvitamin,O
9,D3,O
9,(,O
9,1-1.5,O
9,mg,O
9,daily,O
9,",",O
9,within,O
9,4,O
9,weeks,O
9,),O
9,led,O
9,to,O
9,normalization,O
9,of,O
9,total,O
9,and,O
9,ionized,O
9,form,O
9,of,O
9,Ca2+,O
9,and,O
9,of,O
9,25,O
9,(,O
9,OH,O
9,),O
9,D,O
9,",",O
9,but,O
9,did,O
9,not,O
9,affect,O
9,the,O
9,PTH,O
9,content,O
9,in,O
9,blood,O
9,.,O
,,
10,Concentration,O
10,of,O
10,the,O
10,receptors,B-protein
10,to,O
10,1.25,O
10,(,O
10,OH,O
10,),O
10,2D3,O
10,was,O
10,elevated,O
10,up,O
10,to,O
10,39.7,O
10,fmole/mg,O
10,after,O
10,I,O
10,week,O
10,of,O
10,the,O
10,treatment,O
10,",",O
10,whereas,O
10,it,O
10,was,O
10,decreased,O
10,to,O
10,the,O
10,initial,O
10,level,O
10,24.8,O
10,fmole/mg,O
10,within,O
10,4,O
10,weeks,O
10,;,O
10,simultaneous,O
10,alteration,O
10,in,O
10,the,O
10,cAMP,O
10,content,O
10,was,O
10,observed,O
10,in,O
10,lymphocytes,B-cell_type
10,.,O
,,
11,Treatment,O
11,with,O
11,-1,O
11,(,O
11,OH,O
11,),O
11,D3,O
11,normalized,O
11,also,O
11,the,O
11,T,B-cell_type
11,lymphocytes,I-cell_type
11,content,O
11,in,O
11,peripheric,O
11,blood,O
11,.,O
,,
12,The,O
12,data,O
12,obtained,O
12,suggest,O
12,that,O
12,under,O
12,conditions,O
12,of,O
12,glomerulonephritis,O
12,only,O
12,high,O
12,content,O
12,of,O
12,receptors,B-protein
12,to,O
12,1.25,O
12,(,O
12,OH,O
12,),O
12,2D3,O
12,in,O
12,lymphocytes,B-cell_type
12,enabled,O
12,to,O
12,perform,O
12,the,O
12,cell,O
12,response,O
12,to,O
12,the,O
12,hormone,O
12,effect,O
12,.,O
,,
13,Tumor,O
13,and,O
13,serum,O
13,beta-2-microglobulin,O
13,expression,O
13,in,O
13,women,O
13,with,O
13,breast,O
13,cancer,O
13,.,O
,,
14,To,O
14,investigate,O
14,whether,O
14,the,O
14,tumor,B-cell_type
14,expression,O
14,of,O
14,beta-2-microglobulin,B-protein
14,(,O
14,beta,B-protein
14,2-M,I-protein
14,),O
14,could,O
14,serve,O
14,as,O
14,a,O
14,marker,O
14,of,O
14,tumor,O
14,biologic,O
14,behavior,O
14,",",O
14,the,O
14,authors,O
14,studied,O
14,specimens,O
14,of,O
14,breast,B-cell_type
14,carcinomas,I-cell_type
14,from,O
14,60,O
14,consecutive,O
14,female,O
14,patients,O
14,.,O
,,
15,Presence,O
15,of,O
15,beta,B-protein
15,2-M,I-protein
15,was,O
15,analyzed,O
15,by,O
15,immunohistochemistry,O
15,.,O
,,
16,No,O
16,significant,O
16,correlations,O
16,were,O
16,found,O
16,between,O
16,tumor,B-protein
16,beta,I-protein
16,2-M,I-protein
16,expression,O
16,and,O
16,several,O
16,histologic,O
16,attributes,O
16,such,O
16,as,O
16,type,O
16,",",O
16,histologic,O
16,and,O
16,nuclear,O
16,grades,O
16,",",O
16,mitotic,O
16,index,O
16,",",O
16,necrosis,O
16,",",O
16,vascular,O
16,invasion,O
16,",",O
16,and,O
16,lymphocytic,O
16,infiltration,O
16,.,O
,,
17,Likewise,O
17,",",O
17,beta,B-protein
17,2-M,I-protein
17,was,O
17,not,O
17,associated,O
17,with,O
17,markers,O
17,of,O
17,disease,O
17,extension,O
17,such,O
17,as,O
17,TNM,O
17,",",O
17,(,O
17,UICC,O
17,",",O
17,classification,O
17,of,O
17,malignant,B-cell_type
17,tumors,I-cell_type
17,),O
17,staging,O
17,and,O
17,axillary,O
17,lymph,O
17,node,O
17,involvement,O
17,or,O
17,with,O
17,estrogen,O
17,",",O
17,progesterone,O
17,",",O
17,and,O
17,glucocorticoid,O
17,receptor,O
17,levels,O
17,.,O
,,
18,However,O
18,",",O
18,there,O
18,was,O
18,a,O
18,significantly,O
18,positive,O
18,association,O
18,between,O
18,tumor,B-protein
18,beta,I-protein
18,2-M,I-protein
18,expression,O
18,and,O
18,the,O
18,degree,O
18,of,O
18,lymphocytic,O
18,infiltration,O
18,in,O
18,the,O
18,tumor,O
18,tissue,O
18,.,O
,,
19,Beta,B-protein
19,2-M,I-protein
19,serum,O
19,levels,O
19,were,O
19,determined,O
19,by,O
19,an,O
19,enzyme-linked,O
19,immunosorbent,O
19,assay,O
19,in,O
19,samples,O
19,from,O
19,22,O
19,of,O
19,the,O
19,above,O
19,women,O
19,.,O
,,
20,Although,O
20,some,O
20,of,O
20,the,O
20,highest,O
20,values,O
20,had,O
20,been,O
20,obtained,O
20,in,O
20,women,O
20,with,O
20,larger,O
20,(,O
20,T4,O
20,),O
20,primary,O
20,tumors,O
20,",",O
20,the,O
20,authors,O
20,failed,O
20,to,O
20,detect,O
20,any,O
20,statistical,O
20,relationship,O
20,between,O
20,beta,B-protein
20,2-M,I-protein
20,expression,O
20,in,O
20,the,O
20,tumor,O
20,with,O
20,serum,O
20,levels,O
20,or,O
20,between,O
20,serum,B-protein
20,beta,I-protein
20,2-M,I-protein
20,and,O
20,the,O
20,above,O
20,histologic,O
20,",",O
20,laboratory,O
20,",",O
20,and,O
20,clinical,O
20,factors,O
20,.,O
,,
21,[,O
21,Preliminary,O
21,observation,O
21,of,O
21,level,O
21,free-form,B-protein
21,E,I-protein
21,receptor,I-protein
21,levels,O
21,in,O
21,serum,O
21,of,O
21,normal,O
21,childbearing-aged,O
21,and,O
21,pregnant,O
21,women,O
21,],O
,,
22,In,O
22,137,O
22,cases,O
22,of,O
22,childbearing-aged,O
22,and,O
22,pregnant,O
22,women,O
22,",",O
22,free,B-protein
22,form,I-protein
22,E,I-protein
22,receptor,I-protein
22,levels,O
22,(,O
22,sE,B-protein
22,),O
22,in,O
22,serum,O
22,were,O
22,measured,O
22,by,O
22,ELISA,O
22,.,O
,,
23,The,O
23,level,O
23,of,O
23,sE,B-protein
23,was,O
23,significantly,O
23,decreased,O
23,during,O
23,the,O
23,first,O
23,trimester,O
23,",",O
23,slightly,O
23,higher,O
23,in,O
23,the,O
23,second,O
23,trimester,O
23,",",O
23,and,O
23,recovered,O
23,to,O
23,normal,O
23,in,O
23,the,O
23,third,O
23,trimester,O
23,.,O
,,
24,The,O
24,level,O
24,remained,O
24,lower,O
24,in,O
24,29,O
24,PIH,O
24,women,O
24,but,O
24,appeared,O
24,higher,O
24,in,O
24,overdue,O
24,pregnancies,O
24,as,O
24,compared,O
24,with,O
24,the,O
24,normal,O
24,3rd,O
24,trimester,O
24,range,O
24,.,O
,,
25,The,O
25,results,O
25,indicate,O
25,that,O
25,there,O
25,is,O
25,a,O
25,relationship,O
25,between,O
25,a,O
25,change,O
25,in,O
25,T,B-cell_type
25,cell,I-cell_type
25,function,O
25,and,O
25,pregnancy,O
25,.,O
,,
26,Kappa,B-protein
26,B-specific,I-protein
26,DNA,I-protein
26,binding,I-protein
26,proteins,I-protein
26,:,O
26,role,O
26,in,O
26,the,O
26,regulation,O
26,of,O
26,human,B-DNA
26,interleukin-2,I-DNA
26,gene,I-DNA
26,expression,O
26,.,O
,,
27,Transcriptional,O
27,activation,O
27,of,O
27,the,O
27,human,B-DNA
27,interleukin-2,I-DNA
27,(,I-DNA
27,IL-2,I-DNA
27,),I-DNA
27,gene,I-DNA
27,",",O
27,like,O
27,induction,O
27,of,O
27,the,O
27,IL-2,B-DNA
27,receptor,I-DNA
27,alpha,I-DNA
27,(,I-DNA
27,IL-2R,I-DNA
27,alpha,I-DNA
27,),I-DNA
27,gene,I-DNA
27,and,O
27,the,O
27,type,O
27,1,O
27,human,O
27,immunodeficiency,O
27,virus,O
27,(,O
27,HIV-1,O
27,),O
27,",",O
27,is,O
27,shown,O
27,to,O
27,be,O
27,modulated,O
27,by,O
27,a,O
27,kappa,B-protein
27,B-like,I-protein
27,enhancer,I-protein
27,element,I-protein
27,.,O
,,
28,Mutation,O
28,of,O
28,a,O
28,kappa,B-DNA
28,B,I-DNA
28,core,I-DNA
28,sequence,I-DNA
28,identified,O
28,in,O
28,the,O
28,IL-2,B-DNA
28,promoter,I-DNA
28,(,O
28,-206,O
28,to,O
28,-195,O
28,),O
28,partially,O
28,inhibits,O
28,both,O
28,mitogen-,O
28,and,O
28,HTLV-I,O
28,Tax-mediated,O
28,activation,O
28,of,O
28,this,O
28,transcription,B-protein
28,unit,I-protein
28,and,O
28,blocks,O
28,the,O
28,specific,O
28,binding,O
28,of,O
28,two,O
28,inducible,B-protein
28,cellular,I-protein
28,factors,I-protein
28,.,O
,,
29,These,O
29,kappa,B-protein
29,B-specific,I-protein
29,proteins,I-protein
29,(,O
29,80,O
29,to,O
29,90,O
29,and,O
29,50,O
29,to,O
29,55,O
29,kilodaltons,O
29,),O
29,similarly,O
29,interact,O
29,with,O
29,the,O
29,functional,O
29,kappa,B-protein
29,B,I-protein
29,enhancer,I-protein
29,present,O
29,in,O
29,the,O
29,IL-2R,B-DNA
29,alpha,I-DNA
29,promoter,I-DNA
29,.,O
,,
30,These,O
30,data,O
30,suggest,O
30,that,O
30,these,O
30,kappa,B-protein
30,B-specific,I-protein
30,proteins,I-protein
30,have,O
30,a,O
30,role,O
30,in,O
30,the,O
30,coordinate,O
30,regulation,O
30,of,O
30,this,O
30,growth,O
30,factor-growth,O
30,factor,O
30,receptor,O
30,gene,O
30,system,O
30,that,O
30,controls,O
30,T,B-cell_type
30,cell,I-cell_type
30,proliferation,O
30,.,O
,,
31,Novel,O
31,region,O
31,within,O
31,the,O
31,V,B-DNA
31,kappa,I-DNA
31,gene,I-DNA
31,promoter,I-DNA
31,is,O
31,responsible,O
31,for,O
31,tissue,O
31,and,O
31,stage-specific,O
31,expression,O
31,of,O
31,immunoglobulin,B-DNA
31,genes,I-DNA
31,in,O
31,human,B-cell_type
31,lymphoid,I-cell_type
31,neoplasms,I-cell_type
31,.,O
,,
32,Immunoglobulin,B-protein
32,gene-specific,I-protein
32,transacting,I-protein
32,factors,I-protein
32,have,O
32,been,O
32,shown,O
32,to,O
32,play,O
32,a,O
32,role,O
32,in,O
32,lymphoid,O
32,tissue-specific,O
32,expression,O
32,of,O
32,immunoglobulin,B-DNA
32,genes,I-DNA
32,.,O
,,
33,The,O
33,role,O
33,of,O
33,these,O
33,factors,O
33,in,O
33,B-cell,B-cell_type
33,differentiation,O
33,and,O
33,stage-specific,O
33,expression,O
33,of,O
33,these,O
33,genes,O
33,is,O
33,",",O
33,however,O
33,",",O
33,not,O
33,fully,O
33,understood,O
33,.,O
,,
34,We,O
34,have,O
34,used,O
34,a,O
34,model,O
34,of,O
34,human,O
34,lymphoid,O
34,neoplasia,O
34,to,O
34,address,O
34,this,O
34,question,O
34,.,O
,,
35,Different,O
35,fragments,O
35,of,O
35,unrearranged,B-DNA
35,human,I-DNA
35,variable,I-DNA
35,region,I-DNA
35,of,O
35,immunoglobulin,B-DNA
35,kappa,I-DNA
35,gene,I-DNA
35,(,O
35,V,B-DNA
35,kappa,I-DNA
35,),O
35,were,O
35,used,O
35,for,O
35,cell-free,O
35,in,O
35,vitro,O
35,transcription,O
35,and,O
35,DNA,O
35,mobility,O
35,shift,O
35,assays,O
35,.,O
,,
36,Previously,O
36,described,O
36,enhancement,O
36,of,O
36,in,O
36,vitro,O
36,transcription,O
36,that,O
36,was,O
36,only,O
36,seen,O
36,with,O
36,nuclear,O
36,extracts,O
36,derived,O
36,from,O
36,B-cell,B-cell_type
36,neoplasms,I-cell_type
36,corresponding,O
36,to,O
36,the,O
36,late,O
36,stages,O
36,of,O
36,B-cell,B-cell_type
36,differentiation,O
36,was,O
36,shown,O
36,to,O
36,be,O
36,dependent,O
36,on,O
36,the,O
36,actions,O
36,of,O
36,these,O
36,factor,O
36,(,O
36,s,O
36,),O
36,on,O
36,the,O
36,DNA,O
36,region,O
36,within,O
36,the,O
36,V,B-DNA
36,kappa,I-DNA
36,gene,I-DNA
36,promoter,I-DNA
36,.,O
,,
37,This,O
37,region,O
37,is,O
37,located,O
37,within,O
37,the,O
37,920,O
37,bp,O
37,fragment,O
37,located,O
37,210,O
37,bp,O
37,upstream,O
37,from,O
37,the,O
37,coding,O
37,region,O
37,and,O
37,this,O
37,fragment,O
37,represents,O
37,a,O
37,possible,O
37,novel,O
37,DNA,O
37,region,O
37,",",O
37,which,O
37,plays,O
37,a,O
37,role,O
37,in,O
37,the,O
37,stage-,O
37,and,O
37,tissue-specific,O
37,expression,O
37,of,O
37,immunoglobulin,B-DNA
37,genes,I-DNA
37,.,O
,,
38,[,O
38,Determination,O
38,of,O
38,the,O
38,sensitivity,O
38,to,O
38,glucocorticoids,B-protein
38,in,O
38,vitro,O
38,],O
,,
39,A,O
39,modified,O
39,method,O
39,for,O
39,the,O
39,determination,O
39,of,O
39,glucocorticoid,B-protein
39,receptors,I-protein
39,in,O
39,human,B-cell_type
39,lymphocytes,I-cell_type
39,is,O
39,suggested,O
39,.,O
,,
40,The,O
40,principal,O
40,distinction,O
40,of,O
40,the,O
40,method,O
40,is,O
40,standardization,O
40,by,O
40,the,O
40,lymphocyte,B-cell_type
40,count,O
40,in,O
40,a,O
40,sample,O
40,(,O
40,1,O
40,mln,O
40,),O
40,and,O
40,the,O
40,labeled,O
40,hormone,B-protein
40,concentration,O
40,.,O
,,
41,The,O
41,modification,O
41,saves,O
41,time,O
41,and,O
41,money,O
41,",",O
41,limits,O
41,the,O
41,range,O
41,of,O
41,the,O
41,data,O
41,variations,O
41,",",O
41,and,O
41,makes,O
41,use,O
41,of,O
41,a,O
41,lesser,O
41,volume,O
41,of,O
41,blood,O
41,.,O
,,
42,Examinations,O
42,of,O
42,70,O
42,children,O
42,aged,O
42,4,O
42,to,O
42,15,O
42,suffering,O
42,from,O
42,the,O
42,nephrotic,O
42,form,O
42,of,O
42,glomerulonephritis,O
42,have,O
42,made,O
42,it,O
42,possible,O
42,to,O
42,distinguish,O
42,two,O
42,groups,O
42,of,O
42,patients,O
42,:,O
42,with,O
42,relatively,O
42,high,O
42,values,O
42,of,O
42,specific,O
42,binding,O
42,X,O
42,=,O
42,6820.1,O
42,+/-,O
42,530,O
42,(,O
42,n,O
42,=,O
42,30,O
42,",",O
42,p,O
42,=,O
42,0.95,O
42,",",O
42,t,O
42,=,O
42,2.04,O
42,),O
42,",",O
42,this,O
42,corresponding,O
42,to,O
42,a,O
42,clinical,O
42,form,O
42,of,O
42,hormone,B-protein
42,sensitive,O
42,glomerulonephritis,O
42,",",O
42,and,O
42,with,O
42,relatively,O
42,low,O
42,values,O
42,of,O
42,specific,O
42,binding,O
42,X,O
42,=,O
42,1815.2,O
42,+/-,O
42,302.8,O
42,(,O
42,n,O
42,=,O
42,40,O
42,",",O
42,p,O
42,=,O
42,0.95,O
42,",",O
42,t,O
42,=,O
42,1.96,O
42,),O
42,",",O
42,that,O
42,corresponds,O
42,to,O
42,hormone,B-protein
42,resistant,O
42,glomerulonephritis,O
42,.,O
,,
43,Dynamic,O
43,studies,O
43,have,O
43,not,O
43,shown,O
43,any,O
43,statistically,O
43,significant,O
43,changes,O
43,in,O
43,the,O
43,specific,O
43,binding,O
43,values,O
43,.,O
,,
44,These,O
44,results,O
44,permit,O
44,regarding,O
44,the,O
44,specific,O
44,binding,O
44,value,O
44,as,O
44,a,O
44,prognostic,O
44,criterion,O
44,in,O
44,the,O
44,assessment,O
44,of,O
44,corticosteroid,B-protein
44,therapy,O
44,;,O
44,this,O
44,allows,O
44,a,O
44,wide,O
44,employment,O
44,of,O
44,the,O
44,described,O
44,method,O
44,in,O
44,practical,O
44,nephrology,O
44,.,O
,,
45,Octamer-binding,B-protein
45,proteins,I-protein
45,from,O
45,B,B-cell_line
45,or,I-cell_line
45,HeLa,I-cell_line
45,cells,I-cell_line
45,stimulate,O
45,transcription,O
45,of,O
45,the,O
45,immunoglobulin,B-DNA
45,heavy-chain,I-DNA
45,promoter,I-DNA
45,in,O
45,vitro,O
45,.,O
,,
46,The,O
46,B-cell,B-cell_type
46,type,O
46,specificity,O
46,of,O
46,the,O
46,immunoglobulin,B-protein
46,(,O
46,Ig,B-protein
46,),O
46,heavy-chain,O
46,and,O
46,light-chain,O
46,promoters,O
46,is,O
46,mediated,O
46,by,O
46,an,O
46,octanucleotide,B-DNA
46,(,I-DNA
46,OCTA,I-DNA
46,),I-DNA
46,element,I-DNA
46,",",O
46,ATGCAAAT,O
46,",",O
46,that,O
46,is,O
46,also,O
46,a,O
46,functional,O
46,component,O
46,of,O
46,other,O
46,RNA,B-DNA
46,polymerase,I-DNA
46,II,I-DNA
46,promoters,I-DNA
46,",",O
46,such,O
46,as,O
46,snRNA,O
46,and,O
46,histone,O
46,H2B,O
46,promoters,O
46,.,O
,,
47,Two,O
47,nuclear,B-protein
47,proteins,I-protein
47,that,O
47,bind,O
47,specifically,O
47,and,O
47,with,O
47,high,O
47,affinity,O
47,to,O
47,the,O
47,OCTA,B-DNA
47,element,I-DNA
47,have,O
47,been,O
47,identified,O
47,.,O
,,
48,NF-A1,B-protein
48,is,O
48,present,O
48,in,O
48,a,O
48,variety,O
48,of,O
48,cell,O
48,types,O
48,",",O
48,whereas,O
48,the,O
48,presence,O
48,of,O
48,NF-A2,B-protein
48,is,O
48,essentially,O
48,confined,O
48,to,O
48,B,B-cell_type
48,cells,I-cell_type
48,",",O
48,leading,O
48,to,O
48,the,O
48,hypothesis,O
48,that,O
48,NF-A2,B-protein
48,activates,O
48,cell-type-specific,O
48,transcription,O
48,of,O
48,the,O
48,Ig,B-DNA
48,promoter,I-DNA
48,and,O
48,NF-A1,B-protein
48,mediates,O
48,the,O
48,other,O
48,responses,O
48,of,O
48,the,O
48,OCTA,B-DNA
48,element,I-DNA
48,.,O
,,
49,Extracts,O
49,of,O
49,the,O
49,B-cell,B-cell_line
49,line,I-cell_line
49,",",O
49,BJA-B,B-cell_line
49,",",O
49,contain,O
49,high,O
49,levels,O
49,of,O
49,NF-A2,B-protein
49,and,O
49,specifically,O
49,transcribe,O
49,Ig,B-DNA
49,promoters,I-DNA
49,.,O
,,
50,In,O
50,contrast,O
50,",",O
50,extracts,O
50,from,O
50,HeLa,B-cell_line
50,cells,I-cell_line
50,transcribed,O
50,the,O
50,Ig,B-DNA
50,promoter,I-DNA
50,poorly,O
50,.,O
,,
51,Surprisingly,O
51,",",O
51,addition,O
51,of,O
51,either,O
51,affinity-enriched,O
51,NF-A2,O
51,or,O
51,NF-A1,O
51,to,O
51,either,O
51,a,O
51,HeLa,O
51,extract,O
51,or,O
51,a,O
51,partially,O
51,purified,O
51,reaction,O
51,system,O
51,specifically,O
51,stimulates,O
51,the,O
51,Ig,B-DNA
51,promoter,I-DNA
51,.,O
,,
52,This,O
52,suggests,O
52,that,O
52,the,O
52,constitutive,O
52,OCTA-binding,B-protein
52,factor,I-protein
52,NF-A1,I-protein
52,can,O
52,activate,O
52,transcription,O
52,of,O
52,the,O
52,Ig,B-DNA
52,promoter,I-DNA
52,and,O
52,that,O
52,B-cell,B-cell_type
52,specific,O
52,transcription,O
52,of,O
52,this,O
52,promoter,O
52,",",O
52,at,O
52,least,O
52,in,O
52,vitro,O
52,",",O
52,is,O
52,partially,O
52,due,O
52,to,O
52,a,O
52,quantitative,O
52,difference,O
52,in,O
52,the,O
52,amount,O
52,of,O
52,OCTA-binding,B-protein
52,protein,I-protein
52,.,O
,,
53,Because,O
53,NF-A1,B-protein
53,can,O
53,stimulate,O
53,Ig,B-protein
53,transcription,O
53,",",O
53,the,O
53,inability,O
53,of,O
53,this,O
53,factor,O
53,to,O
53,activate,O
53,in,O
53,vivo,O
53,the,O
53,Ig,B-DNA
53,promoter,I-DNA
53,to,O
53,the,O
53,same,O
53,degree,O
53,as,O
53,the,O
53,snRNA,B-DNA
53,promoters,I-DNA
53,probably,O
53,reflects,O
53,a,O
53,difference,O
53,in,O
53,the,O
53,context,O
53,of,O
53,the,O
53,OCTA,B-DNA
53,element,I-DNA
53,in,O
53,these,O
53,two,O
53,types,O
53,of,O
53,promoters,B-DNA
53,.,O
,,
54,Identification,O
54,of,O
54,a,O
54,putative,O
54,regulator,O
54,of,O
54,early,B-DNA
54,T,I-DNA
54,cell,I-DNA
54,activation,I-DNA
54,genes,I-DNA
54,.,O
,,
55,Molecules,O
55,involved,O
55,in,O
55,the,O
55,antigen,O
55,receptor-dependent,O
55,regulation,O
55,of,O
55,early,B-DNA
55,T,I-DNA
55,cell,I-DNA
55,activation,I-DNA
55,genes,I-DNA
55,were,O
55,investigated,O
55,with,O
55,the,O
55,use,O
55,of,O
55,functional,O
55,sequences,O
55,of,O
55,the,O
55,T,B-protein
55,cell,I-protein
55,activation-specific,I-protein
55,enhancer,I-protein
55,of,O
55,interleukin-2,B-protein
55,(,O
55,IL-2,B-protein
55,),O
55,.,O
,,
56,One,O
56,of,O
56,these,O
56,sequences,O
56,forms,O
56,a,O
56,protein,O
56,complex,O
56,",",O
56,NFAT-1,B-protein
56,",",O
56,specifically,O
56,with,O
56,nuclear,O
56,extracts,O
56,of,O
56,activated,O
56,T,B-cell_type
56,cells,I-cell_type
56,.,O
,,
57,This,O
57,complex,O
57,appeared,O
57,10,O
57,to,O
57,25,O
57,minutes,O
57,before,O
57,the,O
57,activation,O
57,of,O
57,the,O
57,IL-2,B-DNA
57,gene,I-DNA
57,.,O
,,
58,Studies,O
58,with,O
58,inhibitors,O
58,of,O
58,protein,O
58,synthesis,O
58,indicated,O
58,that,O
58,the,O
58,time,O
58,of,O
58,synthesis,O
58,of,O
58,the,O
58,activator,O
58,of,O
58,the,O
58,IL-2,B-DNA
58,gene,I-DNA
58,in,O
58,Jurkat,B-cell_line
58,T,I-cell_line
58,cells,I-cell_line
58,corresponds,O
58,to,O
58,the,O
58,time,O
58,of,O
58,appearance,O
58,of,O
58,NFAT-1,B-protein
58,.,O
,,
59,NFAT-1,B-protein
59,",",O
59,or,O
59,a,O
59,very,O
59,similar,O
59,protein,O
59,",",O
59,bound,O
59,functional,O
59,sequences,O
59,of,O
59,the,O
59,long,B-DNA
59,terminal,I-DNA
59,repeat,I-DNA
59,(,O
59,LTR,B-DNA
59,),O
59,of,O
59,the,O
59,human,O
59,immunodeficiency,O
59,virus,O
59,type,O
59,1,O
59,;,O
59,the,O
59,LTR,B-DNA
59,of,O
59,this,O
59,virus,O
59,is,O
59,known,O
59,to,O
59,be,O
59,stimulated,O
59,during,O
59,early,O
59,T,B-cell_type
59,cell,I-cell_type
59,activation,O
59,.,O
,,
60,The,O
60,binding,B-DNA
60,site,I-DNA
60,for,O
60,this,O
60,complex,O
60,activated,O
60,a,O
60,linked,O
60,promoter,O
60,after,O
60,transfection,O
60,into,O
60,antigen,B-cell_type
60,receptor-activated,I-cell_type
60,T,I-cell_type
60,cells,I-cell_type
60,but,O
60,not,O
60,other,O
60,cell,O
60,types,O
60,.,O
,,
61,These,O
61,characteristics,O
61,suggest,O
61,that,O
61,NFAT-1,B-protein
61,transmits,O
61,signals,O
61,initiated,O
61,at,O
61,the,O
61,T,B-protein
61,cell,I-protein
61,antigen,I-protein
61,receptor,I-protein
61,.,O
,,
62,Characterization,O
62,of,O
62,thyroid,B-protein
62,hormone,I-protein
62,receptors,I-protein
62,in,O
62,human,B-cell_line
62,IM-9,I-cell_line
62,lymphocytes,I-cell_line
62,.,O
,,
63,Although,O
63,putatively,O
63,identified,O
63,more,O
63,than,O
63,10,O
63,years,O
63,ago,O
63,",",O
63,thyroid,B-protein
63,hormone,I-protein
63,receptors,I-protein
63,in,O
63,human,O
63,tissues,O
63,remain,O
63,poorly,O
63,characterized,O
63,.,O
,,
64,As,O
64,a,O
64,first,O
64,step,O
64,towards,O
64,understanding,O
64,the,O
64,mechanism,O
64,of,O
64,thyroid,O
64,hormone,O
64,action,O
64,in,O
64,man,O
64,we,O
64,have,O
64,characterized,O
64,T3,B-protein
64,binding,I-protein
64,sites,I-protein
64,in,O
64,nuclei,O
64,of,O
64,the,O
64,human,B-cell_line
64,lymphoblastoid,I-cell_line
64,line,I-cell_line
64,",",O
64,IM-9,B-cell_line
64,cells,I-cell_line
64,.,O
,,
65,In,O
65,whole,O
65,cell,O
65,experiments,O
65,at,O
65,37,O
65,degrees,O
65,C,O
65,",",O
65,nuclear,O
65,binding,O
65,of,O
65,[,B-protein
65,125I,I-protein
65,],I-protein
65,T3,I-protein
65,was,O
65,saturable,O
65,(,O
65,Kd,O
65,34,O
65,+/-,O
65,6,O
65,pmol/l,O
65,),O
65,and,O
65,of,O
65,finite,O
65,capacity,O
65,(,O
65,approximately,O
65,equal,O
65,to,O
65,350,O
65,sites/cell,O
65,),O
65,.,O
,,
66,The,O
66,binding,B-protein
66,sites,I-protein
66,were,O
66,extracted,O
66,from,O
66,a,O
66,nuclear,O
66,pellet,O
66,by,O
66,treatment,O
66,with,O
66,0.4,O
66,mol/l,O
66,KCl,O
66,and,O
66,sonication,O
66,.,O
,,
67,Separation,O
67,of,O
67,bound,O
67,from,O
67,free,O
67,[,B-protein
67,125I,I-protein
67,],I-protein
67,T3,I-protein
67,in,O
67,the,O
67,extracts,O
67,was,O
67,achieved,O
67,using,O
67,the,O
67,calcium,O
67,phosphate,O
67,matrix,O
67,",",O
67,hydroxyapatite,O
67,at,O
67,a,O
67,concentration,O
67,of,O
67,0.3,O
67,ml,O
67,of,O
67,a,O
67,150,O
67,g/l,O
67,slurry,O
67,.,O
,,
68,Rectilinear,O
68,Scatchard,O
68,plots,O
68,were,O
68,obtained,O
68,only,O
68,when,O
68,the,O
68,hydroxyapatite,O
68,was,O
68,washed,O
68,with,O
68,a,O
68,buffer,O
68,containing,O
68,0.5,O
68,%,O
68,Triton,O
68,X-100,O
68,.,O
,,
69,Under,O
69,these,O
69,conditions,O
69,T3,B-protein
69,binding,I-protein
69,sites,I-protein
69,in,O
69,the,O
69,nuclear,O
69,extracts,O
69,were,O
69,present,O
69,at,O
69,a,O
69,concentration,O
69,of,O
69,22.4,O
69,+/-,O
69,8.6,O
69,fmol/mg,O
69,protein,O
69,and,O
69,showed,O
69,an,O
69,affinity,O
69,of,O
69,(,O
69,Kd,O
69,",",O
69,room,O
69,temperature,O
69,),O
69,140,O
69,+/-,O
69,10,O
69,pmol/l,O
69,.,O
,,
70,The,O
70,same,O
70,assay,O
70,system,O
70,was,O
70,used,O
70,to,O
70,determine,O
70,the,O
70,hierarchy,O
70,of,O
70,affinities,O
70,for,O
70,a,O
70,range,O
70,of,O
70,natural,O
70,and,O
70,synthetic,O
70,analogues,O
70,.,O
,,
71,Calling,O
71,T3,O
71,100,O
71,",",O
71,the,O
71,order,O
71,of,O
71,potencies,O
71,observed,O
71,was,O
71,:,O
71,Triac,O
71,",",O
71,500,O
71,;,O
71,3,O
71,",",O
71,5-diiodo-3'-isopropylthyronine,O
71,",",O
71,89,O
71,;,O
71,T4,O
71,",",O
71,32,O
71,;,O
71,3,O
71,",",O
71,5-dimethyl-3'isopropylthyronine,O
71,2,O
71,;,O
71,3,O
71,",",O
71,5-T2,O
71,",",O
71,0.7,O
71,",",O
71,rT3,O
71,",",O
71,0.4,O
71,;,O
71,3'5'-T2,O
71,",",O
71,less,O
71,than,O
71,0.01,O
71,.,O
,,
72,These,O
72,results,O
72,suggest,O
72,that,O
72,the,O
72,T3,B-protein
72,binding,I-protein
72,sites,I-protein
72,present,O
72,in,O
72,human,B-cell_line
72,IM-9,I-cell_line
72,lymphocyte,I-cell_line
72,nuclei,O
72,and,O
72,extracts,O
72,thereof,O
72,are,O
72,thyroid,B-protein
72,hormone,I-protein
72,receptors,I-protein
72,.,O
,,
73,These,O
73,cells,O
73,may,O
73,be,O
73,a,O
73,useful,O
73,tool,O
73,to,O
73,increase,O
73,our,O
73,understanding,O
73,of,O
73,human,B-protein
73,T3,I-protein
73,receptors,I-protein
,,
74,Definition,O
74,of,O
74,T-cell,B-protein
74,specific,I-protein
74,DNA-binding,I-protein
74,factors,I-protein
74,that,O
74,interact,O
74,with,O
74,a,O
74,3'-silencer,B-DNA
74,in,O
74,the,O
74,CD4+,B-DNA
74,T-cell,I-DNA
74,gene,I-DNA
74,Rpt-1,I-DNA
74,.,O
,,
75,Analysis,O
75,of,O
75,the,O
75,region,O
75,3,O
75,',O
75,to,O
75,the,O
75,CD4+,B-DNA
75,T-cell,I-DNA
75,gene,I-DNA
75,Rpt-1,I-DNA
75,(,O
75,encoding,O
75,regulatory,O
75,protein,O
75,T-lymphocyte,B-protein
75,1,I-protein
75,),O
75,led,O
75,to,O
75,the,O
75,definition,O
75,of,O
75,a,O
75,silencer,B-DNA
75,element,I-DNA
75,that,O
75,inhibits,O
75,heterologous,B-DNA
75,gene,I-DNA
75,expression,O
75,in,O
75,certain,O
75,CD4+,B-cell_type
75,T-cell,I-cell_type
75,lines,I-cell_type
75,but,O
75,not,O
75,in,O
75,B-cell,B-cell_type
75,or,O
75,non-lymphoid,B-cell_type
75,cell,I-cell_type
75,lines,I-cell_type
75,.,O
,,
76,Functional,O
76,silencer,B-DNA
76,activity,O
76,in,O
76,vivo,O
76,was,O
76,associated,O
76,with,O
76,the,O
76,presence,O
76,of,O
76,a,O
76,specific,O
76,silencer-DNA-protein,B-protein
76,complex,I-protein
76,in,O
76,electrophoretic,O
76,mobility,O
76,shift,O
76,assays,O
76,with,O
76,T-cell,B-cell_type
76,extracts,O
76,.,O
,,
77,Formation,O
77,of,O
77,this,O
77,complex,O
77,was,O
77,selectively,O
77,inhibited,O
77,by,O
77,the,O
77,region,O
77,in,O
77,HIV-1,B-DNA
77,containing,O
77,a,O
77,silencer,B-DNA
77,element,I-DNA
77,.,O
,,
78,We,O
78,discuss,O
78,the,O
78,possibility,O
78,that,O
78,DNA-binding,B-protein
78,factors,I-protein
78,may,O
78,coregulate,O
78,HIV-1,O
78,and,O
78,Rpt-1,O
78,gene,O
78,expression,O
78,through,O
78,a,O
78,common,O
78,transcriptional,B-DNA
78,silencer,I-DNA
78,element,I-DNA
78,.,O
,,
79,Congenital,O
79,immunodeficiencies,O
79,associated,O
79,with,O
79,absence,O
79,of,O
79,HLA,B-protein
79,class,I-protein
79,II,I-protein
79,antigens,I-protein
79,on,O
79,lymphocytes,B-cell_type
79,result,O
79,from,O
79,distinct,O
79,mutations,O
79,in,O
79,trans-acting,B-protein
79,factors,I-protein
79,.,O
,,
80,Coordinate,O
80,regulation,O
80,of,O
80,HLA,B-DNA
80,class,I-DNA
80,II,I-DNA
80,gene,I-DNA
80,expression,O
80,during,O
80,development,O
80,and,O
80,coinduction,O
80,of,O
80,class,B-DNA
80,II,I-DNA
80,genes,I-DNA
80,by,O
80,soluble,B-protein
80,factors,I-protein
80,suggests,O
80,that,O
80,common,O
80,trans-acting,B-protein
80,factor,I-protein
80,(,O
80,s,O
80,),O
80,control,O
80,expression,O
80,of,O
80,these,O
80,genes,O
80,.,O
,,
81,In,O
81,B-lymphoblastoid,B-cell_type
81,cell,I-cell_type
81,lines,I-cell_type
81,derived,O
81,from,O
81,two,O
81,independent,O
81,class,O
81,II-deficient,O
81,bare,O
81,lymphocyte,O
81,syndrome,O
81,patients,O
81,",",O
81,we,O
81,observed,O
81,a,O
81,drastic,O
81,decrease,O
81,in,O
81,transcription,O
81,rates,O
81,of,O
81,the,O
81,class,B-DNA
81,II,I-DNA
81,genes,I-DNA
81,.,O
,,
82,When,O
82,these,O
82,cell,O
82,lines,O
82,are,O
82,fused,O
82,",",O
82,class,B-DNA
82,II,I-DNA
82,genes,I-DNA
82,are,O
82,reexpressed,O
82,",",O
82,indicating,O
82,that,O
82,immunodeficiencies,O
82,in,O
82,bare,O
82,lymphocyte,O
82,syndrome,O
82,patients,O
82,are,O
82,the,O
82,result,O
82,of,O
82,two,O
82,distinct,O
82,mutations,O
82,.,O
,,
83,Further,O
83,studies,O
83,show,O
83,that,O
83,genes,O
83,governing,O
83,the,O
83,expression,O
83,of,O
83,class,B-protein
83,II,I-protein
83,antigens,I-protein
83,fall,O
83,into,O
83,at,O
83,least,O
83,three,O
83,complementation,O
83,groups,O
83,;,O
83,two,O
83,of,O
83,these,O
83,were,O
83,previously,O
83,unidentified,O
83,in,O
83,mutant,B-cell_line
83,cell,I-cell_line
83,lines,I-cell_line
83,generated,O
83,in,O
83,vitro,O
83,.,O
,,
84,In,O
84,addition,O
84,",",O
84,we,O
84,report,O
84,the,O
84,identification,O
84,of,O
84,two,O
84,discrete,O
84,complexes,O
84,",",O
84,NFX1.1,B-protein
84,and,O
84,NFX1.2,B-protein
84,",",O
84,that,O
84,bind,O
84,to,O
84,the,O
84,DRA,B-DNA
84,X,I-DNA
84,consensus,I-DNA
84,element,I-DNA
84,.,O
,,
85,Though,O
85,the,O
85,mutation,O
85,in,O
85,at,O
85,least,O
85,one,O
85,mutant,B-cell_line
85,line,I-cell_line
85,generated,O
85,in,O
85,vitro,O
85,(,O
85,RJ2.2.5,B-cell_line
85,),O
85,affects,O
85,products,O
85,functioning,O
85,via,O
85,interaction,O
85,with,O
85,the,O
85,X,B-DNA
85,box,I-DNA
85,",",O
85,clear,O
85,alterations,O
85,in,O
85,either,O
85,NFX1.1,B-protein
85,or,O
85,NFX1.2,B-protein
85,are,O
85,not,O
85,found,O
85,in,O
85,any,O
85,of,O
85,the,O
85,mutant,B-cell_line
85,cell,I-cell_line
85,lines,I-cell_line
85,.,O
,,
86,In,O
86,vivo,O
86,responsiveness,O
86,to,O
86,glucocorticoid,O
86,correlated,O
86,with,O
86,glucocorticoid,B-protein
86,receptor,I-protein
86,content,O
86,in,O
86,peripheral,B-cell_type
86,blood,I-cell_type
86,leukocytes,I-cell_type
86,in,O
86,normal,O
86,humans,O
86,.,O
,,
87,Dexamethasone,O
87,loading,O
87,tests,O
87,(,O
87,0.1,O
87,mg,O
87,dexamethasone/kg,O
87,",",O
87,iv,O
87,),O
87,were,O
87,performed,O
87,in,O
87,18,O
87,normal,O
87,males,O
87,to,O
87,evaluate,O
87,the,O
87,individual,O
87,responsiveness,O
87,to,O
87,glucocorticoid,O
87,.,O
,,
88,There,O
88,were,O
88,inter-individual,O
88,differences,O
88,in,O
88,increase,O
88,in,O
88,peripheral,B-cell_type
88,blood,I-cell_type
88,polymorphonuclear,I-cell_type
88,leukocyte,I-cell_type
88,count,O
88,",",O
88,decrease,O
88,in,O
88,peripheral,B-cell_type
88,blood,I-cell_type
88,lymphocyte,I-cell_type
88,count,O
88,",",O
88,and,O
88,increase,O
88,in,O
88,plasma,O
88,free,O
88,fatty,O
88,acids,O
88,levels,O
88,after,O
88,dexamethasone,O
88,injection,O
88,.,O
,,
89,In,O
89,addition,O
89,",",O
89,there,O
89,was,O
89,a,O
89,significant,O
89,correlation,O
89,between,O
89,the,O
89,maximum,O
89,increase,O
89,in,O
89,polymorphonuclear,B-cell_type
89,leukocytes,I-cell_type
89,and,O
89,the,O
89,maximum,O
89,decrease,O
89,in,O
89,lymphocytes,B-cell_type
89,(,O
89,r,O
89,=,O
89,0.7514,O
89,",",O
89,p,O
89,less,O
89,than,O
89,0.0003,O
89,),O
89,.,O
,,
90,Simultaneous,O
90,measurements,O
90,of,O
90,glucocorticoid,B-protein
90,receptor,I-protein
90,content,O
90,by,O
90,whole-cell,O
90,assay,O
90,revealed,O
90,that,O
90,glucocorticoid,B-protein
90,receptor,I-protein
90,content,O
90,in,O
90,polymorphonuclear,B-cell_type
90,leukocytes,I-cell_type
90,linearly,O
90,correlated,O
90,with,O
90,that,O
90,in,O
90,the,O
90,corresponding,O
90,lymphocytes,B-cell_type
90,(,O
90,r,O
90,=,O
90,0.9482,O
90,",",O
90,p,O
90,less,O
90,than,O
90,0.0001,O
90,),O
90,.,O
,,
91,There,O
91,were,O
91,also,O
91,significant,O
91,correlations,O
91,between,O
91,the,O
91,maximum,O
91,increase,O
91,in,O
91,polymorphonuclear,B-cell_type
91,leukocytes,I-cell_type
91,and,O
91,glucocorticoid,B-protein
91,receptor,I-protein
91,content,O
91,in,O
91,polymorphonuclear,B-cell_type
91,leukocytes,I-cell_type
91,(,O
91,r,O
91,=,O
91,0.7239,O
91,",",O
91,p,O
91,less,O
91,than,O
91,0.0007,O
91,),O
91,",",O
91,and,O
91,between,O
91,the,O
91,maximum,O
91,decrease,O
91,in,O
91,lymphocytes,B-cell_type
91,and,O
91,glucocorticoid,B-protein
91,receptor,I-protein
91,content,O
91,in,O
91,lymphocytes,B-cell_type
91,(,O
91,r,O
91,=,O
91,0.7703,O
91,",",O
91,p,O
91,less,O
91,than,O
91,0.0002,O
91,),O
91,.,O
,,
92,These,O
92,results,O
92,suggest,O
92,that,O
92,individual,O
92,differences,O
92,are,O
92,preserved,O
92,both,O
92,in,O
92,glucocorticoid,O
92,responsiveness,O
92,and,O
92,in,O
92,glucocorticoid,B-protein
92,receptor,I-protein
92,content,O
92,in,O
92,peripheral,B-cell_type
92,blood,I-cell_type
92,leukocytes,I-cell_type
92,in,O
92,normal,O
92,humans,O
92,.,O
,,
93,Estradiol,O
93,receptors,O
93,in,O
93,the,O
93,cytosol,O
93,of,O
93,peripheral,B-cell_type
93,blood,I-cell_type
93,mononuclear,I-cell_type
93,cells,I-cell_type
93,in,O
93,hepatitis,O
93,B,O
93,virus,O
93,carriers,O
93,treated,O
93,with,O
93,interferon-alpha,B-protein
93,.,O
,,
94,Estradiol,B-protein
94,receptors,I-protein
94,in,O
94,the,O
94,cytosol,O
94,of,O
94,peripheral,B-cell_type
94,blood,I-cell_type
94,mononuclear,I-cell_type
94,cells,I-cell_type
94,and,O
94,the,O
94,effects,O
94,of,O
94,interferon-alpha,B-protein
94,(,O
94,IFN-alpha,B-protein
94,),O
94,on,O
94,estradiol,B-protein
94,receptors,I-protein
94,were,O
94,studied,O
94,in,O
94,asymptomatic,O
94,hepatitis,O
94,B,O
94,virus,O
94,(,O
94,HBV,O
94,),O
94,carriers,O
94,",",O
94,patients,O
94,with,O
94,chronic,O
94,hepatitis,O
94,B,O
94,and,O
94,normal,O
94,controls,O
94,.,O
,,
95,The,O
95,level,O
95,of,O
95,estradiol,B-protein
95,receptors,I-protein
95,in,O
95,the,O
95,cytosol,O
95,of,O
95,mononuclear,B-cell_type
95,cells,I-cell_type
95,was,O
95,significantly,O
95,lower,O
95,in,O
95,asymptomatic,O
95,HBV,O
95,carriers,O
95,and,O
95,patients,O
95,with,O
95,chronic,O
95,hepatitis,O
95,B,O
95,",",O
95,compared,O
95,to,O
95,normal,O
95,controls,O
95,.,O
,,
96,This,O
96,low,O
96,level,O
96,of,O
96,cytosol,O
96,estradiol,B-protein
96,receptors,I-protein
96,in,O
96,patients,O
96,with,O
96,chronic,O
96,hepatitis,O
96,B,O
96,was,O
96,increased,O
96,by,O
96,the,O
96,administration,O
96,of,O
96,IFN-alpha,B-protein
96,.,O
,,
97,In,O
97,addition,O
97,",",O
97,when,O
97,peripheral,B-cell_type
97,blood,I-cell_type
97,mononuclear,I-cell_type
97,cells,I-cell_type
97,from,O
97,patients,O
97,with,O
97,chronic,O
97,hepatitis,O
97,B,O
97,were,O
97,incubated,O
97,with,O
97,IFN-alpha,B-protein
97,in,O
97,vitro,O
97,",",O
97,the,O
97,level,O
97,of,O
97,cytosol,O
97,estradiol,B-protein
97,receptors,I-protein
97,also,O
97,increased,O
97,by,O
97,increasing,O
97,the,O
97,concentration,O
97,of,O
97,IFN-alpha,B-protein
97,.,O
,,
98,We,O
98,previously,O
98,reported,O
98,that,O
98,the,O
98,response,O
98,of,O
98,mononuclear,B-cell_type
98,cells,I-cell_type
98,to,O
98,estrogen,O
98,is,O
98,impaired,O
98,in,O
98,HBV,O
98,carriers,O
98,",",O
98,and,O
98,our,O
98,present,O
98,results,O
98,suggested,O
98,that,O
98,this,O
98,may,O
98,be,O
98,due,O
98,to,O
98,the,O
98,low,O
98,level,O
98,of,O
98,estradiol,B-protein
98,receptors,I-protein
98,in,O
98,the,O
98,cytosol,O
98,of,O
98,mononuclear,B-cell_type
98,cells,I-cell_type
98,.,O
,,
99,Association,O
99,of,O
99,increased,O
99,lytic,O
99,effector,O
99,cell,O
99,function,O
99,with,O
99,high,O
99,estrogen,B-protein
99,receptor,I-protein
99,levels,O
99,in,O
99,tumor-bearing,O
99,patients,O
99,with,O
99,breast,O
99,cancer,O
99,.,O
,,
100,Tumor-bearing,O
100,patients,O
100,with,O
100,breast,O
100,cancer,O
100,were,O
100,assayed,O
100,for,O
100,their,O
100,natural,B-cell_type
100,killer,I-cell_type
100,(,I-cell_type
100,NK,I-cell_type
100,),I-cell_type
100,cell,I-cell_type
100,activity,O
100,and,O
100,for,O
100,the,O
100,function,O
100,of,O
100,activated,O
100,cytotoxic,B-cell_type
100,T-cells,I-cell_type
100,",",O
100,as,O
100,assessed,O
100,by,O
100,lectin-dependent,O
100,cellular,O
100,cytotoxicity,O
100,(,O
100,LDCC,O
100,),O
100,.,O
,,
101,Tumor-bearing,O
101,patients,O
101,with,O
101,breast,O
101,cancer,O
101,had,O
101,a,O
101,significant,O
101,increase,O
101,in,O
101,NK,B-cell_type
101,activity,O
101,and,O
101,in,O
101,LDCC,O
101,",",O
101,as,O
101,compared,O
101,with,O
101,healthy,O
101,control,O
101,individuals,O
101,.,O
,,
102,Although,O
102,the,O
102,enhanced,O
102,NK,B-cell_type
102,cell,I-cell_type
102,activity,O
102,and,O
102,LDCC,O
102,were,O
102,closely,O
102,associated,O
102,with,O
102,high,O
102,levels,O
102,(,O
102,greater,O
102,than,O
102,31,O
102,fmol/mg,O
102,),O
102,of,O
102,estrogen,B-protein
102,receptor,I-protein
102,(,O
102,ER,B-protein
102,),O
102,content,O
102,in,O
102,the,O
102,primary,O
102,tumor,O
102,",",O
102,no,O
102,other,O
102,clinical,O
102,or,O
102,histologic,O
102,correlation,O
102,between,O
102,the,O
102,increase,O
102,in,O
102,either,O
102,parameter,O
102,of,O
102,cytotoxic,B-cell_type
102,effector,I-cell_type
102,cell,I-cell_type
102,function,O
102,could,O
102,be,O
102,found,O
102,.,O
,,
103,Thus,O
103,",",O
103,ER,B-protein
103,levels,O
103,greater,O
103,than,O
103,31,O
103,fmol/mg,O
103,might,O
103,be,O
103,associated,O
103,with,O
103,increased,O
103,cytotoxic,B-cell_type
103,effector,I-cell_type
103,cell,I-cell_type
103,function,O
103,in,O
103,tumor-bearing,O
103,patients,O
103,with,O
103,breast,O
103,cancer,O
103,.,O
,,
104,Properties,O
104,of,O
104,glucocorticoid,B-protein
104,receptors,I-protein
104,in,O
104,Epstein-Barr,B-cell_line
104,virus-transformed,I-cell_line
104,lymphocytes,I-cell_line
104,from,O
104,patients,O
104,with,O
104,familial,O
104,cortisol,O
104,resistance,O
104,.,O
,,
105,In,O
105,a,O
105,previous,O
105,report,O
105,of,O
105,two,O
105,patients,O
105,with,O
105,familial,O
105,glucocorticoid,O
105,resistance,O
105,due,O
105,to,O
105,reduced,O
105,numbers,O
105,of,O
105,glucocorticoid,B-protein
105,receptors,I-protein
105,(,O
105,GR,B-protein
105,),O
105,",",O
105,we,O
105,have,O
105,shown,O
105,decreased,O
105,numbers,O
105,of,O
105,GR,B-protein
105,in,O
105,peripheral,B-cell_type
105,mononuclear,I-cell_type
105,cells,I-cell_type
105,and,O
105,cultured,B-cell_line
105,fibroblasts,I-cell_line
105,but,O
105,normal,O
105,affinity,O
105,of,O
105,GR,B-protein
105,in,O
105,both,O
105,patients,O
105,.,O
,,
106,In,O
106,this,O
106,study,O
106,",",O
106,peripheral,B-cell_type
106,lymphocytes,I-cell_type
106,from,O
106,these,O
106,patients,O
106,",",O
106,one,O
106,patient,O
106,'s,O
106,son,O
106,and,O
106,daughter,O
106,",",O
106,and,O
106,normal,O
106,subjects,O
106,were,O
106,transformed,O
106,with,O
106,Epstein-Barr,O
106,virus,O
106,.,O
,,
107,Reduced,O
107,numbers,O
107,and,O
107,normal,O
107,affinity,O
107,of,O
107,GR,B-protein
107,were,O
107,found,O
107,in,O
107,the,O
107,Epstein-Barr,B-cell_line
107,virus-transformed,I-cell_line
107,lymphocytes,I-cell_line
107,from,O
107,both,O
107,patients,O
107,while,O
107,the,O
107,son,O
107,and,O
107,daughter,O
107,had,O
107,normal,O
107,numbers,O
107,and,O
107,affinity,O
107,of,O
107,GR,B-protein
107,.,O
,,
108,The,O
108,thermal,O
108,stability,O
108,of,O
108,GR,B-protein
108,and,O
108,thermal,O
108,activation,O
108,of,O
108,cytosolic,B-protein
108,receptors,I-protein
108,in,O
108,both,O
108,patients,O
108,were,O
108,found,O
108,to,O
108,be,O
108,normal,O
108,.,O
,,
109,Although,O
109,the,O
109,percentages,O
109,of,O
109,nuclear,O
109,bound,O
109,GR,B-protein
109,were,O
109,similar,O
109,in,O
109,both,O
109,patients,O
109,and,O
109,normal,O
109,controls,O
109,",",O
109,the,O
109,absolute,O
109,amounts,O
109,of,O
109,nuclear,O
109,bound,O
109,GR,B-protein
109,of,O
109,the,O
109,patients,O
109,were,O
109,about,O
109,one-half,O
109,that,O
109,of,O
109,normal,O
109,controls,O
109,.,O
,,
110,These,O
110,abnormal,O
110,properties,O
110,of,O
110,GR,B-protein
110,(,O
110,reduced,O
110,numbers,O
110,of,O
110,GR,B-protein
110,),O
110,were,O
110,preserved,O
110,in,O
110,the,O
110,transformed,B-cell_line
110,cells,I-cell_line
110,from,O
110,the,O
110,patients,O
110,.,O
,,
111,Octamer,O
111,transcription,O
111,factors,O
111,1,O
111,and,O
111,2,O
111,each,O
111,bind,O
111,to,O
111,two,O
111,different,O
111,functional,B-DNA
111,elements,I-DNA
111,in,O
111,the,O
111,immunoglobulin,B-DNA
111,heavy-chain,I-DNA
111,promoter,I-DNA
111,.,O
,,
112,Immunoglobulin,B-DNA
112,heavy-chain,I-DNA
112,genes,I-DNA
112,contain,O
112,two,O
112,conserved,B-DNA
112,sequence,I-DNA
112,elements,I-DNA
112,5,O
112,',O
112,to,O
112,the,O
112,site,O
112,of,O
112,transcription,O
112,initiation,O
112,:,O
112,the,O
112,octamer,O
112,ATGCAAAT,O
112,and,O
112,the,O
112,heptamer,O
112,CTCATGA,O
112,.,O
,,
113,Both,O
113,of,O
113,these,O
113,elements,O
113,are,O
113,required,O
113,for,O
113,normal,B-DNA
113,cell-specific,I-DNA
113,promoter,I-DNA
113,function,O
113,.,O
,,
114,The,O
114,present,O
114,study,O
114,demonstrates,O
114,that,O
114,both,O
114,the,O
114,ubiquitous,B-protein
114,and,I-protein
114,lymphoid-cell-specific,I-protein
114,octamer,I-protein
114,transcription,I-protein
114,factors,I-protein
114,(,O
114,OTF-1,B-protein
114,and,O
114,OTF-2,B-protein
114,",",O
114,respectively,O
114,),O
114,interact,O
114,specifically,O
114,with,O
114,each,O
114,of,O
114,the,O
114,two,O
114,conserved,B-DNA
114,sequence,I-DNA
114,elements,I-DNA
114,",",O
114,forming,O
114,either,O
114,homo-,B-protein
114,or,I-protein
114,heterodimeric,I-protein
114,complexes,I-protein
114,.,O
,,
115,This,O
115,was,O
115,surprising,O
115,",",O
115,since,O
115,the,O
115,heptamer,O
115,and,O
115,octamer,O
115,sequence,O
115,motifs,O
115,bear,O
115,no,O
115,obvious,O
115,similarity,O
115,to,O
115,each,O
115,other,O
115,.,O
,,
116,Binding,O
116,of,O
116,either,O
116,factor,O
116,to,O
116,the,O
116,octamer,B-DNA
116,element,I-DNA
116,occurred,O
116,independently,O
116,.,O
,,
117,However,O
117,",",O
117,OTF,B-protein
117,interaction,O
117,with,O
117,the,O
117,heptamer,B-DNA
117,sequence,I-DNA
117,appeared,O
117,to,O
117,require,O
117,the,O
117,presence,O
117,of,O
117,an,O
117,intact,O
117,octamer,O
117,motif,O
117,and,O
117,occurred,O
117,with,O
117,a,O
117,spacing,O
117,of,O
117,either,O
117,2,B-DNA
117,or,I-DNA
117,14,I-DNA
117,base,I-DNA
117,pairs,I-DNA
117,between,O
117,the,O
117,two,O
117,elements,O
117,",",O
117,suggesting,O
117,coordinate,O
117,binding,O
117,resulting,O
117,from,O
117,protein-protein,O
117,interactions,O
117,.,O
,,
118,The,O
118,degeneracy,O
118,in,O
118,sequences,O
118,recognized,O
118,by,O
118,the,O
118,OTFs,B-protein
118,may,O
118,be,O
118,important,O
118,in,O
118,widening,O
118,the,O
118,range,O
118,over,O
118,which,O
118,gene,O
118,expression,O
118,can,O
118,be,O
118,modulated,O
118,and,O
118,in,O
118,establishing,O
118,cell,O
118,type,O
118,specificity,O
118,.,O
,,
119,Identification,O
119,of,O
119,a,O
119,novel,O
119,lymphoid,B-protein
119,specific,I-protein
119,octamer,I-protein
119,binding,I-protein
119,protein,I-protein
119,(,O
119,OTF-2B,B-protein
119,),O
119,by,O
119,proteolytic,O
119,clipping,O
119,bandshift,O
119,assay,O
119,(,O
119,PCBA,O
119,),O
119,.,O
,,
120,The,O
120,octamer,O
120,sequence,O
120,ATGCAAAT,O
120,is,O
120,found,O
120,in,O
120,the,O
120,promoters,O
120,of,O
120,immunoglobulin,B-DNA
120,(,I-DNA
120,Ig,I-DNA
120,),I-DNA
120,heavy,I-DNA
120,and,I-DNA
120,light,I-DNA
120,chain,I-DNA
120,genes,I-DNA
120,and,O
120,in,O
120,the,O
120,heavy,B-DNA
120,chain,I-DNA
120,enhancer,I-DNA
120,and,O
120,is,O
120,a,O
120,major,O
120,determinant,O
120,of,O
120,the,O
120,cell,O
120,type,O
120,specific,O
120,expression,O
120,of,O
120,Ig,B-DNA
120,genes,I-DNA
120,in,O
120,B,B-cell_type
120,cells,I-cell_type
120,.,O
,,
121,An,O
121,apparent,O
121,paradox,O
121,is,O
121,that,O
121,the,O
121,same,O
121,sequence,O
121,serves,O
121,as,O
121,an,O
121,upstream,B-DNA
121,promoter,I-DNA
121,or,I-DNA
121,enhancer,I-DNA
121,element,I-DNA
121,in,O
121,a,O
121,variety,O
121,of,O
121,housekeeping,B-DNA
121,genes,I-DNA
121,such,O
121,as,O
121,the,O
121,histone,B-DNA
121,H2B,I-DNA
121,and,I-DNA
121,U,I-DNA
121,snRNA,I-DNA
121,genes,I-DNA
121,.,O
,,
122,The,O
122,differential,O
122,usage,O
122,of,O
122,this,O
122,regulatory,O
122,sequence,O
122,motif,O
122,is,O
122,thought,O
122,to,O
122,be,O
122,mediated,O
122,by,O
122,different,O
122,species,O
122,of,O
122,octamer,B-protein
122,binding,I-protein
122,proteins,I-protein
122,.,O
,,
123,One,O
123,species,O
123,of,O
123,100,O
123,kd,O
123,",",O
123,designated,O
123,OTF-1,B-protein
123,",",O
123,is,O
123,present,O
123,in,O
123,all,O
123,cell,O
123,types,O
123,and,O
123,may,O
123,exert,O
123,its,O
123,activating,O
123,function,O
123,only,O
123,when,O
123,it,O
123,can,O
123,interact,O
123,with,O
123,additional,O
123,adjacent,O
123,transcription,B-protein
123,factors,I-protein
123,.,O
,,
124,The,O
124,lymphoid,B-protein
124,cell,I-protein
124,specific,I-protein
124,octamer,I-protein
124,binding,I-protein
124,protein,I-protein
124,of,O
124,60,O
124,kd,O
124,(,O
124,OTF-2A,B-protein
124,),O
124,specifically,O
124,stimulates,O
124,Ig,B-DNA
124,promoters,I-DNA
124,which,O
124,consist,O
124,essentially,O
124,of,O
124,a,O
124,TATA-box,B-DNA
124,and,O
124,an,O
124,octamer,B-DNA
124,sequence,I-DNA
124,upstream,O
124,of,O
124,it,O
124,.,O
,,
125,Here,O
125,we,O
125,present,O
125,evidence,O
125,for,O
125,yet,O
125,another,O
125,B,B-protein
125,cell,I-protein
125,specific,I-protein
125,octamer,I-protein
125,binding,I-protein
125,protein,I-protein
125,of,O
125,75,O
125,kd,O
125,(,O
125,OTF-2B,B-protein
125,),O
125,.,O
,,
126,From,O
126,several,O
126,findings,O
126,",",O
126,including,O
126,the,O
126,absence,O
126,of,O
126,OTF-2B,B-protein
126,(,O
126,but,O
126,not,O
126,OTF-2A,B-protein
126,),O
126,from,O
126,a,O
126,lymphocyte,B-cell_line
126,line,I-cell_line
126,that,O
126,can,O
126,not,O
126,respond,O
126,to,O
126,the,O
126,IgH,B-DNA
126,enhancer,I-DNA
126,",",O
126,we,O
126,propose,O
126,a,O
126,role,O
126,of,O
126,the,O
126,novel,B-protein
126,octamer,I-protein
126,factor,I-protein
126,in,O
126,the,O
126,long,O
126,range,O
126,activation,O
126,by,O
126,the,O
126,IgH,B-DNA
126,enhancer,I-DNA
126,.,O
,,
127,We,O
127,have,O
127,used,O
127,the,O
127,proteolytic,O
127,clipping,O
127,bandshift,O
127,assay,O
127,(,O
127,PCBA,O
127,),O
127,technique,O
127,to,O
127,distinguish,O
127,the,O
127,three,O
127,different,O
127,forms,O
127,found,O
127,in,O
127,B,B-cell_type
127,cells,I-cell_type
127,.,O
,,
128,This,O
128,analysis,O
128,indicates,O
128,that,O
128,the,O
128,75,O
128,kd-species,O
128,OTF-2B,B-protein
128,is,O
128,closely,O
128,related,O
128,to,O
128,the,O
128,60,B-protein
128,kd,I-protein
128,species,I-protein
128,OTF-2A,I-protein
128,.,O
,,
129,Inhibition,O
129,of,O
129,interleukin,B-protein
129,2,I-protein
129,induced,O
129,proliferation,O
129,of,O
129,cloned,B-cell_line
129,murine,I-cell_line
129,T,I-cell_line
129,cells,I-cell_line
129,by,O
129,glucocorticoids,O
129,.,O
,,
130,Possible,O
130,involvement,O
130,of,O
130,an,O
130,inhibitory,B-protein
130,protein,I-protein
130,.,O
,,
131,The,O
131,ability,O
131,of,O
131,glucocorticoids,O
131,to,O
131,inhibit,O
131,interleukin,B-protein
131,2,I-protein
131,(,O
131,IL,B-protein
131,2,I-protein
131,),O
131,induced,O
131,T,B-cell_type
131,cell,I-cell_type
131,proliferation,O
131,in,O
131,two,O
131,cytotoxic,B-cell_line
131,T,I-cell_line
131,cell,I-cell_line
131,(,I-cell_line
131,CTL,I-cell_line
131,),I-cell_line
131,clones,I-cell_line
131,has,O
131,been,O
131,studied,O
131,.,O
,,
132,A,O
132,complete,O
132,inhibition,O
132,of,O
132,DNA,O
132,synthesis,O
132,by,O
132,dexamethasone,O
132,(,O
132,Dx,O
132,),O
132,could,O
132,be,O
132,observed,O
132,when,O
132,IL,B-cell_line
132,2-depleted,I-cell_line
132,cultures,I-cell_line
132,of,O
132,CTL,B-cell_line
132,were,O
132,either,O
132,incubated,O
132,for,O
132,6,O
132,h,O
132,with,O
132,the,O
132,hormone,B-protein
132,prior,O
132,to,O
132,the,O
132,addition,O
132,of,O
132,IL,B-protein
132,2,I-protein
132,or,O
132,treated,O
132,simultaneously,O
132,with,O
132,Dx,O
132,and,O
132,a,O
132,low,O
132,concentration,O
132,of,O
132,IL,B-protein
132,2,I-protein
132,.,O
,,
133,No,O
133,significant,O
133,reduction,O
133,in,O
133,the,O
133,number,O
133,and,O
133,affinity,O
133,of,O
133,IL,B-protein
133,2,I-protein
133,receptors,I-protein
133,was,O
133,seen,O
133,after,O
133,6,O
133,h,O
133,incubation,O
133,with,O
133,Dx,O
133,.,O
,,
134,The,O
134,order,O
134,of,O
134,potency,O
134,observed,O
134,with,O
134,the,O
134,different,O
134,steroids,O
134,indicated,O
134,that,O
134,this,O
134,inhibitory,O
134,effect,O
134,was,O
134,mediated,O
134,through,O
134,binding,O
134,to,O
134,a,O
134,specific,O
134,glucocorticoid,B-protein
134,receptor,I-protein
134,.,O
,,
135,The,O
135,action,O
135,of,O
135,these,O
135,hormones,B-protein
135,possibly,O
135,involves,O
135,the,O
135,synthesis,O
135,of,O
135,an,O
135,inhibitory,B-protein
135,protein,I-protein
135,(,O
135,s,O
135,),O
135,",",O
135,since,O
135,the,O
135,presence,O
135,of,O
135,cycloheximide,O
135,during,O
135,the,O
135,incubation,O
135,with,O
135,Dx,O
135,prevented,O
135,the,O
135,inhibition,O
135,of,O
135,DNA,O
135,synthesis,O
135,.,O
,,
136,Furthermore,O
136,",",O
136,supernatant,O
136,from,O
136,Dx-treated,O
136,CTL,B-cell_line
136,contained,O
136,a,O
136,nondialyzable,O
136,factor,O
136,which,O
136,inhibited,O
136,DNA,O
136,synthesis,O
136,and,O
136,cell,O
136,growth,O
136,of,O
136,CTL,B-cell_line
136,clones,I-cell_line
136,induced,O
136,by,O
136,IL,B-protein
136,2,I-protein
136,.,O
,,
137,Blocking,O
137,of,O
137,IL,B-protein
137,2,I-protein
137,synthesis,O
137,and,O
137,IL,B-protein
137,2,I-protein
137,receptor,I-protein
137,formation,O
137,have,O
137,been,O
137,proposed,O
137,as,O
137,one,O
137,of,O
137,the,O
137,major,O
137,mechanisms,O
137,of,O
137,glucocorticoid-induced,O
137,immunosuppression,O
137,.,O
,,
138,Our,O
138,results,O
138,indicate,O
138,that,O
138,these,O
138,hormones,B-protein
138,may,O
138,also,O
138,affect,O
138,T,B-cell_type
138,cell,I-cell_type
138,proliferation,O
138,by,O
138,inhibiting,O
138,IL,B-protein
138,2,I-protein
138,activity,O
138,.,O
,,
139,Identification,O
139,and,O
139,purification,O
139,of,O
139,a,O
139,human,B-protein
139,immunoglobulin-enhancer-binding,I-protein
139,protein,I-protein
139,(,O
139,NF-kappa,B-protein
139,B,I-protein
139,),O
139,that,O
139,activates,O
139,transcription,O
139,from,O
139,a,O
139,human,B-DNA
139,immunodeficiency,I-DNA
139,virus,I-DNA
139,type,I-DNA
139,1,I-DNA
139,promoter,I-DNA
139,in,O
139,vitro,O
139,.,O
,,
140,The,O
140,enhancer-binding,B-protein
140,factor,I-protein
140,NF-kappa,I-protein
140,B,I-protein
140,",",O
140,which,O
140,is,O
140,found,O
140,only,O
140,in,O
140,cells,O
140,that,O
140,transcribe,O
140,immunoglobulin,B-DNA
140,light,I-DNA
140,chain,I-DNA
140,genes,I-DNA
140,",",O
140,has,O
140,been,O
140,purified,O
140,from,O
140,nuclear,O
140,extracts,O
140,of,O
140,Namalwa,B-cell_line
140,cells,I-cell_line
140,(,O
140,human,B-cell_line
140,Burkitt,I-cell_line
140,lymphoma,I-cell_line
140,cells,I-cell_line
140,),O
140,by,O
140,sequence-specific,O
140,DNA,O
140,affinity,O
140,chromatography,O
140,.,O
,,
141,The,O
141,purified,O
141,NF-kappa,B-protein
141,B,I-protein
141,has,O
141,been,O
141,identified,O
141,as,O
141,a,O
141,51-kDa,B-protein
141,polypeptide,I-protein
141,by,O
141,UV-crosslinking,O
141,analysis,O
141,.,O
,,
142,``,O
142,Footprint,O
142,'',O
142,and,O
142,methylation-interference,O
142,analyses,O
142,have,O
142,shown,O
142,that,O
142,purified,O
142,NF-kappa,B-protein
142,B,I-protein
142,has,O
142,a,O
142,binding,O
142,activity,O
142,specific,O
142,for,O
142,the,O
142,kappa,B-DNA
142,light,I-DNA
142,chain,I-DNA
142,enhancer,I-DNA
142,sequence,I-DNA
142,.,O
,,
143,The,O
143,purified,O
143,factor,O
143,activated,O
143,in,O
143,vitro,O
143,transcription,O
143,of,O
143,the,O
143,human,B-DNA
143,immunodeficiency,I-DNA
143,virus,I-DNA
143,type,I-DNA
143,I,I-DNA
143,promoter,I-DNA
143,by,O
143,binding,O
143,to,O
143,an,O
143,upstream,B-DNA
143,NF-kappa,I-DNA
143,B-binding,I-DNA
143,site,I-DNA
,,
144,Lymphocyte,B-cell_type
144,glucocorticoid,B-protein
144,receptor,I-protein
144,binding,O
144,in,O
144,depression,O
144,:,O
144,normal,O
144,values,O
144,following,O
144,recovery,O
144,.,O
,,
145,The,O
145,number,O
145,of,O
145,glucocorticoid,B-protein
145,receptor,I-protein
145,sites,O
145,in,O
145,lymphocytes,B-cell_type
145,and,O
145,plasma,O
145,cortisol,O
145,concentrations,O
145,were,O
145,measured,O
145,in,O
145,20,O
145,patients,O
145,who,O
145,had,O
145,recovered,O
145,from,O
145,major,O
145,depressive,O
145,disorder,O
145,and,O
145,20,O
145,healthy,O
145,control,O
145,subjects,O
145,.,O
,,
146,The,O
146,number,O
146,of,O
146,glucocorticoid,B-protein
146,receptor,I-protein
146,sites,O
146,in,O
146,lymphocytes,B-cell_type
146,from,O
146,the,O
146,recovered,O
146,depressed,O
146,group,O
146,was,O
146,not,O
146,significantly,O
146,different,O
146,from,O
146,that,O
146,of,O
146,the,O
146,control,O
146,group,O
146,.,O
,,
147,Although,O
147,the,O
147,mean,O
147,plasma,O
147,cortisol,O
147,concentration,O
147,in,O
147,recovered,O
147,depressives,O
147,was,O
147,higher,O
147,than,O
147,in,O
147,control,O
147,subjects,O
147,",",O
147,the,O
147,difference,O
147,only,O
147,just,O
147,reached,O
147,significance,O
147,.,O
,,
148,This,O
148,study,O
148,shows,O
148,that,O
148,the,O
148,reduction,O
148,in,O
148,glucocorticoid,B-protein
148,receptor,I-protein
148,numbers,O
148,which,O
148,occurs,O
148,during,O
148,acute,O
148,depressive,O
148,illness,O
148,does,O
148,not,O
148,persist,O
148,on,O
148,recovery,O
148,and,O
148,is,O
148,",",O
148,therefore,O
148,",",O
148,state-dependent,O
148,.,O
,,
149,Identification,O
149,and,O
149,purification,O
149,of,O
149,a,O
149,human,B-protein
149,lymphoid-specific,I-protein
149,octamer-binding,I-protein
149,protein,I-protein
149,(,O
149,OTF-2,B-protein
149,),O
149,that,O
149,activates,O
149,transcription,O
149,of,O
149,an,O
149,immunoglobulin,B-DNA
149,promoter,I-DNA
149,in,O
149,vitro,O
149,.,O
,,
150,The,O
150,octamer,O
150,sequence,O
150,5'-ATGCAAAT,O
150,",",O
150,in,O
150,either,O
150,orientation,O
150,",",O
150,serves,O
150,as,O
150,an,O
150,upstream,B-DNA
150,element,I-DNA
150,in,O
150,a,O
150,variety,O
150,of,O
150,promoters,B-DNA
150,and,O
150,also,O
150,occurs,O
150,as,O
150,a,O
150,modular,B-DNA
150,enhancer,I-DNA
150,element,I-DNA
150,.,O
,,
151,It,O
151,is,O
151,of,O
151,particular,O
151,interest,O
151,in,O
151,immunoglobulin,B-DNA
151,genes,I-DNA
151,since,O
151,it,O
151,is,O
151,found,O
151,in,O
151,the,O
151,upstream,B-DNA
151,regions,I-DNA
151,of,O
151,all,O
151,heavy,B-DNA
151,and,I-DNA
151,light,I-DNA
151,chain,I-DNA
151,promoters,I-DNA
151,and,O
151,in,O
151,the,O
151,heavy,B-DNA
151,chain,I-DNA
151,enhancer,I-DNA
151,",",O
151,both,O
151,of,O
151,which,O
151,are,O
151,known,O
151,to,O
151,be,O
151,necessary,O
151,for,O
151,cell-specific,O
151,expression,O
151,.,O
,,
152,We,O
152,report,O
152,here,O
152,the,O
152,chromatographic,O
152,separation,O
152,of,O
152,ubiquitous,B-protein
152,and,I-protein
152,B,I-protein
152,cell-specific,I-protein
152,octamer-binding,I-protein
152,proteins,I-protein
152,.,O
,,
153,The,O
153,B,B-protein
153,cell,I-protein
153,factor,I-protein
153,was,O
153,purified,O
153,to,O
153,homogeneity,O
153,using,O
153,affinity,O
153,chromatography,O
153,and,O
153,consists,O
153,of,O
153,three,O
153,peptides,O
153,of,O
153,62,O
153,",",O
153,61,O
153,",",O
153,and,O
153,58.5,O
153,+/-,O
153,1.5,O
153,kd,O
153,.,O
,,
154,Each,O
154,of,O
154,the,O
154,polypeptides,O
154,was,O
154,renatured,O
154,after,O
154,SDS-PAGE,O
154,and,O
154,shown,O
154,to,O
154,bind,O
154,to,O
154,the,O
154,octamer,O
154,sequence,O
154,.,O
,,
155,The,O
155,specific,O
155,DNA,O
155,binding,O
155,activity,O
155,of,O
155,the,O
155,pure,O
155,B,B-protein
155,cell-specific,I-protein
155,factor,I-protein
155,was,O
155,indistinguishable,O
155,from,O
155,that,O
155,of,O
155,the,O
155,affinity-purified,B-protein
155,ubiquitous,I-protein
155,factor,I-protein
155,.,O
,,
156,This,O
156,B,B-protein
156,cell-specific,I-protein
156,octamer-binding,I-protein
156,factor,I-protein
156,",",O
156,in,O
156,pure,O
156,form,O
156,",",O
156,activated,O
156,transcription,O
156,from,O
156,a,O
156,kappa,B-DNA
156,light,I-DNA
156,chain,I-DNA
156,promoter,I-DNA
156,in,O
156,vitro,O
156,",",O
156,thus,O
156,demonstrating,O
156,that,O
156,it,O
156,is,O
156,indeed,O
156,a,O
156,B,B-protein
156,cell-specific,I-protein
156,transcription,I-protein
156,factor,I-protein
156,for,O
156,this,O
156,gene,O
156,.,O
,,
157,In,O
157,addition,O
157,to,O
157,the,O
157,ubiquitous,B-protein
157,and,I-protein
157,B,I-protein
157,cell-specific,I-protein
157,octamer-binding,I-protein
157,factors,I-protein
157,",",O
157,we,O
157,identified,O
157,several,O
157,additional,O
157,proteins,O
157,",",O
157,one,O
157,of,O
157,which,O
157,is,O
157,B,B-cell_type
157,cell,I-cell_type
157,specific,O
157,",",O
157,that,O
157,interact,O
157,with,O
157,the,O
157,kappa,B-DNA
157,promoter,I-DNA
157,.,O
,,
158,Decreased,O
158,deoxyribonucleic,O
158,acid,O
158,binding,O
158,of,O
158,glucocorticoid-receptor,B-protein
158,complex,I-protein
158,in,O
158,cultured,O
158,skin,B-cell_line
158,fibroblasts,I-cell_line
158,from,O
158,a,O
158,patient,O
158,with,O
158,the,O
158,glucocorticoid,O
158,resistance,O
158,syndrome,O
158,.,O
,,
159,A,O
159,patient,O
159,with,O
159,the,O
159,syndrome,O
159,of,O
159,glucocorticoid,O
159,resistance,O
159,was,O
159,studied,O
159,.,O
,,
160,A,O
160,27-yr-old,O
160,woman,O
160,initially,O
160,was,O
160,diagnosed,O
160,as,O
160,having,O
160,Cushing,O
160,'s,O
160,disease,O
160,",",O
160,based,O
160,on,O
160,the,O
160,findings,O
160,of,O
160,high,O
160,plasma,O
160,ACTH,O
160,and,O
160,serum,O
160,cortisol,O
160,levels,O
160,",",O
160,increased,O
160,urinary,O
160,cortisol,O
160,secretion,O
160,",",O
160,resistance,O
160,to,O
160,adrenal,O
160,suppression,O
160,with,O
160,dexamethasone,O
160,",",O
160,and,O
160,bilateral,O
160,adrenal,O
160,hyperplasia,O
160,by,O
160,computed,O
160,tomography,O
160,and,O
160,scintigraphy,O
160,of,O
160,the,O
160,adrenal,O
160,glands,O
160,.,O
,,
161,However,O
161,",",O
161,she,O
161,had,O
161,no,O
161,signs,O
161,or,O
161,symptoms,O
161,of,O
161,Cushing,O
161,'s,O
161,syndrome,O
161,.,O
,,
162,During,O
162,a,O
162,5-yr,O
162,follow-up,O
162,",",O
162,no,O
162,clinical,O
162,abnormalities,O
162,developed,O
162,",",O
162,although,O
162,hypercortisolism,O
162,persisted,O
162,.,O
,,
163,End-organ,O
163,resistance,O
163,to,O
163,cortisol,O
163,was,O
163,suspected,O
163,.,O
,,
164,To,O
164,explain,O
164,the,O
164,end-organ,O
164,resistance,O
164,to,O
164,cortisol,O
164,",",O
164,the,O
164,glucocorticoid,B-protein
164,receptors,I-protein
164,(,O
164,GR,B-protein
164,),O
164,in,O
164,peripheral,B-cell_type
164,mononuclear,I-cell_type
164,leukocytes,I-cell_type
164,and,O
164,cultured,B-cell_line
164,skin,I-cell_line
164,fibroblasts,I-cell_line
164,from,O
164,a,O
164,forearm,O
164,skin,O
164,biopsy,O
164,were,O
164,characterized,O
164,and,O
164,compared,O
164,with,O
164,the,O
164,results,O
164,of,O
164,similar,O
164,studies,O
164,in,O
164,normal,O
164,subjects,O
164,.,O
,,
165,The,O
165,patient,O
165,'s,O
165,GR,B-protein
165,in,O
165,whole,O
165,cell,O
165,assays,O
165,had,O
165,an,O
165,increased,O
165,dissociation,O
165,constant,O
165,(,O
165,Kd,O
165,),O
165,.,O
,,
166,In,O
166,the,O
166,cytosol,O
166,of,O
166,cultured,B-cell_line
166,skin,I-cell_line
166,fibroblasts,I-cell_line
166,from,O
166,the,O
166,patient,O
166,",",O
166,there,O
166,was,O
166,also,O
166,decreased,O
166,binding,O
166,capacity,O
166,.,O
,,
167,The,O
167,thermal,O
167,stability,O
167,and,O
167,the,O
167,sedimentation,O
167,coefficient,O
167,in,O
167,a,O
167,sucrose,O
167,density,O
167,gradient,O
167,of,O
167,the,O
167,receptors,O
167,in,O
167,the,O
167,cytosol,O
167,of,O
167,cultured,B-cell_line
167,skin,I-cell_line
167,fibroblasts,I-cell_line
167,from,O
167,the,O
167,patient,O
167,and,O
167,normal,O
167,subjects,O
167,were,O
167,similar,O
167,.,O
,,
168,GR,B-cell_line
168,complex,I-cell_line
168,activation,I-cell_line
168,",",O
168,analyzed,O
168,by,O
168,DEAE-cellulose,B-cell_line
168,chromatography,I-cell_line
168,",",O
168,was,O
168,decreased,O
168,in,O
168,the,O
168,patient,O
168,.,O
,,
169,DNA,B-DNA
169,binding,O
169,of,O
169,the,O
169,GR,B-protein
169,complex,I-protein
169,after,O
169,temperature-induced,O
169,activation,O
169,was,O
169,lower,O
169,in,O
169,the,O
169,patient,O
169,than,O
169,in,O
169,normal,O
169,subjects,O
169,.,O
,,
170,Nuclear,O
170,translocation,O
170,of,O
170,GR,B-protein
170,complexes,I-protein
170,from,O
170,the,O
170,patient,O
170,was,O
170,also,O
170,slightly,O
170,decreased,O
170,.,O
,,
171,These,O
171,results,O
171,suggest,O
171,that,O
171,the,O
171,patient,O
171,'s,O
171,glucocorticoid,O
171,resistance,O
171,was,O
171,due,O
171,to,O
171,a,O
171,decrease,O
171,in,O
171,the,O
171,affinity,O
171,of,O
171,the,O
171,receptor,O
171,for,O
171,glucocorticoids,O
171,and,O
171,a,O
171,decrease,O
171,in,O
171,the,O
171,binding,O
171,of,O
171,the,O
171,GR,B-protein
171,complex,I-protein
171,to,O
171,DNA,B-DNA
171,.,O
,,
172,Granulocyte-macrophage,B-protein
172,colony-stimulating,I-protein
172,factor,I-protein
172,.,O
,,
173,Sensitive,O
173,and,O
173,receptor-mediated,O
173,regulation,O
173,by,O
173,1,O
173,",",O
173,25-dihydroxyvitamin,O
173,D3,O
173,in,O
173,normal,O
173,human,B-cell_type
173,peripheral,I-cell_type
173,blood,I-cell_type
173,lymphocytes,I-cell_type
173,.,O
,,
174,We,O
174,show,O
174,that,O
174,1,O
174,",",O
174,25-dihydroxyvitamin,O
174,D3,O
174,(,O
174,1,O
174,",",O
174,25,O
174,[,O
174,OH,O
174,],O
174,2D3,O
174,),O
174,",",O
174,the,O
174,most,O
174,hormonally,O
174,active,O
174,metabolite,O
174,of,O
174,vitamin,O
174,D3,O
174,",",O
174,modulates,O
174,sensitively,O
174,and,O
174,specifically,O
174,both,O
174,the,O
174,protein,O
174,and,O
174,messenger,B-RNA
174,RNA,I-RNA
174,accumulation,O
174,of,O
174,the,O
174,multilineage,B-protein
174,growth,I-protein
174,factor,I-protein
174,granulocyte-macrophage,B-protein
174,colony-stimulating,I-protein
174,factor,I-protein
174,(,O
174,GM-CSF,B-protein
174,),O
174,.,O
,,
175,The,O
175,regulation,O
175,of,O
175,GM-CSF,B-protein
175,expression,O
175,is,O
175,seen,O
175,in,O
175,both,O
175,normal,B-cell_type
175,human,I-cell_type
175,mitogen-activated,I-cell_type
175,T,I-cell_type
175,lymphocytes,I-cell_type
175,and,O
175,T,B-cell_line
175,lymphocytes,I-cell_line
175,from,I-cell_line
175,a,I-cell_line
175,line,I-cell_line
175,(,I-cell_line
175,S-LB1,I-cell_line
175,),I-cell_line
175,transformed,I-cell_line
175,with,I-cell_line
175,human,I-cell_line
175,T,I-cell_line
175,cell,I-cell_line
175,lymphotropic,I-cell_line
175,virus,I-cell_line
175,1,I-cell_line
175,(,O
175,HTLV-1,O
175,),O
175,.,O
,,
176,In,O
176,contrast,O
176,",",O
176,cells,O
176,from,O
176,a,O
176,HTLV-1,B-cell_line
176,transformed,I-cell_line
176,T,I-cell_line
176,lymphocyte,I-cell_line
176,line,I-cell_line
176,(,O
176,Ab-VDR,B-cell_line
176,),O
176,established,O
176,from,O
176,a,O
176,patient,O
176,with,O
176,vitamin,O
176,D-resistant,O
176,rickets,O
176,type,O
176,II,O
176,with,O
176,undetectable,O
176,1,B-protein
176,",",I-protein
176,25,I-protein
176,(,I-protein
176,OH,I-protein
176,),I-protein
176,2D3,I-protein
176,cellular,I-protein
176,receptors,I-protein
176,are,O
176,resistant,O
176,to,O
176,the,O
176,action,O
176,of,O
176,1,O
176,",",O
176,25,O
176,(,O
176,OH,O
176,),O
176,2D3,O
176,.,O
,,
177,Inhibition,O
177,of,O
177,GM-CSF,B-protein
177,expression,O
177,by,O
177,1,O
177,",",O
177,25,O
177,(,O
177,OH,O
177,),O
177,2D3,O
177,can,O
177,occur,O
177,independently,O
177,of,O
177,interleukin,B-protein
177,2,I-protein
177,regulation,O
177,and,O
177,is,O
177,probably,O
177,mediated,O
177,through,O
177,cellular,B-protein
177,1,I-protein
177,",",I-protein
177,25,I-protein
177,(,I-protein
177,OH,I-protein
177,),I-protein
177,2D3,I-protein
177,receptors,I-protein
177,.,O
,,
178,We,O
178,conclude,O
178,that,O
178,1,O
178,",",O
178,25,O
178,(,O
178,OH,O
178,),O
178,2D3,O
178,may,O
178,be,O
178,important,O
178,in,O
178,the,O
178,physiology,O
178,of,O
178,hematopoiesis,O
178,.,O
,,
179,Altered,O
179,interaction,O
179,between,O
179,triiodothyronine,O
179,and,O
179,its,O
179,nuclear,B-protein
179,receptors,I-protein
179,in,O
179,absence,O
179,of,O
179,cortisol,O
179,:,O
179,a,O
179,proposed,O
179,mechanism,O
179,for,O
179,increased,O
179,thyrotropin,O
179,secretion,O
179,in,O
179,corticosteroid,O
179,deficiency,O
179,states,O
179,.,O
,,
180,Thyroid,O
180,hormones,O
180,occasionally,O
180,appear,O
180,less,O
180,effective,O
180,when,O
180,administered,O
180,alone,O
180,to,O
180,patients,O
180,with,O
180,panhypopituitarism,O
180,",",O
180,and,O
180,manifestations,O
180,suggestive,O
180,of,O
180,hypothyroidism,O
180,have,O
180,been,O
180,reported,O
180,in,O
180,patients,O
180,suffering,O
180,from,O
180,untreated,O
180,Addison,O
180,'s,O
180,disease,O
180,.,O
,,
181,In,O
181,the,O
181,latter,O
181,condition,O
181,",",O
181,thyrotropin,O
181,secretion,O
181,is,O
181,increased,O
181,:,O
181,this,O
181,occurs,O
181,already,O
181,after,O
181,as,O
181,little,O
181,as,O
181,2,O
181,days,O
181,of,O
181,temporary,O
181,withdrawal,O
181,of,O
181,therapy,O
181,with,O
181,substitution,O
181,doses,O
181,of,O
181,corticosteroids,O
181,while,O
181,circulating,O
181,levels,O
181,of,O
181,thyroid,O
181,hormones,O
181,remain,O
181,within,O
181,normal,O
181,limits,O
181,.,O
,,
182,Therefore,O
182,",",O
182,a,O
182,possible,O
182,role,O
182,of,O
182,cortisol,O
182,in,O
182,interaction,O
182,between,O
182,triiodothyronine,O
182,and,O
182,its,O
182,nuclear,B-protein
182,receptors,I-protein
182,was,O
182,examined,O
182,at,O
182,the,O
182,level,O
182,of,O
182,circulating,O
182,lymphocytes,O
182,obtained,O
182,from,O
182,patients,O
182,with,O
182,primary,O
182,or,O
182,secondary,O
182,adrenocortical,O
182,failure,O
182,.,O
,,
183,The,O
183,affinity,O
183,of,O
183,these,O
183,receptors,O
183,was,O
183,found,O
183,to,O
183,be,O
183,decreased,O
183,",",O
183,by,O
183,more,O
183,than,O
183,50,O
183,%,O
183,on,O
183,average,O
183,",",O
183,in,O
183,the,O
183,absence,O
183,of,O
183,cortisol,O
183,treatments,O
183,.,O
,,
184,This,O
184,change,O
184,was,O
184,promptly,O
184,corrected,O
184,upon,O
184,resumption,O
184,of,O
184,therapy,O
184,.,O
,,
185,The,O
185,number,O
185,of,O
185,binding,O
185,sites,O
185,was,O
185,not,O
185,significantly,O
185,modified,O
185,.,O
,,
186,The,O
186,influence,O
186,of,O
186,cortisol,O
186,on,O
186,thyroid,B-protein
186,hormone,I-protein
186,receptors,I-protein
186,discussed,O
186,here,O
186,might,O
186,account,O
186,for,O
186,the,O
186,clinical,O
186,observations,O
186,mentioned,O
186,above,O
186,.,O
,,
187,Inhibition,O
187,by,O
187,cortisol,O
187,of,O
187,human,B-cell_type
187,natural,I-cell_type
187,killer,I-cell_type
187,(,I-cell_type
187,NK,I-cell_type
187,),I-cell_type
187,cell,I-cell_type
187,activity,O
187,.,O
,,
188,The,O
188,effects,O
188,of,O
188,cortisol,O
188,on,O
188,the,O
188,natural,B-cell_type
188,killer,I-cell_type
188,(,O
188,NK,O
188,),O
188,activity,O
188,of,O
188,human,B-cell_type
188,peripheral,I-cell_type
188,blood,I-cell_type
188,mononuclear,I-cell_type
188,(,I-cell_type
188,PBM,I-cell_type
188,),I-cell_type
188,cells,I-cell_type
188,were,O
188,studied,O
188,in,O
188,vitro,O
188,using,O
188,a,O
188,direct,O
188,4-h,O
188,51Cr-release,O
188,assay,O
188,and,O
188,K,B-cell_line
188,562,I-cell_line
188,cell,I-cell_line
188,line,I-cell_line
188,as,O
188,a,O
188,target,O
188,.,O
,,
189,Preincubation,O
189,for,O
189,20,O
189,h,O
189,of,O
189,PBM,B-cell_type
189,cells,I-cell_type
189,drawn,O
189,from,O
189,healthy,O
189,donors,O
189,with,O
189,1,O
189,X,O
189,10,O
189,(,O
189,-8,O
189,),O
189,to,O
189,1,O
189,X,O
189,10,O
189,(,O
189,-5,O
189,),O
189,M,O
189,cortisol,O
189,resulted,O
189,in,O
189,a,O
189,significant,O
189,decrease,O
189,of,O
189,NK,B-cell_type
189,cell,I-cell_type
189,activity,O
189,.,O
,,
190,The,O
190,magnitude,O
190,of,O
190,the,O
190,suppression,O
190,was,O
190,directly,O
190,related,O
190,to,O
190,the,O
190,steroid,O
190,concentration,O
190,and,O
190,inversely,O
190,related,O
190,to,O
190,the,O
190,number,O
190,of,O
190,effector,B-cell_type
190,cells,I-cell_type
190,.,O
,,
191,Cortisol,O
191,was,O
191,able,O
191,to,O
191,minimize,O
191,the,O
191,enhancement,O
191,of,O
191,NK,O
191,cytotoxicity,O
191,obtainable,O
191,in,O
191,the,O
191,presence,O
191,of,O
191,immune,O
191,interferon,O
191,(,O
191,IFN-gamma,O
191,),O
191,.,O
,,
192,A,O
192,significantly,O
192,higher,O
192,suppression,O
192,was,O
192,achieved,O
192,after,O
192,sequential,O
192,exposure,O
192,of,O
192,PBM,B-cell_type
192,cells,I-cell_type
192,to,O
192,cortisol,O
192,and,O
192,equimolar,O
192,levels,O
192,of,O
192,prostaglandin,O
192,E2,O
192,(,O
192,PgE2,O
192,),O
192,.,O
,,
193,The,O
193,concomitant,O
193,incubation,O
193,with,O
193,theophylline,O
193,and,O
193,isobutyl-methylxanthine,O
193,failed,O
193,to,O
193,enhance,O
193,the,O
193,cortisol-induced,O
193,suppression,O
193,",",O
193,whereas,O
193,PgE2-dependent,O
193,inhibition,O
193,significantly,O
193,increased,O
193,after,O
193,exposure,O
193,of,O
193,PBM,B-cell_type
193,cells,I-cell_type
193,to,O
193,methyl-xanthines,O
193,.,O
,,
194,The,O
194,inhibitory,O
194,effect,O
194,of,O
194,cortisol,O
194,was,O
194,partially,O
194,or,O
194,totally,O
194,prevented,O
194,by,O
194,the,O
194,concomitant,O
194,incubation,O
194,with,O
194,equimolar,O
194,amounts,O
194,of,O
194,11-deoxycortisol,O
194,and,O
194,RU,O
194,486,O
194,but,O
194,not,O
194,of,O
194,progesterone,O
194,.,O
,,
195,Treatment,O
195,of,O
195,NK,B-cell_type
195,effectors,I-cell_type
195,with,O
195,a,O
195,monoclonal,B-protein
195,anti-human,I-protein
195,corticosteroid-binding,I-protein
195,globulin,I-protein
195,(,I-protein
195,CBG,I-protein
195,),I-protein
195,antibody,I-protein
195,produced,O
195,an,O
195,enhancement,O
195,of,O
195,the,O
195,spontaneous,O
195,NK,B-cell_type
195,activity,O
195,and,O
195,a,O
195,partial,O
195,suppression,O
195,of,O
195,cortisol-mediated,O
195,effects,O
195,.,O
,,
196,Our,O
196,results,O
196,suggest,O
196,that,O
196,endogenous,O
196,glucocorticoids,O
196,play,O
196,a,O
196,role,O
196,in,O
196,the,O
196,regulation,O
196,of,O
196,NK,O
196,cell-mediated,O
196,cytotoxicity,O
196,.,O
,,
197,Since,O
197,the,O
197,effect,O
197,of,O
197,cortisol,O
197,was,O
197,additive,O
197,to,O
197,that,O
197,of,O
197,PgE2,O
197,and,O
197,was,O
197,not,O
197,changed,O
197,by,O
197,phosphodiesterase,B-protein
197,inhibitors,O
197,",",O
197,it,O
197,is,O
197,conceivable,O
197,that,O
197,the,O
197,hormone,O
197,acts,O
197,at,O
197,a,O
197,level,O
197,different,O
197,from,O
197,the,O
197,adenylate,B-protein
197,cyclase,I-protein
197,-,O
197,phosphodiesterase,B-protein
197,system,O
197,.,O
,,
198,Data,O
198,obtained,O
198,with,O
198,the,O
198,use,O
198,of,O
198,antiglucocorticoids,O
198,and,O
198,the,O
198,anti-CBG,B-protein
198,antibody,I-protein
198,are,O
198,compatible,O
198,with,O
198,a,O
198,role,O
198,both,O
198,of,O
198,high-affinity,O
198,glucocorticoid,B-protein
198,receptors,I-protein
198,and,O
198,of,O
198,CBG,B-protein
198,in,O
198,mediating,O
198,cortisol,O
198,action,O
198,on,O
198,the,O
198,human,B-cell_type
198,NK,I-cell_type
198,cell,I-cell_type
198,activity,O
198,.,O
,,
199,Interaction,O
199,of,O
199,cell-type-specific,B-protein
199,nuclear,I-protein
199,proteins,I-protein
199,with,O
199,immunoglobulin,B-DNA
199,VH,I-DNA
199,promoter,I-DNA
199,region,I-DNA
199,sequences,I-DNA
199,.,O
,,
200,All,O
200,human,B-DNA
200,and,I-DNA
200,murine,I-DNA
200,immunoglobulin,I-DNA
200,heavy,I-DNA
200,chain,I-DNA
200,variable,I-DNA
200,region,I-DNA
200,(,I-DNA
200,VH,I-DNA
200,),I-DNA
200,genes,I-DNA
200,contain,O
200,the,O
200,sequence,O
200,ATGCAAAT,O
200,approximately,O
200,70,O
200,nucleotides,O
200,5,O
200,',O
200,from,O
200,the,O
200,site,O
200,of,O
200,transcription,O
200,initiation,O
200,.,O
,,
201,This,O
201,octanucleotide,O
201,",",O
201,in,O
201,reverse,O
201,orientation,O
201,",",O
201,is,O
201,also,O
201,found,O
201,in,O
201,all,O
201,light,B-DNA
201,chain,I-DNA
201,variable,I-DNA
201,region,I-DNA
201,(,I-DNA
201,VL,I-DNA
201,),I-DNA
201,genes,I-DNA
201,",",O
201,and,O
201,in,O
201,the,O
201,immunoglobulin,B-DNA
201,heavy,I-DNA
201,chain,I-DNA
201,transcriptional,I-DNA
201,enhancer,I-DNA
201,.,O
,,
202,Transfection,O
202,studies,O
202,have,O
202,established,O
202,that,O
202,this,O
202,octamer,O
202,is,O
202,involved,O
202,in,O
202,the,O
202,lymphoid-specific,O
202,transcription,O
202,of,O
202,immunoglobulin,B-DNA
202,genes,I-DNA
202,.,O
,,
203,Octamer-containing,B-DNA
203,fragments,I-DNA
203,have,O
203,been,O
203,reported,O
203,to,O
203,bind,O
203,a,O
203,factor,O
203,present,O
203,in,O
203,nuclear,O
203,extracts,O
203,of,O
203,human,B-cell_line
203,cell,I-cell_line
203,lines,I-cell_line
203,;,O
203,however,O
203,",",O
203,identical,O
203,binding,O
203,activity,O
203,was,O
203,detected,O
203,in,O
203,both,O
203,B,B-cell_line
203,lymphoid,I-cell_line
203,and,I-cell_line
203,non-lymphoid,I-cell_line
203,cells,I-cell_line
203,.,O
,,
204,Here,O
204,we,O
204,establish,O
204,that,O
204,nuclear,O
204,extracts,O
204,from,O
204,distinct,O
204,cell,O
204,types,O
204,differ,O
204,in,O
204,their,O
204,ability,O
204,to,O
204,interact,O
204,with,O
204,octamer-containing,B-DNA
204,fragments,I-DNA
204,.,O
,,
205,We,O
205,have,O
205,also,O
205,detected,O
205,a,O
205,DNA-protein,O
205,interaction,O
205,that,O
205,may,O
205,be,O
205,involved,O
205,in,O
205,the,O
205,cell-type,O
205,specificity,O
205,of,O
205,immunoglobulin,B-protein
205,expression,O
205,",",O
205,and,O
205,we,O
205,have,O
205,determined,O
205,that,O
205,a,O
205,sequence,O
205,upstream,O
205,of,O
205,the,O
205,octamer,O
205,participates,O
205,in,O
205,an,O
205,interaction,O
205,with,O
205,a,O
205,nuclear,B-protein
205,protein,I-protein
205,(,O
205,s,O
205,),O
205,.,O
,,
206,Preferential,O
206,transcription,O
206,of,O
206,HTLV-I,B-DNA
206,LTR,I-DNA
206,in,O
206,cell-free,O
206,extracts,O
206,of,O
206,human,B-cell_type
206,T,I-cell_type
206,cells,I-cell_type
206,producing,O
206,HTLV-I,B-protein
206,viral,I-protein
206,proteins,I-protein
206,.,O
,,
207,The,O
207,promoters,B-DNA
207,of,O
207,the,O
207,adenovirus,B-DNA
207,2,I-DNA
207,major,I-DNA
207,late,I-DNA
207,gene,I-DNA
207,",",O
207,the,O
207,mouse,B-DNA
207,beta-globin,I-DNA
207,gene,I-DNA
207,",",O
207,the,O
207,mouse,B-DNA
207,immunoglobulin,I-DNA
207,VH,I-DNA
207,gene,I-DNA
207,and,O
207,the,O
207,LTR,B-DNA
207,of,O
207,the,O
207,human,O
207,T-lymphotropic,O
207,retrovirus,O
207,type,O
207,I,O
207,were,O
207,tested,O
207,for,O
207,their,O
207,transcription,O
207,activities,O
207,in,O
207,cell-free,O
207,extracts,O
207,of,O
207,four,O
207,cell,O
207,lines,O
207,;,O
207,HeLa,B-cell_line
207,",",O
207,CESS,B-cell_line
207,(,O
207,Epstein-Barr,B-cell_line
207,virus-transformed,I-cell_line
207,human,I-cell_line
207,B,I-cell_line
207,cell,I-cell_line
207,line,I-cell_line
207,),O
207,",",O
207,MT-1,B-cell_line
207,(,O
207,HTLV-I-infected,B-cell_line
207,human,I-cell_line
207,T,I-cell_line
207,cell,I-cell_line
207,line,I-cell_line
207,without,O
207,viral,O
207,protein,O
207,synthesis,O
207,),O
207,",",O
207,and,O
207,MT-2,B-cell_line
207,(,O
207,HTLV-I-infected,B-cell_line
207,human,I-cell_line
207,T,I-cell_line
207,cell,I-cell_line
207,line,I-cell_line
207,producing,O
207,viral,B-protein
207,proteins,I-protein
207,),O
207,.,O
,,
208,LTR,B-DNA
208,was,O
208,preferentially,O
208,transcribed,O
208,in,O
208,the,O
208,extracts,O
208,of,O
208,MT-2,B-cell_line
208,although,O
208,the,O
208,other,O
208,three,O
208,genes,O
208,were,O
208,transcribed,O
208,with,O
208,relatively,O
208,constant,O
208,efficiencies,O
208,in,O
208,different,O
208,extracts,O
208,.,O
,,
209,The,O
209,results,O
209,agree,O
209,well,O
209,with,O
209,the,O
209,previous,O
209,in,O
209,vivo,O
209,studies,O
209,on,O
209,the,O
209,promoter,O
209,activity,O
209,of,O
209,HTLV-I,B-DNA
209,LTR,I-DNA
209,.,O
,,
210,Mixing,O
210,of,O
210,HeLa,O
210,and,O
210,MT-2,O
210,extracts,O
210,revealed,O
210,the,O
210,presence,O
210,of,O
210,a,O
210,LTR-specific,O
210,stimulating,O
210,activity,O
210,in,O
210,MT-2,O
210,extracts,O
210,.,O
,,
211,A,O
211,nuclear,B-protein
211,factor,I-protein
211,that,O
211,binds,O
211,to,O
211,a,O
211,conserved,O
211,sequence,O
211,motif,O
211,in,O
211,transcriptional,B-DNA
211,control,I-DNA
211,elements,I-DNA
211,of,O
211,immunoglobulin,B-DNA
211,genes,I-DNA
211,.,O
,,
212,Trans-acting,B-protein
212,factors,I-protein
212,that,O
212,mediate,O
212,B-cell,O
212,specific,O
212,transcription,O
212,of,O
212,immunoglobulin,B-DNA
212,genes,I-DNA
212,have,O
212,been,O
212,postulated,O
212,based,O
212,on,O
212,an,O
212,analysis,O
212,of,O
212,the,O
212,expression,O
212,of,O
212,exogenously,O
212,introduced,O
212,immunoglobulin,B-DNA
212,gene,I-DNA
212,recombinants,I-DNA
212,in,O
212,lymphoid,B-cell_type
212,and,I-cell_type
212,non-lymphoid,I-cell_type
212,cells,I-cell_type
212,.,O
,,
213,Two,O
213,B-cell-specific,O
213,",",O
213,cis-acting,B-DNA
213,transcriptional,I-DNA
213,regulatory,I-DNA
213,elements,I-DNA
213,have,O
213,been,O
213,identified,O
213,.,O
,,
214,One,O
214,element,O
214,is,O
214,located,O
214,in,O
214,the,O
214,intron,O
214,between,O
214,the,O
214,variable,O
214,(,O
214,V,O
214,),O
214,and,O
214,constant,O
214,(,O
214,C,O
214,),O
214,regions,O
214,of,O
214,both,O
214,heavy,B-DNA
214,and,I-DNA
214,kappa,I-DNA
214,light-chain,I-DNA
214,genes,I-DNA
214,and,O
214,acts,O
214,as,O
214,a,O
214,transcriptional,O
214,enhancer,O
214,.,O
,,
215,The,O
215,second,O
215,element,B-DNA
215,is,O
215,found,O
215,upstream,O
215,of,O
215,both,O
215,heavy,B-DNA
215,and,I-DNA
215,kappa,I-DNA
215,light-chain,I-DNA
215,gene,I-DNA
215,promoters,I-DNA
215,.,O
,,
216,This,O
216,element,O
216,directs,O
216,lymphoid-specific,O
216,transcription,O
216,even,O
216,in,O
216,the,O
216,presence,O
216,of,O
216,viral,B-DNA
216,enhancers,I-DNA
216,.,O
,,
217,We,O
217,have,O
217,sought,O
217,nuclear,O
217,factors,O
217,that,O
217,might,O
217,bind,O
217,specifically,O
217,to,O
217,these,O
217,two,O
217,regulatory,B-DNA
217,elements,I-DNA
217,by,O
217,application,O
217,of,O
217,a,O
217,modified,O
217,gel,O
217,electrophoresis,O
217,DNA,O
217,binding,O
217,assay,O
217,.,O
,,
218,We,O
218,report,O
218,here,O
218,the,O
218,identification,O
218,of,O
218,a,O
218,human,B-protein
218,B-cell,I-protein
218,nuclear,I-protein
218,factor,I-protein
218,(,O
218,IgNF-A,B-protein
218,),O
218,that,O
218,binds,O
218,to,O
218,DNA,B-DNA
218,sequences,I-DNA
218,in,O
218,the,O
218,upstream,B-DNA
218,regions,I-DNA
218,of,O
218,both,O
218,the,O
218,mouse,B-DNA
218,heavy,I-DNA
218,and,I-DNA
218,kappa,I-DNA
218,light-chain,I-DNA
218,gene,I-DNA
218,promoters,I-DNA
218,and,O
218,also,O
218,to,O
218,the,O
218,mouse,B-DNA
218,heavy-chain,I-DNA
218,gene,I-DNA
218,enhancer,I-DNA
218,.,O
,,
219,This,O
219,sequence-specific,O
219,binding,O
219,is,O
219,probably,O
219,mediated,O
219,by,O
219,a,O
219,highly,O
219,conserved,O
219,sequence,O
219,motif,O
219,",",O
219,ATTTGCAT,O
219,",",O
219,present,O
219,in,O
219,all,O
219,three,O
219,transcriptional,B-DNA
219,elements,I-DNA
219,.,O
,,
220,Interestingly,O
220,",",O
220,a,O
220,factor,O
220,showing,O
220,similar,O
220,binding,O
220,specificity,O
220,to,O
220,IgNF-A,B-DNA
220,is,O
220,also,O
220,present,O
220,in,O
220,human,B-cell_line
220,HeLa,I-cell_line
220,cells,I-cell_line
220,.,O
,,
221,The,O
221,new,O
221,world,O
221,primates,O
221,as,O
221,animal,O
221,models,O
221,of,O
221,glucocorticoid,O
221,resistance,O
221,.,O
,,
222,Many,O
222,New,O
222,World,O
222,primate,O
222,species,O
222,have,O
222,greatly,O
222,increased,O
222,plasma,O
222,cortisol,O
222,concentrations,O
222,",",O
222,decreased,O
222,plasma,O
222,cortisol,O
222,binding,O
222,globulin,O
222,capacity,O
222,and,O
222,affinity,O
222,",",O
222,marked,O
222,resistance,O
222,of,O
222,the,O
222,hypothalamic-pituitary-adrenal,O
222,axis,O
222,to,O
222,suppression,O
222,by,O
222,dexamethasone,O
222,",",O
222,and,O
222,no,O
222,biological,O
222,evidence,O
222,of,O
222,glucocorticoid,O
222,excess,O
222,.,O
,,
223,These,O
223,primates,O
223,also,O
223,have,O
223,high,O
223,levels,O
223,of,O
223,circulating,O
223,progesterone,O
223,",",O
223,estrogen,O
223,",",O
223,mineralocorticoid,O
223,",",O
223,androgen,O
223,and,O
223,vitamin,O
223,D,O
223,.,O
,,
224,The,O
224,glucocorticoid,O
224,target,O
224,tissues,O
224,that,O
224,have,O
224,been,O
224,examined,O
224,(,O
224,circulating,B-cell_type
224,mononuclear,I-cell_type
224,lymphocytes,I-cell_type
224,and,O
224,cultured,B-cell_line
224,skin,I-cell_line
224,fibroblasts,I-cell_line
224,),O
224,have,O
224,normal,O
224,concentrations,O
224,of,O
224,glucocorticoid,B-protein
224,receptors,I-protein
224,with,O
224,decreased,O
224,affinity,O
224,for,O
224,dexamethasone,O
224,.,O
,,
225,Transformation,O
225,of,O
225,B-lymphocytes,B-cell_type
225,with,O
225,the,O
225,Epstein-Barr,O
225,virus,O
225,leads,O
225,to,O
225,glucocorticoid,B-protein
225,receptor,I-protein
225,induction,O
225,that,O
225,is,O
225,less,O
225,than,O
225,that,O
225,observed,O
225,with,O
225,cells,O
225,from,O
225,Old,O
225,World,O
225,primates,O
225,.,O
,,
226,The,O
226,receptor,O
226,in,O
226,these,O
226,cells,O
226,has,O
226,a,O
226,low,O
226,affinity,O
226,for,O
226,dexamethasone,O
226,.,O
,,
227,The,O
227,low,O
227,affinity,O
227,leads,O
227,to,O
227,an,O
227,increased,O
227,loss,O
227,of,O
227,specific,O
227,bound,O
227,ligand,O
227,during,O
227,thermal,O
227,activation,O
227,.,O
,,
228,Meroreceptor,O
228,generation,O
228,is,O
228,normal,O
228,.,O
,,
229,The,O
229,molecular,O
229,weight,O
229,of,O
229,the,O
229,receptor,O
229,",",O
229,determined,O
229,by,O
229,SDS-PAGE,O
229,",",O
229,is,O
229,similar,O
229,to,O
229,that,O
229,of,O
229,Old,O
229,World,O
229,primates,O
229,(,O
229,approximately,O
229,92,O
229,",",O
229,0,O
229,),O
229,and,O
229,the,O
229,activation,O
229,pattern,O
229,per,O
229,se,O
229,",",O
229,examined,O
229,in,O
229,vitro,O
229,by,O
229,heating,O
229,cytosol,O
229,and,O
229,performing,O
229,phosphocellulose,O
229,chromatography,O
229,",",O
229,appears,O
229,similar,O
229,to,O
229,that,O
229,of,O
229,human,O
229,controls,O
229,.,O
,,
230,The,O
230,ratios,O
230,of,O
230,nuclear,O
230,to,O
230,cytosolic,B-protein
230,hormone-receptor-complexes,I-protein
230,and,O
230,of,O
230,cytosolic,O
230,activated,O
230,to,O
230,unactivated,B-protein
230,receptor,I-protein
230,complexes,I-protein
230,in,O
230,intact,O
230,cells,O
230,are,O
230,similar,O
230,to,O
230,Old,O
230,World,O
230,primates,O
230,.,O
,,
231,Results,O
231,from,O
231,mixing,O
231,studies,O
231,do,O
231,not,O
231,support,O
231,the,O
231,hypothesis,O
231,that,O
231,a,O
231,binding,O
231,inhibitor,O
231,(,O
231,s,O
231,),O
231,or,O
231,a,O
231,deficient,O
231,cytosolic,O
231,positive,O
231,modifier,O
231,(,O
231,s,O
231,),O
231,of,O
231,binding,O
231,underlies,O
231,the,O
231,findings,O
231,in,O
231,these,O
231,primates,O
231,.,O
,,
232,The,O
232,New,O
232,World,O
232,primates,O
232,",",O
232,unlike,O
232,men,O
232,with,O
232,the,O
232,syndrome,O
232,of,O
232,primary,O
232,cortisol,O
232,resistance,O
232,",",O
232,have,O
232,compensated,O
232,for,O
232,their,O
232,condition,O
232,with,O
232,intra-adrenal,O
232,and,O
232,mineralocorticoid,O
232,receptor,O
232,adaptations,O
232,.,O
,,
233,Thus,O
233,",",O
233,unlike,O
233,Old,O
233,World,O
233,primates,O
233,",",O
233,cortisol,O
233,in,O
233,New,O
233,World,O
233,primates,O
233,has,O
233,only,O
233,weak,O
233,sodium-retaining,O
233,potency,O
233,because,O
233,the,O
233,aldosterone,B-protein
233,receptor,I-protein
233,has,O
233,a,O
233,low,O
233,affinity,O
233,for,O
233,cortisol,O
233,.,O
,,
234,The,O
234,common,O
234,element,O
234,that,O
234,would,O
234,explain,O
234,the,O
234,apparent,O
234,resistance,O
234,to,O
234,six,O
234,steroid,O
234,hormones,O
234,in,O
234,New,O
234,World,O
234,primates,O
,,
235,Acetylation,O
235,and,O
235,modulation,O
235,of,O
235,erythroid,B-protein
235,Kruppel-like,I-protein
235,factor,I-protein
235,(,O
235,EKLF,B-protein
235,),O
235,activity,O
235,by,O
235,interaction,O
235,with,O
235,histone,B-protein
235,acetyltransferases,I-protein
235,.,O
,,
236,Erythroid,B-protein
236,Kruppel-like,I-protein
236,factor,I-protein
236,(,O
236,EKLF,B-protein
236,),O
236,is,O
236,a,O
236,red,B-protein
236,cell-specific,I-protein
236,transcriptional,I-protein
236,activator,I-protein
236,that,O
236,is,O
236,crucial,O
236,for,O
236,consolidating,O
236,the,O
236,switch,O
236,to,O
236,high,O
236,levels,O
236,of,O
236,adult,O
236,beta-globin,O
236,expression,O
236,during,O
236,erythroid,O
236,ontogeny,O
236,.,O
,,
237,EKLF,B-protein
237,is,O
237,required,O
237,for,O
237,integrity,O
237,of,O
237,the,O
237,chromatin,O
237,structure,O
237,at,O
237,the,O
237,beta-like,B-DNA
237,globin,I-DNA
237,locus,I-DNA
237,",",O
237,and,O
237,it,O
237,interacts,O
237,with,O
237,a,O
237,positive-acting,B-protein
237,factor,I-protein
237,in,O
237,vivo,O
237,.,O
,,
238,We,O
238,find,O
238,that,O
238,EKLF,B-protein
238,is,O
238,an,O
238,acetylated,B-protein
238,transcription,I-protein
238,factor,I-protein
238,",",O
238,and,O
238,that,O
238,it,O
238,interacts,O
238,in,O
238,vivo,O
238,with,O
238,CBP,B-protein
238,",",O
238,p300,B-protein
238,",",O
238,and,O
238,P/CAF,B-protein
238,.,O
,,
239,However,O
239,",",O
239,its,O
239,interactions,O
239,with,O
239,these,O
239,histone,B-protein
239,acetyltransferases,I-protein
239,are,O
239,not,O
239,equivalent,O
239,",",O
239,as,O
239,CBP,B-protein
239,and,O
239,p300,B-protein
239,",",O
239,but,O
239,not,O
239,P/CAF,B-protein
239,",",O
239,utilize,O
239,EKLF,B-protein
239,as,O
239,a,O
239,substrate,O
239,for,O
239,in,O
239,vitro,O
239,acetylation,O
239,within,O
239,its,O
239,trans-activation,O
239,region,O
239,.,O
,,
240,The,O
240,functional,O
240,effects,O
240,of,O
240,these,O
240,interactions,O
240,are,O
240,that,O
240,CBP,B-protein
240,and,O
240,p300,B-protein
240,",",O
240,but,O
240,not,O
240,P/CAF,B-protein
240,",",O
240,enhance,O
240,EKLF,B-protein
240,'s,O
240,transcriptional,O
240,activation,O
240,of,O
240,the,O
240,beta-globin,B-DNA
240,promoter,I-DNA
240,in,O
240,erythroid,B-cell_type
240,cells,I-cell_type
240,.,O
,,
241,These,O
241,results,O
241,establish,O
241,EKLF,B-protein
241,as,O
241,a,O
241,tissue-specific,B-protein
241,transcription,I-protein
241,factor,I-protein
241,that,O
241,undergoes,O
241,post-translational,O
241,acetylation,O
241,and,O
241,suggest,O
241,a,O
241,mechanism,O
241,by,O
241,which,O
241,EKLF,B-protein
241,is,O
241,able,O
241,to,O
241,alter,O
241,chromatin,O
241,structure,O
241,and,O
241,induce,O
241,beta-globin,O
241,expression,O
241,within,O
241,the,O
241,beta-like,B-DNA
241,globin,I-DNA
241,cluster,I-DNA
241,.,O
,,
242,Recognition,O
242,of,O
242,herpes,B-protein
242,simplex,I-protein
242,virus,I-protein
242,type,I-protein
242,2,I-protein
242,tegument,I-protein
242,proteins,I-protein
242,by,O
242,CD4,B-cell_type
242,T,I-cell_type
242,cells,I-cell_type
242,infiltrating,O
242,human,O
242,genital,O
242,herpes,O
242,lesions,O
242,.,O
,,
243,The,O
243,local,O
243,cellular,O
243,immune,O
243,response,O
243,to,O
243,herpes,O
243,simplex,O
243,virus,O
243,(,O
243,HSV,O
243,),O
243,is,O
243,important,O
243,in,O
243,the,O
243,control,O
243,of,O
243,recurrent,O
243,HSV,O
243,infection,O
243,.,O
,,
244,The,O
244,antiviral,O
244,functions,O
244,of,O
244,infiltrating,B-cell_type
244,CD4-bearing,I-cell_type
244,T,I-cell_type
244,cells,I-cell_type
244,may,O
244,include,O
244,cytotoxicity,O
244,",",O
244,inhibition,O
244,of,O
244,viral,O
244,growth,O
244,",",O
244,lymphokine,O
244,secretion,O
244,",",O
244,and,O
244,support,O
244,of,O
244,humoral,O
244,and,O
244,CD8,O
244,responses,O
244,.,O
,,
245,The,O
245,antigens,O
245,recognized,O
245,by,O
245,many,O
245,HSV-specific,B-cell_type
245,CD4,I-cell_type
245,T,I-cell_type
245,cells,I-cell_type
245,localizing,O
245,to,O
245,genital,O
245,HSV-2,O
245,lesions,O
245,are,O
245,unknown,O
245,.,O
,,
246,T,B-cell_type
246,cells,I-cell_type
246,recognizing,O
246,antigens,O
246,encoded,O
246,within,O
246,map,O
246,units,O
246,0.67,O
246,to,O
246,0.73,O
246,of,O
246,HSV,B-DNA
246,DNA,I-DNA
246,are,O
246,frequently,O
246,recovered,O
246,from,O
246,herpetic,O
246,lesions,O
246,.,O
,,
247,Expression,O
247,cloning,O
247,with,O
247,this,O
247,region,O
247,of,O
247,DNA,O
247,now,O
247,shows,O
247,that,O
247,tegument,B-protein
247,protein,I-protein
247,VP22,B-protein
247,and,O
247,the,O
247,viral,B-protein
247,dUTPase,I-protein
247,",",O
247,encoded,O
247,by,O
247,genes,B-DNA
247,UL49,I-DNA
247,and,I-DNA
247,UL50,I-DNA
247,",",O
247,respectively,O
247,",",O
247,are,O
247,T-cell,B-protein
247,antigens,I-protein
247,.,O
,,
248,Separate,O
248,epitopes,B-protein
248,in,O
248,VP22,B-protein
248,were,O
248,defined,O
248,for,O
248,T-cell,B-cell_line
248,clones,I-cell_line
248,from,O
248,each,O
248,of,O
248,three,O
248,patients,O
248,.,O
,,
249,Reactivity,O
249,with,O
249,the,O
249,tegument,B-protein
249,protein,I-protein
249,encoded,O
249,by,O
249,UL21,B-DNA
249,was,O
249,identified,O
249,for,O
249,an,O
249,additional,O
249,patient,O
249,.,O
,,
250,Three,O
250,new,O
250,epitopes,O
250,were,O
250,identified,O
250,in,O
250,VP16,B-protein
250,",",O
250,a,O
250,tegument,B-protein
250,protein,I-protein
250,associated,O
250,with,O
250,VP22,B-protein
250,.,O
,,
251,Some,O
251,tegument-specific,B-cell_line
251,CD4,I-cell_line
251,T-cell,I-cell_line
251,clones,I-cell_line
251,exhibited,O
251,cytotoxic,O
251,activity,O
251,against,O
251,HSV-infected,B-cell_type
251,cells,I-cell_type
251,.,O
,,
252,These,O
252,results,O
252,suggest,O
252,that,O
252,herpes,B-protein
252,simplex,I-protein
252,tegument,I-protein
252,proteins,I-protein
252,are,O
252,processed,O
252,for,O
252,antigen,O
252,presentation,O
252,in,O
252,vivo,O
252,and,O
252,are,O
252,possible,O
252,candidate,O
252,compounds,O
252,for,O
252,herpes,O
252,simplex,O
252,vaccines,O
252,.,O
,,
253,Fibrinogen,B-protein
253,activates,O
253,NF-kappa,B-protein
253,B,I-protein
253,transcription,I-protein
253,factors,I-protein
253,in,O
253,mononuclear,B-cell_type
253,phagocytes,I-cell_type
253,.,O
,,
254,Adhesion,O
254,to,O
254,extracellular,O
254,matrices,O
254,is,O
254,known,O
254,to,O
254,modulate,O
254,leukocyte,O
254,activation,O
254,",",O
254,although,O
254,the,O
254,mechanisms,O
254,are,O
254,not,O
254,fully,O
254,understood,O
254,.,O
,,
255,Mononuclear,B-cell_type
255,phagocytes,I-cell_type
255,are,O
255,exposed,O
255,to,O
255,fibrinous,O
255,provisional,O
255,matrix,O
255,throughout,O
255,migration,O
255,into,O
255,inflammatory,O
255,foci,O
255,",",O
255,so,O
255,this,O
255,study,O
255,was,O
255,undertaken,O
255,to,O
255,determine,O
255,whether,O
255,fibrinogen,O
255,triggers,O
255,activation,O
255,of,O
255,NF-kappa,B-protein
255,B,I-protein
255,transcription,I-protein
255,factors,I-protein
255,.,O
,,
256,U937,B-cell_line
256,cells,I-cell_line
256,differentiated,O
256,with,O
256,PMA,O
256,in,O
256,nonadherent,B-cell_line
256,culture,I-cell_line
256,were,O
256,shown,O
256,to,O
256,express,O
256,two,O
256,fibrinogen-binding,B-protein
256,integrins,I-protein
256,",",O
256,predominately,O
256,CD11b/CD18,B-protein
256,",",O
256,and,O
256,to,O
256,a,O
256,lesser,O
256,extent,O
256,",",O
256,CD11c/CD18,B-protein
256,.,O
,,
257,Cells,O
257,stimulated,O
257,with,O
257,fibrinogen,B-protein
257,(,O
257,10-100,O
257,microg/ml,O
257,),O
257,/Mn2+,O
257,(,O
257,50,O
257,microM,O
257,),O
257,for,O
257,2,O
257,h,O
257,were,O
257,examined,O
257,by,O
257,electrophoretic,O
257,mobility,O
257,shift,O
257,assay,O
257,.,O
,,
258,NF-kappa,B-protein
258,B,I-protein
258,activation,O
258,",",O
258,minimal,O
258,in,O
258,unstimulated,B-cell_type
258,cells,I-cell_type
258,",",O
258,was,O
258,substantially,O
258,up-regulated,O
258,by,O
258,fibrinogen,B-protein
258,.,O
,,
259,Fibrinogen,B-protein
259,also,O
259,caused,O
259,activation,O
259,of,O
259,AP-1,B-protein
259,",",O
259,but,O
259,not,O
259,SP1,B-protein
259,or,O
259,cAMP,B-protein
259,response,I-protein
259,element-binding,I-protein
259,protein,I-protein
259,(,I-protein
259,CREB,I-protein
259,),I-protein
259,factors,I-protein
259,.,O
,,
260,Blocking,O
260,mAbs,B-protein
260,against,O
260,CD18,B-protein
260,and,O
260,CD11b,B-protein
260,abrogated,O
260,fibrinogen,B-protein
260,induced,O
260,NF-kappa,B-protein
260,B,I-protein
260,activation,O
260,.,O
,,
261,To,O
261,determine,O
261,the,O
261,effects,O
261,on,O
261,transcriptional,O
261,regulation,O
261,",",O
261,U937,B-cell_line
261,cells,I-cell_line
261,were,O
261,transfected,O
261,with,O
261,a,O
261,plasmid,O
261,containing,O
261,the,O
261,HIV-1,B-DNA
261,enhancer,I-DNA
261,(,O
261,bearing,O
261,two,O
261,NF-kappa,B-DNA
261,B,I-DNA
261,sites,I-DNA
261,),O
261,coupled,O
261,to,O
261,a,O
261,chloramphenicol,B-DNA
261,acetyltransferase,I-DNA
261,(,I-DNA
261,CAT,I-DNA
261,),I-DNA
261,reporter,I-DNA
261,.,O
,,
262,Cells,O
262,were,O
262,subsequently,O
262,stimulated,O
262,with,O
262,1,O
262,),O
262,PMA,O
262,for,O
262,24,O
262,h,O
262,",",O
262,inducing,O
262,CAT,O
262,activity,O
262,by,O
262,2.6-fold,O
262,",",O
262,2,O
262,),O
262,fibrinogen,B-protein
262,/Mn2+,O
262,for,O
262,2,O
262,h,O
262,",",O
262,inducing,O
262,CAT,O
262,activity,O
262,by,O
262,3.2-fold,O
262,",",O
262,or,O
262,3,O
262,),O
262,costimulation,O
262,with,O
262,fibrinogen,B-protein
262,and,O
262,PMA,O
262,",",O
262,inducing,O
262,5.7-fold,O
262,the,O
262,CAT,O
262,activity,O
262,induced,O
262,by,O
262,PMA,O
262,alone,O
262,.,O
,,
263,We,O
263,conclude,O
263,that,O
263,contact,O
263,with,O
263,fibrinogen-derived,B-protein
263,proteins,I-protein
263,may,O
263,contribute,O
263,to,O
263,mononuclear,O
263,phagocyte,O
263,activation,O
263,by,O
263,signaling,O
263,through,O
263,CD11b/CD18,B-protein
263,",",O
263,resulting,O
263,in,O
263,selective,O
263,activation,O
263,of,O
263,transcriptional,B-protein
263,regulatory,I-protein
263,factors,I-protein
263,",",O
263,including,O
263,NF-kappa,B-protein
263,B,I-protein
263,.,O
,,
264,Peripheral,B-cell_type
264,blood,I-cell_type
264,T,I-cell_type
264,cells,I-cell_type
264,and,I-cell_type
264,monocytes,I-cell_type
264,and,O
264,B,B-cell_line
264,cell,I-cell_line
264,lines,I-cell_line
264,derived,O
264,from,O
264,patients,O
264,with,O
264,lupus,O
264,express,O
264,estrogen,O
264,receptor,O
264,transcripts,O
264,similar,O
264,to,O
264,those,O
264,of,O
264,normal,B-cell_type
264,cells,I-cell_type
264,.,O
,,
265,OBJECTIVE,O
265,:,O
265,To,O
265,identify,O
265,and,O
265,characterize,O
265,estrogen,B-RNA
265,receptor,I-RNA
265,(,I-RNA
265,ER,I-RNA
265,),I-RNA
265,transcripts,I-RNA
265,expressed,O
265,in,O
265,immune,B-cell_type
265,cells,I-cell_type
265,of,O
265,patients,O
265,with,O
265,systemic,O
265,lupus,O
265,erythematosus,O
265,(,O
265,SLE,O
265,),O
265,and,O
265,healthy,O
265,donors,O
265,.,O
,,
266,METHODS,O
266,:,O
266,Peripheral,B-cell_type
266,blood,I-cell_type
266,monocytes,I-cell_type
266,and,I-cell_type
266,T,I-cell_type
266,cells,I-cell_type
266,were,O
266,prepared,O
266,from,O
266,patients,O
266,with,O
266,SLE,O
266,(,O
266,n,O
266,=,O
266,6,O
266,),O
266,and,O
266,healthy,O
266,donors,O
266,(,O
266,n,O
266,=,O
266,8,O
266,),O
266,.,O
,,
267,T,B-cell_type
267,cells,I-cell_type
267,were,O
267,separated,O
267,into,O
267,CD4,B-cell_type
267,and,O
267,CD8,B-cell_type
267,.,O
,,
268,Some,O
268,monocytes,B-cell_type
268,and,O
268,T,B-cell_type
268,cells,I-cell_type
268,were,O
268,stimulated,O
268,with,O
268,estradiol,O
268,",",O
268,PMA,O
268,",",O
268,and,O
268,ionomycin,O
268,.,O
,,
269,Epstein-Barr,O
269,virus-transformed,O
269,B,B-cell_line
269,cell,I-cell_line
269,lines,I-cell_line
269,(,O
269,n,O
269,=,O
269,7,O
269,),O
269,and,O
269,B,B-cell_line
269,cell,I-cell_line
269,hybridomas,I-cell_line
269,(,O
269,n,O
269,=,O
269,2,O
269,),O
269,established,O
269,from,O
269,patients,O
269,with,O
269,SLE,O
269,and,O
269,a,O
269,healthy,O
269,individual,O
269,were,O
269,used,O
269,as,O
269,a,O
269,B,O
269,cell,O
269,source,O
269,.,O
,,
270,These,O
270,cells,O
270,were,O
270,examined,O
270,for,O
270,ER,B-RNA
270,mRNA,I-RNA
270,by,O
270,reverse,O
270,transcription,O
270,nested,O
270,polymerase,O
270,chain,O
270,reaction,O
270,.,O
,,
271,Amplified,O
271,cDNA,B-DNA
271,were,O
271,sequenced,O
271,by,O
271,standard,O
271,methods,O
271,.,O
,,
272,RESULTS,O
272,:,O
272,In,O
272,all,O
272,cells,O
272,tested,O
272,",",O
272,ER,B-RNA
272,mRNA,I-RNA
272,was,O
272,expressed,O
272,without,O
272,prior,O
272,in,O
272,vitro,O
272,stimulation,O
272,.,O
,,
273,Partial,O
273,sequences,O
273,from,O
273,exons,B-DNA
273,8-Jan,I-DNA
273,were,O
273,nearly,O
273,identical,O
273,to,O
273,the,O
273,published,O
273,sequence,O
273,of,O
273,the,O
273,human,B-RNA
273,ER,I-RNA
273,mRNA,I-RNA
273,.,O
,,
274,There,O
274,were,O
274,no,O
274,notable,O
274,differences,O
274,in,O
274,the,O
274,ER,B-RNA
274,transcripts,I-RNA
274,between,O
274,patients,O
274,and,O
274,healthy,O
274,controls,O
274,.,O
,,
275,Variant,O
275,receptor,O
275,transcripts,O
275,lacking,O
275,exon,B-DNA
275,5,I-DNA
275,or,O
275,exon,B-DNA
275,7,I-DNA
275,",",O
275,which,O
275,encodes,O
275,the,O
275,hormone,B-protein
275,binding,I-protein
275,domain,I-protein
275,",",O
275,were,O
275,identified,O
275,in,O
275,the,O
275,majority,O
275,of,O
275,the,O
275,cells,O
275,.,O
,,
276,Precise,O
276,deletion,O
276,of,O
276,the,O
276,exons,O
276,suggests,O
276,that,O
276,they,O
276,are,O
276,alternatively,O
276,spliced,O
276,transcripts,O
276,.,O
,,
277,Whether,O
277,the,O
277,detected,O
277,transcripts,O
277,are,O
277,translated,O
277,into,O
277,functional,B-protein
277,receptor,I-protein
277,proteins,I-protein
277,remains,O
277,to,O
277,be,O
277,determined,O
277,.,O
,,
278,In,O
278,vitro,O
278,stimulation,O
278,did,O
278,not,O
278,affect,O
278,ER,B-RNA
278,mRNA,I-RNA
278,expression,O
278,.,O
,,
279,The,O
279,presence,O
279,of,O
279,variants,O
279,did,O
279,not,O
279,correlate,O
279,with,O
279,disease,O
279,activity,O
279,or,O
279,medication,O
279,.,O
,,
280,CONCLUSION,O
280,:,O
280,Monocytes,B-cell_type
280,",",O
280,T,B-cell_type
280,cells,I-cell_type
280,",",O
280,and,O
280,B,B-cell_type
280,cells,I-cell_type
280,in,O
280,patients,O
280,express,O
280,transcripts,O
280,of,O
280,the,O
280,normal,O
280,wild,B-protein
280,type,I-protein
280,ER,I-protein
280,and,O
280,the,O
280,hormone,B-protein
280,binding,I-protein
280,domain,I-protein
280,variants,I-protein
280,in,O
280,vivo,O
280,.,O
,,
281,DNA,O
281,damaging,O
281,agents,O
281,induce,O
281,expression,O
281,of,O
281,Fas,B-protein
281,ligand,I-protein
281,and,O
281,subsequent,O
281,apoptosis,O
281,in,O
281,T,B-cell_type
281,lymphocytes,I-cell_type
281,via,O
281,the,O
281,activation,O
281,of,O
281,NF-kappa,B-protein
281,B,I-protein
281,and,O
281,AP-1,B-protein
281,.,O
,,
282,Apoptosis,O
282,induced,O
282,by,O
282,DNA,O
282,damage,O
282,and,O
282,other,O
282,stresses,O
282,can,O
282,proceed,O
282,via,O
282,expression,O
282,of,O
282,Fas,B-protein
282,ligand,I-protein
282,(,O
282,FasL,B-protein
282,),O
282,and,O
282,ligation,O
282,of,O
282,its,O
282,receptor,O
282,",",O
282,Fas,O
282,(,O
282,CD95,O
282,),O
282,.,O
,,
283,We,O
283,report,O
283,that,O
283,activation,O
283,of,O
283,the,O
283,two,O
283,transcription,B-protein
283,factors,I-protein
283,NF-kappa,I-protein
283,B,I-protein
283,and,I-protein
283,AP-1,I-protein
283,is,O
283,crucially,O
283,involved,O
283,in,O
283,FasL,B-protein
283,expression,O
283,induced,O
283,by,O
283,etoposide,O
283,",",O
283,teniposide,O
283,",",O
283,and,O
283,UV,O
283,irradiation,O
283,.,O
,,
284,A,O
284,nondegradable,B-protein
284,mutant,I-protein
284,of,O
284,I,B-protein
284,kappa,I-protein
284,B,I-protein
284,blocked,O
284,both,O
284,FasL,B-protein
284,expression,O
284,and,O
284,apoptosis,O
284,induced,O
284,by,O
284,DNA,O
284,damage,O
284,but,O
284,not,O
284,Fas,O
284,ligation,O
284,.,O
,,
285,These,O
285,stimuli,O
285,also,O
285,induced,O
285,the,O
285,stress-activated,O
285,kinase,O
285,pathway,O
285,(,O
285,SAPK/JNK,O
285,),O
285,",",O
285,which,O
285,was,O
285,required,O
285,for,O
285,the,O
285,maximal,O
285,induction,O
285,of,O
285,apoptosis,O
285,.,O
,,
286,A,O
286,1.2,O
286,kb,O
286,FasL,B-DNA
286,promoter,I-DNA
286,responded,O
286,to,O
286,DNA,O
286,damage,O
286,",",O
286,as,O
286,well,O
286,as,O
286,coexpression,O
286,with,O
286,p65,B-protein
286,Rel,I-protein
286,or,O
286,Fos/Jun,B-protein
286,.,O
,,
287,Mutations,O
287,in,O
287,the,O
287,relevant,O
287,NF-kappa,B-DNA
287,B,I-DNA
287,and,I-DNA
287,AP-1,I-DNA
287,binding,I-DNA
287,sites,I-DNA
287,eliminated,O
287,these,O
287,responses,O
287,.,O
,,
288,Thus,O
288,",",O
288,activation,O
288,of,O
288,NF-kappa,B-protein
288,B,I-protein
288,and,O
288,AP-1,B-protein
288,contributes,O
288,to,O
288,stress-induced,O
288,apoptosis,O
288,via,O
288,the,O
288,expression,O
288,of,O
288,FasL,B-protein
288,.,O
,,
289,A,O
289,small,O
289,",",O
289,nonpeptidyl,O
289,mimic,O
289,of,O
289,granulocyte-colony-stimulating,B-protein
289,factor,I-protein
289,[,O
289,see,O
289,commetns,O
289,],O
,,
290,A,O
290,nonpeptidyl,O
290,small,O
290,molecule,O
290,SB,O
290,247464,O
290,",",O
290,capable,O
290,of,O
290,activating,O
290,granulocyte-colony-stimulating,B-protein
290,factor,I-protein
290,(,O
290,G-CSF,B-protein
290,),O
290,signal,O
290,transduction,O
290,pathways,O
290,",",O
290,was,O
290,identified,O
290,in,O
290,a,O
290,high-throughput,O
290,assay,O
290,in,O
290,cultured,B-cell_type
290,cells,I-cell_type
290,.,O
,,
291,Like,O
291,G-CSF,B-protein
291,",",O
291,SB,O
291,247464,O
291,induced,O
291,tyrosine,O
291,phosphorylation,O
291,of,O
291,multiple,B-protein
291,signaling,I-protein
291,proteins,I-protein
291,and,O
291,stimulated,O
291,primary,B-cell_type
291,murine,I-cell_type
291,bone,I-cell_type
291,marrow,I-cell_type
291,cells,I-cell_type
291,to,O
291,form,O
291,granulocytic,B-cell_type
291,colonies,I-cell_type
291,in,O
291,vitro,O
291,.,O
,,
292,It,O
292,also,O
292,elevated,O
292,peripheral,B-cell_type
292,blood,I-cell_type
292,neutrophil,I-cell_type
292,counts,O
292,in,O
292,mice,O
292,.,O
,,
293,The,O
293,extracellular,O
293,domain,O
293,of,O
293,the,O
293,murine,B-protein
293,G-CSF,I-protein
293,receptor,I-protein
293,was,O
293,required,O
293,for,O
293,the,O
293,activity,O
293,of,O
293,SB,O
293,247464,O
293,",",O
293,suggesting,O
293,that,O
293,the,O
293,compound,O
293,acts,O
293,by,O
293,oligomerizing,B-protein
293,receptor,I-protein
293,chains,I-protein
293,.,O
,,
294,The,O
294,results,O
294,indicate,O
294,that,O
294,a,O
294,small,O
294,molecule,O
294,can,O
294,activate,O
294,a,O
294,receptor,O
294,that,O
294,normally,O
294,binds,O
294,a,O
294,relatively,O
294,large,O
294,protein,O
294,ligand,O
294,.,O
,,
295,Minimal,O
295,residual,O
295,disease,O
295,in,O
295,acute,O
295,myelogenous,O
295,leukemia,O
295,with,O
295,PML/RAR,B-protein
295,alpha,I-protein
295,or,O
295,AML1/ETO,B-RNA
295,mRNA,I-RNA
295,and,O
295,phenotypic,O
295,analysis,O
295,of,O
295,possible,O
295,T,B-cell_type
295,and,I-cell_type
295,natural,I-cell_type
295,killer,I-cell_type
295,cells,I-cell_type
295,in,O
295,bone,O
295,marrow,O
295,.,O
,,
296,Here,O
296,we,O
296,studied,O
296,minimal,O
296,residual,O
296,disease,O
296,(,O
296,MRD,O
296,),O
296,of,O
296,patients,O
296,with,O
296,acute,O
296,myeloid,O
296,leukemia,O
296,(,O
296,AML,O
296,),O
296,who,O
296,have,O
296,PML/RAR,B-protein
296,alpha,I-protein
296,or,O
296,AML1/ETO,B-protein
296,as,O
296,well,O
296,as,O
296,the,O
296,phenotypic,O
296,analysis,O
296,of,O
296,lymphocyte,B-cell_type
296,subsets,I-cell_type
296,involved,O
296,in,O
296,antitumor,O
296,immunity,O
296,.,O
,,
297,Eight,O
297,patients,O
297,in,O
297,long-term,O
297,(,O
297,LT,O
297,;,O
297,3,O
297,to,O
297,15,O
297,years,O
297,),O
297,and,O
297,15,O
297,patients,O
297,in,O
297,short-term,O
297,(,O
297,ST,O
297,;,O
297,up,O
297,to,O
297,3,O
297,years,O
297,),O
297,remission,O
297,were,O
297,studied,O
297,.,O
,,
298,Using,O
298,the,O
298,reverse,O
298,transcription-polymerase,O
298,chain,O
298,reaction,O
298,(,O
298,RT,O
298,),O
298,assay,O
298,",",O
298,the,O
298,limit,O
298,of,O
298,detection,O
298,was,O
298,10,O
298,(,O
298,-5,O
298,),O
298,to,O
298,10,O
298,(,O
298,-6,O
298,),O
298,for,O
298,PML/RAR,B-RNA
298,alpha,I-RNA
298,transcript,I-RNA
298,and,O
298,10,O
298,(,O
298,-4,O
298,),O
298,to,O
298,10,O
298,(,O
298,-5,O
298,),O
298,for,O
298,the,O
298,AML1/ETO,B-RNA
298,transcript,I-RNA
298,.,O
,,
299,Simultaneously,O
299,",",O
299,T,B-cell_type
299,lymphocyte,I-cell_type
299,subsets,I-cell_type
299,and,O
299,NK,B-cell_type
299,cells,I-cell_type
299,from,O
299,the,O
299,peripheral,O
299,blood,O
299,(,O
299,PB,O
299,),O
299,and,O
299,bone,O
299,marrow,O
299,(,O
299,BM,O
299,),O
299,were,O
299,investigated,O
299,by,O
299,flow,O
299,cytometric,O
299,analysis,O
299,.,O
,,
300,Four,O
300,of,O
300,the,O
300,eight,O
300,patients,O
300,in,O
300,LT,O
300,and,O
300,7,O
300,of,O
300,the,O
300,15,O
300,patients,O
300,in,O
300,ST,O
300,remission,O
300,were,O
300,MRD-positive,O
300,.,O
,,
301,Although,O
301,all,O
301,MRD-positive,O
301,patients,O
301,in,O
301,LT,O
301,remission,O
301,are,O
301,still,O
301,until,O
301,now,O
301,event-free,O
301,",",O
301,3,O
301,of,O
301,the,O
301,7,O
301,MRD-positive,O
301,(,O
301,MRD+,O
301,),O
301,patients,O
301,in,O
301,ST,O
301,remission,O
301,soon,O
301,relapsed,O
301,.,O
,,
302,The,O
302,total,O
302,populations,O
302,of,O
302,CD4,B-protein
302,+,O
302,",",O
302,CD8,B-protein
302,+,O
302,and,O
302,CD56,B-protein
302,+,O
302,[,O
302,possible,O
302,T-cell,B-cell_type
302,and,I-cell_type
302,natural,I-cell_type
302,killer,I-cell_type
302,(,I-cell_type
302,T/NK,I-cell_type
302,),I-cell_type
302,populations,I-cell_type
302,],O
302,in,O
302,the,O
302,BM,O
302,of,O
302,ST,O
302,patients,O
302,and,O
302,MRD+/LT,O
302,patients,O
302,were,O
302,significantly,O
302,(,O
302,p,O
302,<,O
302,0.01,O
302,),O
302,low,O
302,.,O
,,
303,The,O
303,CD8+,B-cell_type
303,CD28+,I-cell_type
303,population,I-cell_type
303,showed,O
303,the,O
303,same,O
303,tendency,O
303,(,O
303,p,O
303,<,O
303,.01-.02,O
303,),O
303,.,O
,,
304,The,O
304,T/NK,B-cell_type
304,subsets,I-cell_type
304,in,O
304,the,O
304,BM,O
304,of,O
304,MRD-negative,O
304,(,O
304,MRD-,O
304,),O
304,LT,O
304,(,O
304,MRD-/LT,O
304,),O
304,patients,O
304,showed,O
304,similar,O
304,numbers,O
304,of,O
304,cells,O
304,as,O
304,normal,O
304,volunteers,O
304,.,O
,,
305,Basically,O
305,",",O
305,the,O
305,total,O
305,percentage,O
305,of,O
305,the,O
305,CD4+,B-cell_type
305,",",I-cell_type
305,CD8+,I-cell_type
305,and,I-cell_type
305,CD56+,I-cell_type
305,cell,I-cell_type
305,populations,I-cell_type
305,in,O
305,the,O
305,BM,O
305,was,O
305,increased,O
305,and,O
305,in,O
305,the,O
305,following,O
305,order,O
305,:,O
305,MRD-/LT,O
305,patients,O
305,",",O
305,normal,O
305,volunteers,O
305,",",O
305,MRD+/LT,O
305,patients,O
305,and,O
305,MRD+,O
305,or,O
305,-/ST,O
305,patients,O
305,.,O
,,
306,The,O
306,percentages,O
306,of,O
306,the,O
306,T/NK-cell,B-cell_type
306,subsets,I-cell_type
306,in,O
306,the,O
306,PB,O
306,were,O
306,not,O
306,significantly,O
306,different,O
306,among,O
306,these,O
306,groups,O
306,.,O
,,
307,Thus,O
307,",",O
307,the,O
307,difference,O
307,of,O
307,the,O
307,possible,O
307,T/NK-cell,B-cell_type
307,phenotype,O
307,in,O
307,the,O
307,BM,O
307,may,O
307,strongly,O
307,influence,O
307,clinical,O
307,and,O
307,molecular,O
307,remission,O
307,.,O
,,
308,These,O
308,results,O
308,still,O
308,remain,O
308,to,O
308,be,O
308,confirmed,O
308,by,O
308,further,O
308,studies,O
308,of,O
308,the,O
308,functional,O
308,anti-tumor,O
308,immunity,O
308,of,O
308,T/NK,B-cell_type
308,cells,I-cell_type
308,of,O
308,AML,B-cell_type
308,in,O
308,remission,O
308,.,O
,,
309,Mycobacterium,O
309,tuberculosis,O
309,mannose-capped,O
309,lipoarabinomannan,O
309,can,O
309,induce,O
309,NF-kappaB,B-protein
309,dependent,O
309,activation,O
309,of,O
309,human,B-DNA
309,immunodeficiency,I-DNA
309,virus,I-DNA
309,type,I-DNA
309,1,I-DNA
309,long,I-DNA
309,terminal,I-DNA
309,repeat,I-DNA
309,in,O
309,T,B-cell_type
309,cells,I-cell_type
309,.,O
,,
310,Tuberculosis,O
310,has,O
310,emerged,O
310,as,O
310,an,O
310,epidemic,O
310,",",O
310,extended,O
310,by,O
310,the,O
310,large,O
310,number,O
310,of,O
310,individuals,O
310,infected,O
310,with,O
310,human,O
310,immunodeficiency,O
310,virus,O
310,type,O
310,1,O
310,(,O
310,HIV-1,O
310,),O
310,.,O
,,
311,The,O
311,major,O
311,goal,O
311,of,O
311,this,O
311,study,O
311,was,O
311,to,O
311,determine,O
311,whether,O
311,the,O
311,mycobacterial,O
311,cell,O
311,wall,O
311,component,O
311,mannose-capped,O
311,lipoarabinomannan,O
311,(,O
311,ManLAM,O
311,),O
311,of,O
311,Mycobacterium,O
311,tuberculosis,O
311,(,O
311,M.,O
311,tuberculosis,O
311,),O
311,could,O
311,activate,O
311,transcription,O
311,of,O
311,HIV-1,O
311,in,O
311,T,B-cell_type
311,cells,I-cell_type
311,with,O
311,the,O
311,use,O
311,of,O
311,an,O
311,in,O
311,vitro,O
311,cell,O
311,culture,O
311,system,O
311,.,O
,,
312,These,O
312,experiments,O
312,are,O
312,of,O
312,prime,O
312,importance,O
312,considering,O
312,that,O
312,CD4,B-protein
312,expressing,O
312,T,B-cell_type
312,lymphocytes,I-cell_type
312,represent,O
312,the,O
312,major,O
312,virus,O
312,reservoir,O
312,in,O
312,the,O
312,peripheral,O
312,blood,O
312,of,O
312,infected,O
312,individuals,O
312,.,O
,,
313,Using,O
313,the,O
313,1G5,B-cell_line
313,cell,I-cell_line
313,line,I-cell_line
313,harbouring,O
313,the,O
313,luciferase,O
313,reporter,O
313,gene,O
313,under,O
313,the,O
313,control,O
313,of,O
313,the,O
313,HIV-1,B-DNA
313,LTR,I-DNA
313,",",O
313,it,O
313,was,O
313,first,O
313,found,O
313,that,O
313,culture,O
313,protein,O
313,filtrates,O
313,(,O
313,CFP,O
313,),O
313,from,O
313,M.,O
313,tuberculosis,O
313,or,O
313,purified,O
313,ManLAM,O
313,could,O
313,activate,O
313,HIV-1,B-DNA
313,LTR-dependent,I-DNA
313,gene,I-DNA
313,expression,O
313,unlike,O
313,similarly,O
313,prepared,O
313,CFP,O
313,extracts,O
313,devoid,O
313,of,O
313,ManLAM,O
313,.,O
,,
314,The,O
314,implication,O
314,of,O
314,protein,B-protein
314,tyrosine,I-protein
314,kinase,I-protein
314,(,I-protein
314,s,I-protein
314,),I-protein
314,",",O
314,protein,B-protein
314,kinase,I-protein
314,A,I-protein
314,and/or,O
314,protein,B-protein
314,kinase,I-protein
314,C,I-protein
314,was,O
314,highlighted,O
314,by,O
314,the,O
314,abrogation,O
314,of,O
314,the,O
314,ManLAM-mediated,O
314,activation,O
314,of,O
314,HIV-1,O
314,LTR-driven,O
314,gene,O
314,expression,O
314,using,O
314,herbimycin,O
314,A,O
314,and,O
314,H7,O
314,.,O
,,
315,It,O
315,was,O
315,also,O
315,determined,O
315,",",O
315,using,O
315,electrophoresis,O
315,mobility,O
315,shift,O
315,assays,O
315,",",O
315,that,O
315,M.,O
315,tuberculosis,O
315,ManLAM,O
315,led,O
315,to,O
315,the,O
315,nuclear,O
315,translocation,O
315,of,O
315,the,O
315,transcription,B-protein
315,factor,I-protein
315,NF-kappaB,I-protein
315,.,O
,,
316,M.,O
316,tuberculosis,O
316,ManLAM,O
316,resulted,O
316,in,O
316,clear,O
316,induction,O
316,of,O
316,the,O
316,luciferase,B-DNA
316,gene,I-DNA
316,placed,O
316,under,O
316,the,O
316,control,O
316,of,O
316,the,O
316,wild-type,B-DNA
316,",",I-DNA
316,but,I-DNA
316,not,I-DNA
316,the,I-DNA
316,kappaB-mutated,I-DNA
316,",",I-DNA
316,HIV-1,I-DNA
316,LTR,I-DNA
316,region,I-DNA
316,.,O
,,
317,Finally,O
317,",",O
317,the,O
317,ManLAM-mediated,O
317,activation,O
317,of,O
317,HIV-1,O
317,LTR,O
317,transcription,O
317,was,O
317,found,O
317,to,O
317,be,O
317,independent,O
317,of,O
317,the,O
317,autocrine,O
317,or,O
317,paracrine,O
317,action,O
317,of,O
317,endogenous,B-protein
317,TNF-alpha,I-protein
317,.,O
,,
318,The,O
318,results,O
318,suggest,O
318,that,O
318,M.,O
318,tuberculosis,O
318,can,O
318,upregulate,O
318,HIV-1,O
318,expression,O
318,in,O
318,T,B-cell_type
318,cells,I-cell_type
318,and,O
318,could,O
318,thus,O
318,have,O
318,the,O
318,potential,O
318,to,O
318,influence,O
318,the,O
318,pathogenesis,O
318,of,O
318,HIV-1,O
318,infection,O
318,.,O
,,
319,Human,B-DNA
319,immunodeficiency,I-DNA
319,virus,I-DNA
319,type,I-DNA
319,1,I-DNA
319,long,I-DNA
319,terminal,I-DNA
319,repeat,I-DNA
319,quasispecies,O
319,differ,O
319,in,O
319,basal,O
319,transcription,O
319,and,O
319,nuclear,O
319,factor,O
319,recruitment,O
319,in,O
319,human,B-cell_type
319,glial,I-cell_type
319,cells,I-cell_type
319,and,I-cell_type
319,lymphocytes,I-cell_type
319,.,O
,,
320,The,O
320,generation,O
320,of,O
320,genomic,O
320,diversity,O
320,during,O
320,the,O
320,course,O
320,of,O
320,infection,O
320,has,O
320,the,O
320,potential,O
320,to,O
320,affect,O
320,all,O
320,aspects,O
320,of,O
320,HIV-1,O
320,replication,O
320,",",O
320,including,O
320,expression,O
320,of,O
320,the,O
320,proviral,O
320,genome,O
320,.,O
,,
321,To,O
321,gain,O
321,a,O
321,better,O
321,understanding,O
321,of,O
321,the,O
321,impact,O
321,of,O
321,long,B-DNA
321,terminal,I-DNA
321,repeat,I-DNA
321,(,O
321,LTR,B-DNA
321,),O
321,sequence,O
321,diversity,O
321,on,O
321,LTR-directed,B-DNA
321,gene,I-DNA
321,expression,O
321,in,O
321,cells,O
321,of,O
321,the,O
321,central,O
321,nervous,O
321,system,O
321,(,O
321,CNS,O
321,),O
321,and,O
321,immune,O
321,system,O
321,",",O
321,we,O
321,amplified,O
321,and,O
321,cloned,O
321,LTRs,B-DNA
321,from,O
321,proviral,O
321,DNA,O
321,in,O
321,HIV-1-infected,O
321,peripheral,O
321,blood,O
321,.,O
,,
322,Sequence,O
322,analysis,O
322,of,O
322,nineteen,O
322,LTRs,B-DNA
322,cloned,O
322,from,O
322,2,O
322,adult,O
322,and,O
322,3,O
322,pediatric,O
322,patients,O
322,revealed,O
322,an,O
322,average,O
322,of,O
322,33,O
322,nucleotide,O
322,changes,O
322,(,O
322,with,O
322,respect,O
322,to,O
322,the,O
322,sequence,O
322,of,O
322,the,O
322,LAI,B-DNA
322,LTR,I-DNA
322,),O
322,within,O
322,the,O
322,455-bp,B-DNA
322,U3,I-DNA
322,region,I-DNA
322,.,O
,,
323,Transient,O
323,expression,O
323,analyses,O
323,in,O
323,cells,O
323,of,O
323,neuroglial,O
323,and,O
323,lymphocytic,O
323,origin,O
323,demonstrated,O
323,that,O
323,some,O
323,of,O
323,these,O
323,LTRs,B-DNA
323,had,O
323,activities,O
323,which,O
323,varied,O
323,significantly,O
323,from,O
323,the,O
323,LAI,B-DNA
323,LTR,I-DNA
323,in,O
323,U-373,B-cell_line
323,MG,I-cell_line
323,cells,I-cell_line
323,(,O
323,an,O
323,astrocytoma,B-cell_line
323,cell,I-cell_line
323,line,I-cell_line
323,),O
323,as,O
323,well,O
323,as,O
323,in,O
323,Jurkat,B-cell_line
323,cells,I-cell_line
323,(,O
323,a,O
323,CD4-positive,B-cell_line
323,lymphocyte,I-cell_line
323,cell,I-cell_line
323,line,I-cell_line
323,),O
323,.,O
,,
324,While,O
324,LTRs,B-DNA
324,which,O
324,demonstrated,O
324,the,O
324,highest,O
324,activities,O
324,in,O
324,U-373,B-cell_line
324,MG,I-cell_line
324,cells,I-cell_line
324,also,O
324,yielded,O
324,high,O
324,activities,O
324,in,O
324,Jurkat,B-cell_line
324,cells,I-cell_line
324,",",O
324,the,O
324,LTRs,B-DNA
324,were,O
324,generally,O
324,more,O
324,active,O
324,in,O
324,Jurkat,B-cell_line
324,cells,I-cell_line
324,when,O
324,compared,O
324,to,O
324,the,O
324,LAI,B-DNA
324,LTR,I-DNA
324,.,O
,,
325,Differences,O
325,in,O
325,LTR,B-DNA
325,sequence,I-DNA
325,also,O
325,resulted,O
325,in,O
325,differences,O
325,in,O
325,transcription,O
325,factor,O
325,recruitment,O
325,to,O
325,cis-acting,B-DNA
325,sites,I-DNA
325,within,O
325,the,O
325,U3,B-DNA
325,region,I-DNA
325,of,O
325,the,O
325,LTR,B-DNA
325,",",O
325,as,O
325,demonstrated,O
325,by,O
325,electrophoretic,O
325,mobility,O
325,shift,O
325,assays,O
325,.,O
,,
326,In,O
326,particular,O
326,",",O
326,naturally,O
326,occurring,O
326,sequence,O
326,variation,O
326,impacted,O
326,transcription,B-protein
326,factor,I-protein
326,binding,O
326,to,O
326,an,O
326,activating,B-protein
326,transcription,I-protein
326,factor,I-protein
326,/,O
326,cAMP,B-protein
326,response,I-protein
326,element,I-protein
326,binding,I-protein
326,(,O
326,ATF,B-protein
326,/,O
326,CREB,B-protein
326,),O
326,binding,O
326,site,O
326,(,O
326,located,O
326,between,O
326,the,O
326,LEF-1,B-DNA
326,and,I-DNA
326,distal,I-DNA
326,NF-kappaB,I-DNA
326,transcription,I-DNA
326,factor,I-DNA
326,binding,I-DNA
326,sites,I-DNA
326,),O
326,that,O
326,we,O
326,identified,O
326,in,O
326,previous,O
326,studies,O
326,of,O
326,the,O
326,HIV-1,B-DNA
326,LTR,I-DNA
326,.,O
,,
327,These,O
327,findings,O
327,suggest,O
327,that,O
327,LTR,B-DNA
327,sequence,I-DNA
327,changes,O
327,can,O
327,significantly,O
327,affect,O
327,basal,O
327,LTR,O
327,function,O
327,and,O
327,transcription,O
327,factor,O
327,recruitment,O
327,",",O
327,which,O
327,may,O
327,",",O
327,in,O
327,turn,O
327,",",O
327,alter,O
327,the,O
327,course,O
327,of,O
327,viral,O
327,replication,O
327,in,O
327,cells,O
327,of,O
327,CNS,O
327,and,O
327,immune,O
327,system,O
327,origin,O
327,.,O
,,
328,HMG,B-protein
328,box,I-protein
328,containing,I-protein
328,transcription,I-protein
328,factors,I-protein
328,in,O
328,lymphocyte,B-cell_type
328,differentiation,O
328,.,O
,,
329,The,O
329,identification,O
329,of,O
329,the,O
329,mammalian,B-DNA
329,sex-determining,I-DNA
329,gene,I-DNA
329,Sry,I-DNA
329,has,O
329,led,O
329,to,O
329,the,O
329,discovery,O
329,of,O
329,a,O
329,large,O
329,family,O
329,of,O
329,related,O
329,(,O
329,',O
329,HMG,B-protein
329,box,I-protein
329,',O
329,),O
329,transcription,B-protein
329,factors,I-protein
329,that,O
329,control,O
329,developmental,O
329,events,O
329,in,O
329,yeast,O
329,",",O
329,C.,O
329,elegans,O
329,",",O
329,Drosophila,O
329,and,O
329,vertebrates,O
329,.,O
,,
330,In,O
330,lymphocyte,B-cell_type
330,differentiation,O
330,",",O
330,several,O
330,HMG,B-protein
330,box,I-protein
330,proteins,I-protein
330,play,O
330,a,O
330,decisive,O
330,role,O
330,.,O
,,
331,Sox-4,B-protein
331,is,O
331,important,O
331,for,O
331,very,O
331,early,O
331,B-cell,O
331,differentiation,O
331,",",O
331,while,O
331,TCF-1,B-protein
331,/,O
331,LEF-1,B-protein
331,play,O
331,a,O
331,crucial,O
331,role,O
331,in,O
331,early,O
331,thymocyte,O
331,development,O
331,.,O
,,
332,TCF/LEF,B-protein
332,proteins,I-protein
332,have,O
332,recently,O
332,been,O
332,found,O
332,to,O
332,constitute,O
332,a,O
332,downstream,O
332,component,O
332,of,O
332,the,O
332,Wingless/Wnt,O
332,signal,O
332,transduction,O
332,pathway,O
332,.,O
,,
333,In,O
333,flies,O
333,",",O
333,this,O
333,pathway,O
333,controls,O
333,segment,O
333,polarity,O
333,;,O
333,in,O
333,Xenopus,O
333,it,O
333,controls,O
333,the,O
333,definition,O
333,of,O
333,the,O
333,body,O
333,axis,O
333,.,O
,,
334,Deregulation,O
334,of,O
334,the,O
334,pathway,O
334,occurs,O
334,in,O
334,several,O
334,human,B-cell_type
334,tumors,I-cell_type
334,.,O
,,
335,These,O
335,insights,O
335,in,O
335,the,O
335,molecular,O
335,events,O
335,that,O
335,are,O
335,involved,O
335,in,O
335,TCF/LEF,B-protein
335,function,O
335,in,O
335,these,O
335,organisms,O
335,may,O
335,eventually,O
335,lead,O
335,to,O
335,the,O
335,understanding,O
335,of,O
335,the,O
335,function,O
335,of,O
335,these,O
335,HMG,B-protein
335,box,I-protein
335,proteins,I-protein
335,in,O
335,lymphoid,O
335,development,O
,,
336,Transcriptional,O
336,regulation,O
336,by,O
336,C/EBP,B-protein
336,alpha,I-protein
336,and,I-protein
336,beta,I-protein
336,in,O
336,the,O
336,expression,O
336,of,O
336,the,O
336,gene,O
336,for,O
336,the,O
336,MRP14,B-protein
336,myeloid,I-protein
336,calcium,I-protein
336,binding,I-protein
336,protein,I-protein
336,.,O
,,
337,Transcriptional,O
337,regulation,O
337,of,O
337,the,O
337,gene,O
337,for,O
337,the,O
337,myeloid,B-protein
337,calcium,I-protein
337,binding,I-protein
337,protein,I-protein
337,",",O
337,MRP14,B-protein
337,",",O
337,was,O
337,investigated,O
337,in,O
337,human,B-cell_line
337,monocytic,I-cell_line
337,leukemia,I-cell_line
337,cell,I-cell_line
337,lines,I-cell_line
337,.,O
,,
338,The,O
338,MRP14,B-DNA
338,gene,I-DNA
338,was,O
338,not,O
338,expressed,O
338,in,O
338,monoblastic,B-cell_line
338,ML-1,I-cell_line
338,cells,I-cell_line
338,",",O
338,promonocytic,B-cell_line
338,U-937,I-cell_line
338,cells,I-cell_line
338,",",O
338,or,O
338,promyelocytic,B-cell_line
338,HL-60,I-cell_line
338,cells,I-cell_line
338,.,O
,,
339,On,O
339,the,O
339,other,O
339,hand,O
339,",",O
339,the,O
339,gene,O
339,was,O
339,expressed,O
339,in,O
339,monocytic,B-cell_line
339,THP-1,I-cell_line
339,cells,I-cell_line
339,and,O
339,in,O
339,the,O
339,HL-60,B-cell_line
339,cells,I-cell_line
339,treated,O
339,with,O
339,1,O
339,",",O
339,25-dihydroxyvitamin,O
339,D3,O
339,(,O
339,VD3,O
339,),O
339,.,O
,,
340,The,O
340,level,O
340,of,O
340,MRP14,B-protein
340,in,O
340,VD3-treated,O
340,HL-60,B-cell_line
340,cells,I-cell_line
340,was,O
340,two-fold,O
340,higher,O
340,than,O
340,that,O
340,in,O
340,THP-1,B-cell_line
340,cells,I-cell_line
340,.,O
,,
341,Among,O
341,several,O
341,known,O
341,transcription,B-DNA
341,factor,I-DNA
341,binding,I-DNA
341,motifs,I-DNA
341,",",O
341,nuclear,B-protein
341,protein,I-protein
341,(,I-protein
341,s,I-protein
341,),I-protein
341,of,O
341,VD3-treated,B-cell_line
341,HL-60,I-cell_line
341,cells,I-cell_line
341,and,I-cell_line
341,THP-1,I-cell_line
341,cells,I-cell_line
341,bound,O
341,to,O
341,the,O
341,CCAAT/enhancer,B-DNA
341,binding,I-DNA
341,protein,I-DNA
341,(,I-DNA
341,C/EBP,I-DNA
341,),I-DNA
341,binding,I-DNA
341,motif,I-DNA
341,that,O
341,was,O
341,located,O
341,in,O
341,the,O
341,upstream,B-DNA
341,region,I-DNA
341,of,O
341,the,O
341,MRP14,B-DNA
341,gene,I-DNA
341,(,O
341,-81,O
341,),O
341,",",O
341,as,O
341,evidenced,O
341,by,O
341,the,O
341,competitive,O
341,gel,O
341,mobility-shift,O
341,assay,O
341,.,O
,,
342,An,O
342,antibody,O
342,for,O
342,C/EBP,B-protein
342,alpha,I-protein
342,super-shifted,O
342,the,O
342,nucleoprotein,B-protein
342,complex,I-protein
342,in,O
342,THP-1,B-cell_line
342,cells,I-cell_line
342,but,O
342,not,O
342,in,O
342,the,O
342,VD3-treated,B-cell_line
342,HL-60,I-cell_line
342,cells,I-cell_line
342,",",O
342,whereas,O
342,an,O
342,antibody,O
342,for,O
342,C/EBP,B-protein
342,beta,I-protein
342,blocked,O
342,the,O
342,formation,O
342,of,O
342,the,O
342,complex,O
342,with,O
342,the,O
342,nuclear,B-protein
342,factor,I-protein
342,of,O
342,the,O
342,HL-60,B-cell_line
342,cells,I-cell_line
342,but,O
342,not,O
342,with,O
342,that,O
342,of,O
342,THP-1,B-cell_line
342,cells,I-cell_line
342,.,O
,,
343,An,O
343,anti-C/EBP,B-protein
343,delta,I-protein
343,antibody,I-protein
343,had,O
343,no,O
343,effect,O
343,on,O
343,the,O
343,complex,O
343,in,O
343,either,O
343,cell,O
343,.,O
,,
344,Thus,O
344,",",O
344,it,O
344,was,O
344,concluded,O
344,that,O
344,C/EBP,B-protein
344,alpha,I-protein
344,and,I-protein
344,beta,I-protein
344,were,O
344,able,O
344,to,O
344,bind,O
344,to,O
344,the,O
344,C/EBP,B-protein
344,motif,I-protein
344,",",O
344,and,O
344,that,O
344,C/EBP,B-protein
344,alpha,I-protein
344,bound,O
344,to,O
344,the,O
344,motif,O
344,in,O
344,THP-1,B-cell_line
344,cells,I-cell_line
344,and,O
344,C/EBP,B-protein
344,beta,I-protein
344,bound,O
344,to,O
344,that,O
344,in,O
344,the,O
344,VD3-treated,B-cell_line
344,HL-60,I-cell_line
344,cells,I-cell_line
344,.,O
,,
345,Furthermore,O
345,",",O
345,to,O
345,examine,O
345,the,O
345,transcriptional,O
345,activity,O
345,of,O
345,the,O
345,C/EBP,B-protein
345,motif,I-protein
345,",",O
345,we,O
345,transfected,O
345,several,O
345,constructed,O
345,luciferase,B-DNA
345,reporter,I-DNA
345,DNAs,I-DNA
345,into,O
345,HL-60,B-cell_line
345,cells,I-cell_line
345,and,O
345,THP-1,B-cell_line
345,cells,I-cell_line
345,.,O
,,
346,The,O
346,luciferase,O
346,activity,O
346,of,O
346,the,O
346,C/EBP,B-protein
346,motif,I-protein
346,in,O
346,HL-60,B-cell_line
346,cells,I-cell_line
346,was,O
346,increased,O
346,by,O
346,VD3,O
346,treatment,O
346,.,O
,,
347,The,O
347,C/EBP,B-protein
347,motif,I-protein
347,in,O
347,the,O
347,MRP14,B-DNA
347,gene,I-DNA
347,was,O
347,confirmed,O
347,to,O
347,function,O
347,as,O
347,a,O
347,regulatory,O
347,region,O
347,in,O
347,VD3-treated,B-cell_line
347,HL-60,I-cell_line
347,cells,I-cell_line
347,and,I-cell_line
347,THP-1,I-cell_line
347,cells,I-cell_line
347,by,O
347,the,O
347,assay,O
347,.,O
,,
348,Since,O
348,C/EBP,B-protein
348,beta,I-protein
348,was,O
348,also,O
348,detected,O
348,in,O
348,VD3-untreated,B-cell_line
348,HL-60,I-cell_line
348,cells,I-cell_line
348,by,O
348,immunoblotting,O
348,",",O
348,VD3,O
348,activated,O
348,C/EBP,B-protein
348,beta,I-protein
348,to,O
348,bind,O
348,to,O
348,the,O
348,motif,O
348,",",O
348,probably,O
348,through,O
348,post-translational,O
348,modification,O
348,.,O
,,
349,Patients,O
349,with,O
349,high-risk,O
349,myelodysplastic,O
349,syndrome,O
349,can,O
349,have,O
349,polyclonal,O
349,or,O
349,clonal,O
349,haemopoiesis,O
349,in,O
349,complete,O
349,haematological,O
349,remission,O
349,.,O
,,
350,The,O
350,clonality,O
350,of,O
350,mature,B-cell_type
350,peripheral,I-cell_type
350,blood-derived,I-cell_type
350,myeloid,I-cell_type
350,and,I-cell_type
350,lymphoid,I-cell_type
350,cells,I-cell_type
350,and,O
350,bone,B-cell_type
350,marrow,I-cell_type
350,haemopoietic,I-cell_type
350,progenitors,I-cell_type
350,from,O
350,18,O
350,females,O
350,with,O
350,myelodysplasia,O
350,(,O
350,MDS,O
350,),O
350,(,O
350,five,O
350,refractory,O
350,anaemia,O
350,",",O
350,RA,O
350,;,O
350,one,O
350,RA,O
350,with,O
350,ringed,B-cell_type
350,sideroblasts,I-cell_type
350,",",O
350,RARS,O
350,;,O
350,three,O
350,chronic,O
350,myelomonocytic,O
350,leukaemia,O
350,",",O
350,CMML,O
350,;,O
350,four,O
350,RA,O
350,with,O
350,excess,O
350,of,O
350,blasts,O
350,",",O
350,RAEB,O
350,;,O
350,five,O
350,RAEB,O
350,in,O
350,transformation,O
350,",",O
350,RAEB-t,O
350,),O
350,was,O
350,studied,O
350,by,O
350,X-chromosome,B-DNA
350,inactivation,O
350,analysis,O
350,.,O
,,
351,Using,O
351,the,O
351,human,O
351,androgen-receptor,O
351,(,O
351,HUMARA,O
351,),O
351,assay,O
351,",",O
351,we,O
351,analysed,O
351,the,O
351,clonal,O
351,patterns,O
351,of,O
351,highly,B-cell_type
351,purified,I-cell_type
351,immature,I-cell_type
351,CD34+,I-cell_type
351,-38,I-cell_type
351,and,I-cell_type
351,committed,I-cell_type
351,CD34+,I-cell_type
351,38+,I-cell_type
351,marrow-derived,I-cell_type
351,progenitors,I-cell_type
351,",",O
351,and,O
351,CD16+,B-cell_type
351,-14,I-cell_type
351,granulocytes,I-cell_type
351,",",O
351,CD14+,B-cell_type
351,monocytes,I-cell_type
351,",",O
351,CD3+,B-cell_type
351,T,I-cell_type
351,and,I-cell_type
351,CD19+,I-cell_type
351,B,I-cell_type
351,lymphocytes,I-cell_type
351,from,O
351,peripheral,O
351,blood,O
351,.,O
,,
352,In,O
352,high-risk,O
352,patients,O
352,(,O
352,RAEB,O
352,",",O
352,RAEB-t,O
352,),O
352,",",O
352,clonality,O
352,analysis,O
352,was,O
352,performed,O
352,before,O
352,and,O
352,after,O
352,intensive,O
352,remission-induction,O
352,treatment,O
352,.,O
,,
353,All,O
353,patients,O
353,",",O
353,except,O
353,one,O
353,with,O
353,RA,O
353,",",O
353,had,O
353,predominance,O
353,of,O
353,a,O
353,single,O
353,clone,O
353,in,O
353,their,O
353,granulocytes,B-cell_type
353,and,O
353,monocytes,B-cell_type
353,.,O
,,
354,The,O
354,same,O
354,clonal,O
354,pattern,O
354,was,O
354,found,O
354,in,O
354,CD34+,B-cell_type
354,progenitor,I-cell_type
354,cells,I-cell_type
354,.,O
,,
355,In,O
355,contrast,O
355,",",O
355,CD3+,B-cell_type
355,T,I-cell_type
355,lymphocytes,I-cell_type
355,were,O
355,polyclonal,O
355,or,O
355,oligoclonal,O
355,in,O
355,14/18,O
355,patients,O
355,.,O
,,
356,X-chromosome,B-DNA
356,inactivation,O
356,patterns,O
356,of,O
356,CD19+,B-cell_type
356,B,I-cell_type
356,cells,I-cell_type
356,were,O
356,highly,O
356,concordant,O
356,with,O
356,CD3+,B-cell_type
356,T,I-cell_type
356,cells,I-cell_type
356,except,O
356,for,O
356,two,O
356,patients,O
356,(,O
356,one,O
356,RA,O
356,",",O
356,one,O
356,CMML,O
356,),O
356,with,O
356,monoclonal,B-cell_type
356,B,I-cell_type
356,and,I-cell_type
356,polyclonal,I-cell_type
356,T,I-cell_type
356,lymphocytes,I-cell_type
356,",",O
356,therefore,O
356,suggesting,O
356,a,O
356,clonal,O
356,mutation,O
356,in,O
356,a,O
356,progenitor,B-cell_type
356,common,O
356,to,O
356,the,O
356,myeloid,B-cell_type
356,and,I-cell_type
356,B-lymphoid,I-cell_type
356,lineages,I-cell_type
356,or,O
356,the,O
356,coexistence,O
356,of,O
356,MDS,O
356,and,O
356,a,O
356,B-cell,O
356,disorder,O
356,in,O
356,these,O
356,particular,O
356,patients,O
356,.,O
,,
357,After,O
357,high-dose,O
357,non-myeloablative,O
357,chemotherapy,O
357,",",O
357,polyclonal,O
357,haemopoiesis,O
357,was,O
357,reinstalled,O
357,in,O
357,the,O
357,mature,B-cell_type
357,myeloid,I-cell_type
357,cells,I-cell_type
357,and,O
357,immature,O
357,and,O
357,committed,B-cell_type
357,marrow,I-cell_type
357,progenitors,I-cell_type
357,in,O
357,three,O
357,of,O
357,four,O
357,patients,O
357,achieving,O
357,complete,O
357,haematological,O
357,remission,O
357,.,O
,,
358,Therefore,O
358,we,O
358,conclude,O
358,that,O
358,most,O
358,haematological,O
358,remissions,O
358,in,O
358,MDS,O
358,are,O
358,associated,O
358,with,O
358,restoration,O
358,of,O
358,polyclonal,O
358,haemopoiesis,O
358,.,O
,,
359,Prominent,O
359,sex,O
359,steroid,O
359,metabolism,O
359,in,O
359,human,B-cell_type
359,lymphocytes,I-cell_type
359,.,O
,,
360,Steroid,O
360,metabolism,O
360,was,O
360,investigated,O
360,in,O
360,cultured,B-cell_line
360,human,I-cell_line
360,B-lymphoblastoid,I-cell_line
360,cells,I-cell_line
360,(,O
360,B-LCL,B-cell_line
360,),O
360,",",O
360,and,O
360,peripheral,B-cell_type
360,blood,I-cell_type
360,T,I-cell_type
360,and,I-cell_type
360,B,I-cell_type
360,cells,I-cell_type
360,.,O
,,
361,Gene,O
361,expression,O
361,was,O
361,examined,O
361,by,O
361,reverse-transcription,O
361,polymerase,O
361,chain,O
361,reaction,O
361,amplification,O
361,(,O
361,RT-PCR,O
361,),O
361,.,O
,,
362,Appropriate,O
362,sized,O
362,transcripts,B-RNA
362,were,O
362,detected,O
362,in,O
362,both,O
362,cultured,O
362,and,O
362,fresh,O
362,peripheral,B-cell_type
362,lymphocytes,I-cell_type
362,for,O
362,CYP11A,B-protein
362,",",O
362,CYP17,B-protein
362,",",O
362,HSD11L,B-protein
362,(,O
362,11beta-hydroxysteroid,B-protein
362,dehydrogenase,I-protein
362,I,I-protein
362,),O
362,",",O
362,HSD17B1,B-protein
362,(,O
362,17beta-hydroxysteroid,B-protein
362,dehydrogenase,I-protein
362,type,I-protein
362,I,I-protein
362,),O
362,and,O
362,SRD5A1,B-protein
362,(,O
362,5alpha-reductase,B-protein
362,I,I-protein
362,),O
362,.,O
,,
363,B-LCL,O
363,",",O
363,but,O
363,not,O
363,T,B-cell_type
363,and,I-cell_type
363,B,I-cell_type
363,cells,I-cell_type
363,",",O
363,expressed,O
363,CYP11B,B-protein
363,.,O
,,
364,There,O
364,was,O
364,minimal,O
364,expression,O
364,of,O
364,HSD3B1,B-protein
364,and,O
364,HSD3B2,B-protein
364,(,O
364,3beta-hydroxysteroid,B-protein
364,dehydrogenase,I-protein
364,I,I-protein
364,and,I-protein
364,II,I-protein
364,),O
364,in,O
364,B-LCL,B-cell_line
364,and,O
364,T,B-cell_type
364,cells,I-cell_type
364,.,O
,,
365,Transcripts,O
365,for,O
365,CYP19,B-protein
365,and,O
365,HSD11K,B-protein
365,were,O
365,not,O
365,detected,O
365,.,O
,,
366,Corresponding,O
366,enzymatic,O
366,activity,O
366,was,O
366,detectable,O
366,only,O
366,for,O
366,17-hydroxysteroid,B-protein
366,dehydrogenase,I-protein
366,and,O
366,5alpha-reductase,B-protein
366,",",O
366,respectively,O
366,producing,O
366,testosterone,O
366,and,O
366,5alpha-dihydrotestosterone,O
366,.,O
,,
367,Steroid,O
367,identities,O
367,were,O
367,confirmed,O
367,by,O
367,gas,O
367,chromatography/mass,O
367,spectrometry,O
367,(,O
367,GC/MS,O
367,),O
367,.,O
,,
368,One,O
368,metabolite,O
368,thought,O
368,to,O
368,be,O
368,deoxycorticosterone,O
368,was,O
368,identified,O
368,by,O
368,GC/MS,O
368,as,O
368,6alpha-hydroxypregnanolone,O
368,.,O
,,
369,It,O
369,was,O
369,concluded,O
369,that,O
369,sex,O
369,hormone,O
369,metabolism,O
369,",",O
369,including,O
369,androgen,O
369,synthesis,O
369,",",O
369,occurs,O
369,in,O
369,lymphocytes,O
369,",",O
369,and,O
369,may,O
369,modulate,O
369,immune,O
369,response,O
369,.,O
,,
370,Human,B-cell_type
370,white,I-cell_type
370,blood,I-cell_type
370,cells,I-cell_type
370,and,O
370,hair,O
370,follicles,O
370,are,O
370,good,O
370,sources,O
370,of,O
370,mRNA,B-RNA
370,for,O
370,the,O
370,pterin,B-protein
370,carbinolamine,I-protein
370,dehydratase/dimerization,I-protein
370,cofactor,I-protein
370,of,O
370,HNF1,B-protein
370,for,O
370,mutation,O
370,detection,O
370,.,O
,,
371,Pterin,B-protein
371,carbinolamine,I-protein
371,dehydratase/dimerization,I-protein
371,cofactor,I-protein
371,of,O
371,HNF1,B-protein
371,(,O
371,PCD/DCoH,B-protein
371,),O
371,is,O
371,a,O
371,protein,O
371,that,O
371,has,O
371,a,O
371,dual,O
371,function,O
371,.,O
,,
372,It,O
372,is,O
372,a,O
372,pterin,B-protein
372,4alpha-carbinolamine,I-protein
372,dehydratase,I-protein
372,that,O
372,is,O
372,involved,O
372,in,O
372,the,O
372,regeneration,O
372,of,O
372,the,O
372,cofactor,B-protein
372,tetrahydrobiopterin,I-protein
372,during,O
372,the,O
372,phenylalanine,O
372,hydroxylase-,O
372,catalyzed,O
372,hydroxylation,O
372,of,O
372,phenylalanine,O
372,.,O
,,
373,In,O
373,addition,O
373,",",O
373,it,O
373,is,O
373,the,O
373,dimerization,O
373,cofactor,O
373,of,O
373,HNF1,B-protein
373,that,O
373,is,O
373,able,O
373,to,O
373,activate,O
373,the,O
373,transcriptional,O
373,activity,O
373,of,O
373,HNF1,B-protein
373,.,O
,,
374,Deficiencies,O
374,in,O
374,the,O
374,gene,O
374,for,O
374,this,O
374,dual,B-protein
374,functional,I-protein
374,protein,I-protein
374,result,O
374,in,O
374,hyperphenylalaninemia,O
374,.,O
,,
375,Here,O
375,we,O
375,report,O
375,for,O
375,the,O
375,first,O
375,time,O
375,that,O
375,the,O
375,PCD/DCoH,B-RNA
375,mRNA,I-RNA
375,is,O
375,present,O
375,in,O
375,human,B-cell_type
375,white,I-cell_type
375,blood,I-cell_type
375,cells,I-cell_type
375,and,O
375,hair,O
375,follicles,O
375,.,O
,,
376,Taking,O
376,advantage,O
376,of,O
376,this,O
376,finding,O
376,",",O
376,a,O
376,sensitive,O
376,",",O
376,rapid,O
376,and,O
376,convenient,O
376,method,O
376,for,O
376,screening,O
376,mutations,O
376,occurring,O
376,in,O
376,the,O
376,coding,O
376,region,O
376,of,O
376,this,O
376,gene,O
376,has,O
376,been,O
376,described,O
376,.,O
,,
377,Copyright,O
377,1998,O
377,Academic,O
377,Press,O
377,.,O
,,
378,Biochemical,O
378,characterization,O
378,of,O
378,the,O
378,NF-Y,B-protein
378,transcription,I-protein
378,factor,I-protein
378,complex,I-protein
378,during,O
378,B,O
378,lymphocyte,O
378,development,O
378,.,O
,,
379,The,O
379,transcription,B-protein
379,factor,I-protein
379,",",O
379,NF-Y,B-protein
379,",",O
379,plays,O
379,a,O
379,critical,O
379,role,O
379,in,O
379,tissue-specific,O
379,major,B-DNA
379,histocompatibility,I-DNA
379,complex,I-DNA
379,class,I-DNA
379,II,I-DNA
379,gene,I-DNA
379,transcription,O
379,.,O
,,
380,In,O
380,this,O
380,report,O
380,the,O
380,biochemical,O
380,properties,O
380,of,O
380,the,O
380,heterotrimeric,B-protein
380,NF-Y,I-protein
380,complex,I-protein
380,have,O
380,been,O
380,characterized,O
380,during,O
380,stage-specific,O
380,B-cell,O
380,development,O
380,",",O
380,and,O
380,in,O
380,several,O
380,class,B-cell_line
380,II-,I-cell_line
380,mutant,I-cell_line
380,B-cell,I-cell_line
380,lines,I-cell_line
380,",",O
380,which,O
380,represent,O
380,distinct,O
380,bare,O
380,lymphocyte,O
380,syndrome,O
380,class,O
380,II,O
380,genetic,O
380,complementation,O
380,groups,O
380,.,O
,,
381,The,O
381,NF-Y,B-protein
381,complex,I-protein
381,derived,O
381,from,O
381,class,B-cell_type
381,II+,I-cell_type
381,mature,I-cell_type
381,B-cells,I-cell_type
381,bound,O
381,with,O
381,high,O
381,affinity,O
381,to,O
381,anion,B-protein
381,exchangers,I-protein
381,",",O
381,and,O
381,eluted,O
381,as,O
381,an,O
381,intact,O
381,trimeric,B-protein
381,complex,I-protein
381,",",O
381,whereas,O
381,",",O
381,NF-Y,B-protein
381,derived,O
381,from,O
381,class,B-cell_type
381,II-,I-cell_type
381,plasma,I-cell_type
381,B-cells,I-cell_type
381,",",O
381,and,O
381,from,O
381,bare,B-cell_line
381,lymphocyte,I-cell_line
381,syndrome,I-cell_line
381,group,I-cell_line
381,II,I-cell_line
381,cell,I-cell_line
381,lines,I-cell_line
381,",",O
381,RJ2.2.5,B-cell_line
381,and,O
381,RM3,B-cell_line
381,",",O
381,dissociated,O
381,into,O
381,discrete,O
381,NF-YA,B-protein
381,and,O
381,NF-YB,B-protein
381,:,I-protein
381,C,I-protein
381,subunit,B-protein
381,fractions,I-protein
381,.,O
,,
382,Recombination,O
382,of,O
382,the,O
382,MPC11,B-protein
382,plasma,I-protein
382,B-cell,I-protein
382,derived,I-protein
382,NF-Y,I-protein
382,A,I-protein
382,:,I-protein
382,B,I-protein
382,:,I-protein
382,C,I-protein
382,complex,I-protein
382,with,O
382,the,O
382,low,O
382,molecular,O
382,mass,O
382,protein,O
382,fraction,O
382,",",O
382,NF-Y-associated,B-protein
382,factors,I-protein
382,(,O
382,YAFs,B-protein
382,),O
382,",",O
382,derived,O
382,from,O
382,mature,O
382,A20,O
382,B-cell,O
382,nuclei,O
382,",",O
382,conferred,O
382,high,O
382,affinity,O
382,anion,O
382,exchange,O
382,binding,O
382,to,O
382,NF-Y,B-protein
382,as,O
382,an,O
382,intact,B-protein
382,trimeric,I-protein
382,complex,I-protein
382,.,O
,,
383,Recombination,O
383,of,O
383,the,O
383,native,B-protein
383,NF-YA,I-protein
383,:,I-protein
383,B,I-protein
383,:,I-protein
383,C,I-protein
383,complex,I-protein
383,with,O
383,the,O
383,transcriptional,B-protein
383,cofactor,I-protein
383,",",O
383,PC4,B-protein
383,",",O
383,likewise,O
383,conferred,O
383,high,B-protein
383,affinity,I-protein
383,NF-Y,I-protein
383,binding,O
383,to,O
383,anion,B-protein
383,exchangers,I-protein
383,",",O
383,and,O
383,stabilized,O
383,NF-Y,B-protein
383,interaction,O
383,with,O
383,CCAAT-box,B-DNA
383,DNA,I-DNA
383,motifs,I-DNA
383,in,O
383,vitro,O
383,.,O
,,
384,Interaction,O
384,between,O
384,PC4,B-protein
384,and,O
384,NF-Y,B-protein
384,was,O
384,mapped,O
384,to,O
384,the,O
384,C-terminal,B-protein
384,region,I-protein
384,of,O
384,PC4,B-protein
384,",",O
384,and,O
384,the,O
384,subunit,B-protein
384,interaction,I-protein
384,subdomain,I-protein
384,of,O
384,the,O
384,highly,B-protein
384,conserved,I-protein
384,DNA,I-protein
384,binding-subunit,I-protein
384,interaction,I-protein
384,domain,I-protein
384,(,O
384,DBD,B-protein
384,),O
384,of,O
384,NF-YA,B-protein
384,.,O
,,
385,These,O
385,results,O
385,suggest,O
385,that,O
385,in,O
385,class,B-cell_type
385,II+,I-cell_type
385,mature,I-cell_type
385,B-cells,I-cell_type
385,NF-Y,B-protein
385,is,O
385,associated,O
385,with,O
385,the,O
385,protein,O
385,cofactor,O
385,",",O
385,PC4,B-protein
385,",",O
385,which,O
385,may,O
385,play,O
385,an,O
385,important,O
385,role,O
385,in,O
385,NF-Y-mediated,O
385,transcriptional,O
385,control,O
385,of,O
385,class,B-DNA
385,II,I-DNA
385,genes,I-DNA
385,.,O
,,
386,Arrest,O
386,of,O
386,B,O
386,lymphocyte,O
386,terminal,O
386,differentiation,O
386,by,O
386,CD40,O
386,signaling,O
386,:,O
386,mechanism,O
386,for,O
386,lack,O
386,of,O
386,antibody-secreting,B-cell_type
386,cells,I-cell_type
386,in,O
386,germinal,O
386,centers,O
386,.,O
,,
387,Despite,O
387,extensive,O
387,research,O
387,",",O
387,the,O
387,role,O
387,of,O
387,CD40,B-protein
387,signaling,O
387,in,O
387,B,O
387,cell,O
387,terminal,O
387,differentiation,O
387,remains,O
387,controversial,O
387,.,O
,,
388,Here,O
388,we,O
388,show,O
388,that,O
388,CD40,B-protein
388,engagement,O
388,arrests,O
388,B,O
388,cell,O
388,differentiation,O
388,prior,O
388,to,O
388,plasma,O
388,cell,O
388,formation,O
388,.,O
,,
389,This,O
389,arrest,O
389,is,O
389,manifested,O
389,at,O
389,a,O
389,molecular,O
389,level,O
389,as,O
389,a,O
389,reduction,O
389,in,O
389,mRNA,O
389,levels,O
389,of,O
389,secretory,O
389,immunoglobulin,O
389,gene,O
389,products,O
389,such,O
389,as,O
389,mu,O
389,(,O
389,s,O
389,),O
389,and,O
389,J,O
389,chain,O
389,as,O
389,well,O
389,as,O
389,the,O
389,loss,O
389,of,O
389,the,O
389,transcriptional,B-protein
389,regulator,I-protein
389,BLIMP-1,B-protein
389,.,O
,,
390,Furthermore,O
390,",",O
390,the,O
390,inhibition,O
390,of,O
390,B,O
390,cell,O
390,differentiation,O
390,by,O
390,CD40,B-protein
390,engagement,O
390,could,O
390,not,O
390,be,O
390,overcome,O
390,by,O
390,either,O
390,mitogens,B-protein
390,or,O
390,cytokines,B-protein
390,",",O
390,but,O
390,could,O
390,be,O
390,reversed,O
390,by,O
390,antibodies,O
390,that,O
390,interfere,O
390,with,O
390,the,O
390,CD40,B-protein
390,/,O
390,gp39,B-protein
390,interaction,O
390,.,O
,,
391,These,O
391,data,O
391,suggest,O
391,that,O
391,secretory,O
391,immunoglobulin,O
391,is,O
391,not,O
391,produced,O
391,by,O
391,B,B-cell_type
391,cells,I-cell_type
391,that,O
391,are,O
391,actively,O
391,engaged,O
391,by,O
391,gp39-expressing,B-cell_type
391,T,I-cell_type
391,cells,I-cell_type
391,.,O
,,
392,A,O
392,positively,O
392,charged,O
392,alpha-lipoic,O
392,acid,O
392,analogue,O
392,with,O
392,increased,O
392,cellular,O
392,uptake,O
392,and,O
392,more,O
392,potent,O
392,immunomodulatory,O
392,activity,O
392,.,O
,,
393,alpha-Lipoic,O
393,acid,O
393,(,O
393,LA,O
393,),O
393,is,O
393,taken,O
393,up,O
393,by,O
393,cells,O
393,and,O
393,reduced,O
393,to,O
393,its,O
393,potent,O
393,dithiol,O
393,form,O
393,",",O
393,dihydrolipoate,O
393,(,O
393,DHLA,O
393,),O
393,",",O
393,much,O
393,of,O
393,which,O
393,is,O
393,rapidly,O
393,effluxed,O
393,out,O
393,from,O
393,cells,O
393,.,O
,,
394,To,O
394,improve,O
394,retention,O
394,in,O
394,cells,O
394,",",O
394,the,O
394,LA,O
394,molecule,O
394,was,O
394,modified,O
394,to,O
394,confer,O
394,a,O
394,positive,O
394,charge,O
394,at,O
394,physiological,O
394,pH,O
394,.,O
,,
395,N,O
395,",",O
395,N-dimethyl,O
395,",",O
395,N'-2-amidoethyl-lipoate,O
395,was,O
395,synthesized,O
395,.,O
,,
396,The,O
396,protonated,O
396,form,O
396,of,O
396,the,O
396,new,O
396,molecule,O
396,is,O
396,referred,O
396,to,O
396,as,O
396,LA-Plus,O
396,.,O
,,
397,The,O
397,uptake,O
397,of,O
397,LA-Plus,O
397,by,O
397,human,B-cell_type
397,Wurzburg,I-cell_type
397,T,I-cell_type
397,cells,I-cell_type
397,was,O
397,higher,O
397,compared,O
397,to,O
397,that,O
397,of,O
397,LA,O
397,.,O
,,
398,Several-fold,O
398,higher,O
398,amounts,O
398,of,O
398,DHLA-Plus,O
398,",",O
398,the,O
398,corresponding,O
398,reduced,O
398,form,O
398,of,O
398,LA-Plus,O
398,",",O
398,were,O
398,detected,O
398,in,O
398,LA-Plus,O
398,treated,O
398,cells,O
398,compared,O
398,to,O
398,the,O
398,amount,O
398,of,O
398,DHLA,O
398,found,O
398,in,O
398,cells,O
398,treated,O
398,with,O
398,LA,O
398,.,O
,,
399,At,O
399,100,O
399,microM,O
399,",",O
399,LA,O
399,did,O
399,not,O
399,but,O
399,LA-Plus,O
399,inhibited,O
399,H2O2,O
399,induced,O
399,NF-kappaB,B-protein
399,activation,O
399,and,O
399,NF-kappaB,B-protein
399,directed,O
399,IL-2,B-protein
399,receptor,I-protein
399,expression,O
399,.,O
,,
400,Both,O
400,LA,O
400,and,O
400,LA-Plus,O
400,synergised,O
400,with,O
400,selenium,O
400,in,O
400,inhibiting,O
400,H2O2,O
400,induced,O
400,NF-kappaB,B-protein
400,activation,O
400,.,O
,,
401,At,O
401,150,O
401,microM,O
401,LA-Plus,O
401,",",O
401,but,O
401,not,O
401,LA,O
401,",",O
401,inhibited,O
401,TNFalpha,B-protein
401,induced,O
401,NF-kappaB,B-protein
401,activation,O
401,.,O
,,
402,At,O
402,5,O
402,microM,O
402,LA-Plus,O
402,",",O
402,but,O
402,not,O
402,LA,O
402,",",O
402,protected,O
402,against,O
402,both,O
402,spontaneous,O
402,and,O
402,etoposide,O
402,induced,O
402,apoptosis,O
402,in,O
402,rat,B-cell_type
402,thymocytes,I-cell_type
402,.,O
,,
403,LA-Plus,O
403,is,O
403,thus,O
403,an,O
403,improved,O
403,form,O
403,of,O
403,LA,O
403,with,O
403,increased,O
403,therapeutic,O
403,potential,O
403,.,O
,,
404,Copyright,O
404,1998,O
404,Academic,O
404,Press,O
404,.,O
,,
405,Carrier,O
405,identification,O
405,in,O
405,X-linked,O
405,immunodeficiency,O
405,diseases,O
405,.,O
,,
406,OBJECTIVE,O
406,:,O
406,Carrier,O
406,identification,O
406,in,O
406,X-linked,O
406,immunodeficiency,O
406,disorders,O
406,can,O
406,be,O
406,based,O
406,on,O
406,the,O
406,demonstration,O
406,of,O
406,non-random,O
406,X,O
406,inactivation,O
406,(,O
406,NRXI,O
406,),O
406,in,O
406,affected,B-cell_type
406,blood,I-cell_type
406,cell,I-cell_type
406,lineages,I-cell_type
406,when,O
406,growth,O
406,is,O
406,impaired,O
406,in,O
406,cells,O
406,expressing,O
406,the,O
406,abnormal,B-DNA
406,gene,I-DNA
406,.,O
,,
407,We,O
407,examined,O
407,the,O
407,utility,O
407,of,O
407,seeking,O
407,evidence,O
407,of,O
407,NRXI,O
407,to,O
407,test,O
407,the,O
407,carrier,O
407,status,O
407,of,O
407,women,O
407,in,O
407,families,O
407,affected,O
407,by,O
407,X-linked,O
407,severe,O
407,combined,O
407,immunodeficiency,O
407,(,O
407,XSCID,O
407,),O
407,and,O
407,X-linked,O
407,hypogammaglobulinaemia,O
407,(,O
407,XLH,O
407,),O
407,",",O
407,to,O
407,identify,O
407,as,O
407,carriers,O
407,the,O
407,mothers,O
407,of,O
407,boys,O
407,with,O
407,SCID,O
407,or,O
407,hypogammaglobulinaemia,O
407,whose,O
407,phenotype,O
407,suggested,O
407,X-linkage,O
407,and,O
407,to,O
407,infer,O
407,X-linkage,O
407,in,O
407,boys,O
407,with,O
407,SCID,O
407,or,O
407,hypogammaglobulinaemia,O
407,whose,O
407,disease,O
407,was,O
407,not,O
407,clearly,O
407,X-linked,O
407,on,O
407,the,O
407,basis,O
407,either,O
407,of,O
407,family,O
407,history,O
407,or,O
407,clinical,O
407,and,O
407,immunological,O
407,characteristics,O
407,.,O
,,
408,METHODOLOGY,O
408,:,O
408,A,O
408,polymerase,O
408,chain,O
408,reaction-based,O
408,method,O
408,was,O
408,used,O
408,to,O
408,amplify,O
408,a,O
408,polymorphic,O
408,CAG,B-DNA
408,repeat,I-DNA
408,in,O
408,the,O
408,first,B-DNA
408,exon,I-DNA
408,of,O
408,the,O
408,androgen,B-DNA
408,receptor,I-DNA
408,gene,I-DNA
408,after,O
408,selective,O
408,digestion,O
408,of,O
408,the,O
408,active,B-DNA
408,X,I-DNA
408,chromosome,I-DNA
408,with,O
408,a,O
408,methylation-sensitive,B-protein
408,enzyme,I-protein
408,",",O
408,HpaII,B-protein
408,to,O
408,distinguish,O
408,between,O
408,the,O
408,paternal,B-DNA
408,and,I-DNA
408,maternal,I-DNA
408,alleles,I-DNA
408,and,O
408,to,O
408,identify,O
408,their,O
408,methylation,O
408,status,O
408,.,O
,,
409,RESULTS,O
409,:,O
409,Heterozygosity,O
409,was,O
409,found,O
409,in,O
409,24,O
409,of,O
409,31,O
409,female,O
409,subjects,O
409,(,O
409,77,O
409,%,O
409,),O
409,.,O
,,
410,As,O
410,anticipated,O
410,",",O
410,NRXI,O
410,could,O
410,be,O
410,demonstrated,O
410,in,O
410,all,O
410,lymphoid,B-cell_type
410,cells,I-cell_type
410,studied,O
410,from,O
410,obligate,O
410,carriers,O
410,of,O
410,XSCID,O
410,and,O
410,an,O
410,obligate,O
410,carrier,O
410,of,O
410,XLH,O
410,but,O
410,not,O
410,on,O
410,a,O
410,carrier,O
410,of,O
410,X-linked,O
410,immunodeficiency,O
410,with,O
410,hyper-IgM,B-protein
410,.,O
,,
411,The,O
411,finding,O
411,of,O
411,NRXI,O
411,in,O
411,the,O
411,mother,O
411,of,O
411,a,O
411,boy,O
411,with,O
411,a,O
411,SCID,O
411,variant,O
411,showed,O
411,her,O
411,to,O
411,be,O
411,a,O
411,carrier,O
411,of,O
411,XSCID,O
411,and,O
411,establishes,O
411,that,O
411,her,O
411,son,O
411,has,O
411,XSCID,O
411,",",O
411,not,O
411,otherwise,O
411,evident,O
411,from,O
411,available,O
411,data,O
411,.,O
,,
412,CONCLUSIONS,O
412,:,O
412,This,O
412,PCR,O
412,assay,O
412,provides,O
412,a,O
412,rapid,O
412,method,O
412,for,O
412,carrier,O
412,detection,O
412,of,O
412,X-linked,O
412,immunodeficiencies,O
412,",",O
412,and,O
412,has,O
412,allowed,O
412,us,O
412,to,O
412,expand,O
412,the,O
412,phenotype,O
412,of,O
412,XSCID,O
,,
413,Leukocyte-endothelial,O
413,interaction,O
413,is,O
413,augmented,O
413,by,O
413,high,O
413,glucose,O
413,concentrations,O
413,and,O
413,hyperglycemia,O
413,in,O
413,a,O
413,NF-kB-dependent,O
413,fashion,O
413,.,O
,,
414,We,O
414,addressed,O
414,the,O
414,role,O
414,of,O
414,hyperglycemia,O
414,in,O
414,leukocyte-endothelium,O
414,interaction,O
414,under,O
414,flow,O
414,conditions,O
414,by,O
414,exposing,O
414,human,B-cell_type
414,umbilical,I-cell_type
414,vein,I-cell_type
414,endothelial,I-cell_type
414,cells,I-cell_type
414,for,O
414,24,O
414,h,O
414,to,O
414,normal,O
414,(,O
414,5,O
414,mM,O
414,),O
414,",",O
414,high,O
414,concentration,O
414,of,O
414,glucose,O
414,(,O
414,30,O
414,mM,O
414,),O
414,",",O
414,advanced,O
414,glycosylation,O
414,end,O
414,product-albumin,B-protein
414,(,O
414,100,O
414,microg/ml,O
414,),O
414,",",O
414,or,O
414,hyperglycemic,O
414,(,O
414,174-316,O
414,mg/dl,O
414,),O
414,sera,O
414,from,O
414,patients,O
414,with,O
414,diabetes,O
414,and,O
414,abnormal,O
414,hemoglobin,O
414,A1c,O
414,(,O
414,8.1+/-1.4,O
414,%,O
414,),O
414,.,O
,,
415,At,O
415,the,O
415,end,O
415,of,O
415,incubation,O
415,endothelial,B-cell_type
415,cells,I-cell_type
415,were,O
415,perfused,O
415,with,O
415,total,O
415,leukocyte,O
415,suspension,O
415,in,O
415,a,O
415,parallel,O
415,plate,O
415,flow,O
415,chamber,O
415,under,O
415,laminar,O
415,flow,O
415,(,O
415,1.5,O
415,dyn/cm2,O
415,),O
415,.,O
,,
416,Rolling,O
416,and,O
416,adherent,B-cell_type
416,cells,I-cell_type
416,were,O
416,evaluated,O
416,by,O
416,digital,O
416,image,O
416,processing,O
416,.,O
,,
417,Results,O
417,showed,O
417,that,O
417,30,O
417,mM,O
417,glucose,O
417,significantly,O
417,(,O
417,P,O
417,<,O
417,0.01,O
417,),O
417,increased,O
417,the,O
417,number,O
417,of,O
417,adherent,B-cell_type
417,leukocytes,I-cell_type
417,to,O
417,endothelial,B-cell_type
417,cells,I-cell_type
417,in,O
417,respect,O
417,to,O
417,control,O
417,(,O
417,5,O
417,mM,O
417,glucose,O
417,;,O
417,151+/-19,O
417,versus,O
417,33+/-8,O
417,cells/mm2,O
417,),O
417,.,O
,,
418,A,O
418,similar,O
418,response,O
418,was,O
418,induced,O
418,by,O
418,endothelial,O
418,stimulation,O
418,with,O
418,IL-1beta,B-protein
418,",",O
418,here,O
418,used,O
418,as,O
418,positive,O
418,control,O
418,(,O
418,195+/-20,O
418,cells/mm2,O
418,),O
418,.,O
,,
419,The,O
419,number,O
419,of,O
419,rolling,B-cell_type
419,cells,I-cell_type
419,on,O
419,endothelial,O
419,surface,O
419,was,O
419,not,O
419,affected,O
419,by,O
419,high,O
419,glucose,O
419,level,O
419,.,O
,,
420,Stable,O
420,adhesion,O
420,of,O
420,leukocytes,B-cell_type
420,to,O
420,glucose-treated,O
420,as,O
420,well,O
420,as,O
420,to,O
420,IL-1beta-stimulated,B-cell_type
420,endothelial,I-cell_type
420,cells,I-cell_type
420,was,O
420,preceded,O
420,by,O
420,short,O
420,interaction,O
420,of,O
420,leukocytes,B-cell_type
420,with,O
420,the,O
420,endothelial,O
420,surface,O
420,.,O
,,
421,The,O
421,distance,O
421,travelled,O
421,by,O
421,leukocytes,B-cell_type
421,before,O
421,arrest,O
421,on,O
421,30,O
421,mM,O
421,glucose,O
421,",",O
421,or,O
421,on,O
421,IL-1beta-treated,B-cell_type
421,endothelial,I-cell_type
421,cells,I-cell_type
421,",",O
421,was,O
421,significantly,O
421,(,O
421,P,O
421,<,O
421,0.01,O
421,),O
421,higher,O
421,than,O
421,that,O
421,observed,O
421,for,O
421,leukocytes,B-cell_type
421,adhering,O
421,on,O
421,control,O
421,endothelium,O
421,(,O
421,30,O
421,mM,O
421,glucose,O
421,:,O
421,76.7+/-3.5,O
421,;,O
421,IL1beta,O
421,:,O
421,69.7+/-4,O
421,versus,O
421,5,O
421,mM,O
421,glucose,O
421,:,O
421,21.5+/-5,O
421,microm,O
421,),O
421,.,O
,,
422,Functional,O
422,blocking,O
422,of,O
422,E-selectin,B-protein
422,",",O
422,intercellular,B-protein
422,cell,I-protein
422,adhesion,I-protein
422,molecule-1,I-protein
422,",",O
422,and,O
422,vascular,B-protein
422,cell,I-protein
422,adhesion,I-protein
422,molecule-1,I-protein
422,on,O
422,endothelial,B-cell_type
422,cells,I-cell_type
422,with,O
422,the,O
422,corresponding,O
422,mouse,B-protein
422,mAb,I-protein
422,significantly,O
422,inhibited,O
422,glucose-induced,O
422,increase,O
422,in,O
422,leukocyte,O
422,adhesion,O
422,(,O
422,67+/-16,O
422,",",O
422,83+/-12,O
422,",",O
422,62+/-8,O
422,versus,O
422,144+/-21,O
422,cells/,O
422,mm2,O
422,),O
422,.,O
,,
423,Confocal,O
423,fluorescence,O
423,microscopy,O
423,studies,O
423,showed,O
423,that,O
423,30,O
423,mM,O
423,glucose,O
423,induced,O
423,an,O
423,increase,O
423,in,O
423,endothelial,O
423,surface,O
423,expression,O
423,of,O
423,E-selectin,B-protein
423,",",O
423,intercellular,B-protein
423,cell,I-protein
423,adhesion,I-protein
423,molecule-1,I-protein
423,",",O
423,and,O
423,vascular,B-protein
423,cell,I-protein
423,adhesion,I-protein
423,molecule-1,I-protein
423,.,O
,,
424,Electrophoretic,O
424,mobility,O
424,shift,O
424,assay,O
424,of,O
424,nuclear,O
424,extracts,O
424,of,O
424,human,B-cell_type
424,umbilical,I-cell_type
424,vein,I-cell_type
424,endothelial,I-cell_type
424,cells,I-cell_type
424,(,O
424,HUVEC,O
424,),O
424,exposed,O
424,for,O
424,1,O
424,h,O
424,to,O
424,30,O
424,mM,O
424,glucose,O
424,revealed,O
424,an,O
424,intense,O
424,NF-kB,B-protein
424,activation,O
424,.,O
,,
425,Treatment,O
425,of,O
425,HUVEC,O
425,exposed,O
425,to,O
425,high,O
425,glucose,O
425,with,O
425,the,O
425,NF-kB,B-protein
425,inhibitors,I-protein
425,pyrrolidinedithiocarbamate,O
425,(,O
425,100,O
425,microM,O
425,),O
425,and,O
425,tosyl-phe-chloromethylketone,O
425,(,O
425,25,O
425,microM,O
425,),O
425,significantly,O
425,reduced,O
425,(,O
425,P,O
425,<,O
425,0.05,O
425,),O
425,leukocyte,O
425,adhesion,O
425,in,O
425,respect,O
425,to,O
425,HUVEC,O
425,treated,O
425,with,O
425,glucose,O
425,alone,O
425,.,O
,,
426,A,O
426,significant,O
426,(,O
426,P,O
426,<,O
426,0.01,O
426,),O
426,inhibitory,O
426,effect,O
426,on,O
426,glucose-induced,O
426,leukocyte,O
426,adhesion,O
426,was,O
426,observed,O
426,after,O
426,blocking,O
426,protein,B-protein
426,kinase,I-protein
426,C,I-protein
426,activity,O
426,with,O
426,staurosporine,O
426,(,O
426,5,O
426,nM,O
426,),O
426,.,O
,,
427,When,O
427,HUVEC,O
427,were,O
427,treated,O
427,with,O
427,specific,O
427,antisense,O
427,oligodesoxynucleotides,O
427,against,O
427,PKCalpha,B-protein
427,and,I-protein
427,PKCepsilon,I-protein
427,isoforms,I-protein
427,before,O
427,the,O
427,addition,O
427,of,O
427,30,O
427,mM,O
427,glucose,O
427,",",O
427,a,O
427,significant,O
427,(,O
427,P,O
427,<,O
427,0.05,O
427,),O
427,reduction,O
427,in,O
427,the,O
427,adhesion,O
427,was,O
427,also,O
427,seen,O
427,.,O
,,
428,Advanced,O
428,glycosylation,O
428,end,O
428,product-albumin,B-protein
428,significantly,O
428,increased,O
428,the,O
428,number,O
428,of,O
428,adhering,B-cell_type
428,leukocytes,I-cell_type
428,in,O
428,respect,O
428,to,O
428,native,B-protein
428,albumin,I-protein
428,used,O
428,as,O
428,control,O
428,(,O
428,110+/-16,O
428,versus,O
428,66+/-7,O
428,",",O
428,P,O
428,<,O
428,0.01,O
428,),O
428,.,O
,,
429,Sera,O
429,from,O
429,diabetic,O
429,patients,O
429,significantly,O
429,(,O
429,P,O
429,<,O
429,0.01,O
429,),O
429,enhanced,O
429,leukocyte,O
429,adhesion,O
429,as,O
429,compared,O
429,with,O
429,controls,O
429,",",O
429,despite,O
429,normal,O
429,levels,O
429,of,O
429,IL-1beta,B-protein
429,and,O
429,TNFalpha,B-protein
429,in,O
429,these,O
429,sera,O
429,.,O
,,
430,These,O
430,data,O
430,indicate,O
430,that,O
430,high,O
430,glucose,O
430,concentration,O
430,and,O
430,hyperglycemia,O
430,promote,O
430,leukocyte,O
430,adhesion,O
430,to,O
430,the,O
430,endothelium,O
430,through,O
430,upregulation,O
430,of,O
430,cell,O
430,surface,O
430,expression,O
430,of,O
430,adhesive,O
430,proteins,O
430,",",O
430,possibly,O
430,depending,O
430,on,O
430,NF-kB,B-protein
430,activation,O
430,.,O
,,
431,Ikaros,B-protein
431,in,O
431,hemopoietic,O
431,lineage,O
431,determination,O
431,and,O
431,homeostasis,O
431,.,O
,,
432,Studies,O
432,on,O
432,the,O
432,molecular,O
432,mechanisms,O
432,that,O
432,control,O
432,hemopoietic,O
432,differentiation,O
432,have,O
432,focused,O
432,on,O
432,signaling,O
432,cascades,O
432,and,O
432,nuclear,O
432,effectors,O
432,that,O
432,drive,O
432,this,O
432,complex,O
432,developmental,O
432,system,O
432,in,O
432,a,O
432,regulated,O
432,fashion,O
432,.,O
,,
433,Here,O
433,we,O
433,review,O
433,the,O
433,role,O
433,of,O
433,Ikaros,B-protein
433,",",O
433,the,O
433,founding,O
433,member,O
433,of,O
433,a,O
433,unique,O
433,family,O
433,of,O
433,zinc,B-protein
433,finger,I-protein
433,transcription,I-protein
433,factors,I-protein
433,in,O
433,this,O
433,developmental,O
433,process,O
433,.,O
,,
434,Studies,O
434,on,O
434,an,O
434,Ikaros,B-protein
434,null,O
434,mutation,O
434,have,O
434,revealed,O
434,an,O
434,essential,O
434,role,O
434,for,O
434,this,O
434,factor,O
434,in,O
434,lymphoid,O
434,cell,O
434,fate,O
434,determination,O
434,and,O
434,at,O
434,subsequent,O
434,branch,O
434,points,O
434,of,O
434,the,O
434,T,O
434,cell,O
434,differentiation,O
434,pathway,O
434,.,O
,,
435,Differences,O
435,in,O
435,the,O
435,phenotypes,O
435,of,O
435,a,O
435,null,O
435,and,O
435,a,O
435,dominant,B-DNA
435,negative,I-DNA
435,(,I-DNA
435,DN,I-DNA
435,),I-DNA
435,Ikaros,I-DNA
435,mutation,I-DNA
435,provide,O
435,insight,O
435,into,O
435,a,O
435,regulatory,O
435,network,O
435,through,O
435,which,O
435,Ikaros,B-protein
435,proteins,I-protein
435,exert,O
435,their,O
435,effects,O
435,in,O
435,development,O
435,.,O
,,
436,In,O
436,addition,O
436,a,O
436,comparative,O
436,analysis,O
436,of,O
436,the,O
436,hemopoietic,B-cell_type
436,stem,I-cell_type
436,cell,I-cell_type
436,and,O
436,precursor,O
436,compartment,O
436,resulting,O
436,from,O
436,the,O
436,two,O
436,Ikaros,B-DNA
436,mutations,I-DNA
436,reveals,O
436,a,O
436,profound,O
436,yet,O
436,not,O
436,absolute,O
436,requirement,O
436,for,O
436,Ikaros,B-protein
,,
437,Induction,O
437,of,O
437,early,B-protein
437,B,I-protein
437,cell,I-protein
437,factor,I-protein
437,(,O
437,EBF,B-protein
437,),O
437,and,O
437,multiple,B-DNA
437,B,I-DNA
437,lineage,I-DNA
437,genes,I-DNA
437,by,O
437,the,O
437,basic,B-protein
437,helix-loop-helix,I-protein
437,transcription,I-protein
437,factor,I-protein
437,E12,B-protein
437,.,O
,,
438,The,O
438,transcription,B-protein
438,factors,I-protein
438,encoded,O
438,by,O
438,the,O
438,E2A,B-protein
438,and,O
438,early,B-protein
438,B,I-protein
438,cell,I-protein
438,factor,I-protein
438,(,O
438,EBF,B-protein
438,),O
438,genes,O
438,are,O
438,required,O
438,for,O
438,the,O
438,proper,O
438,development,O
438,of,O
438,B,B-cell_type
438,lymphocytes,I-cell_type
438,.,O
,,
439,However,O
439,",",O
439,the,O
439,absence,O
439,of,O
439,B,B-cell_type
439,lineage,I-cell_type
439,cells,I-cell_type
439,in,O
439,E2A-,O
439,and,O
439,EBF-deficient,O
439,mice,O
439,has,O
439,made,O
439,it,O
439,difficult,O
439,to,O
439,determine,O
439,the,O
439,function,O
439,or,O
439,relationship,O
439,between,O
439,these,O
439,proteins,O
439,.,O
,,
440,We,O
440,report,O
440,the,O
440,identification,O
440,of,O
440,a,O
440,novel,O
440,model,O
440,system,O
440,in,O
440,which,O
440,the,O
440,role,O
440,of,O
440,E2A,B-protein
440,and,O
440,EBF,B-protein
440,in,O
440,the,O
440,regulation,O
440,of,O
440,multiple,O
440,B,O
440,lineage,O
440,traits,O
440,can,O
440,be,O
440,studied,O
440,.,O
,,
441,We,O
441,found,O
441,that,O
441,the,O
441,conversion,O
441,of,O
441,70Z/3,B-cell_line
441,pre-B,I-cell_line
441,lymphocytes,I-cell_line
441,to,O
441,cells,O
441,with,O
441,a,O
441,macrophage-like,O
441,phenotype,O
441,is,O
441,associated,O
441,with,O
441,the,O
441,loss,O
441,of,O
441,E2A,B-protein
441,and,O
441,EBF,B-protein
441,.,O
,,
442,Moreover,O
442,",",O
442,we,O
442,show,O
442,that,O
442,ectopic,O
442,expression,O
442,of,O
442,the,O
442,E2A,B-protein
442,protein,O
442,E12,B-protein
442,in,O
442,this,O
442,macrophage,B-cell_line
442,line,I-cell_line
442,results,O
442,in,O
442,the,O
442,induction,O
442,of,O
442,many,B-DNA
442,B,I-DNA
442,lineage,I-DNA
442,genes,I-DNA
442,",",O
442,including,O
442,EBF,B-protein
442,",",O
442,IL7Ralpha,B-protein
442,",",O
442,lambda5,B-protein
442,",",O
442,and,O
442,Rag-1,O
442,",",O
442,and,O
442,the,O
442,ability,O
442,to,O
442,induce,O
442,kappa,B-protein
442,light,I-protein
442,chain,I-protein
442,in,O
442,response,O
442,to,O
442,mitogen,O
442,.,O
,,
443,Activation,O
443,of,O
443,EBF,B-protein
443,may,O
443,be,O
443,one,O
443,of,O
443,the,O
443,critical,O
443,functions,O
443,of,O
443,E12,B-protein
443,in,O
443,regulating,O
443,the,O
443,B,O
443,lineage,O
443,phenotype,O
443,since,O
443,expression,O
443,of,O
443,EBF,B-protein
443,alone,O
443,leads,O
443,to,O
443,the,O
443,activation,O
443,of,O
443,a,O
443,subset,O
443,of,O
443,E12,B-protein
443,inducible,O
443,traits,O
443,.,O
,,
444,Our,O
444,data,O
444,demonstrate,O
444,that,O
444,",",O
444,in,O
444,the,O
444,context,O
444,of,O
444,this,O
444,macrophage,B-cell_line
444,line,I-cell_line
444,",",O
444,E12,B-protein
444,induces,O
444,expression,O
444,of,O
444,EBF,B-protein
444,and,O
444,together,O
444,these,O
444,transcription,B-protein
444,factors,I-protein
444,coordinately,O
444,regulate,O
444,numerous,O
444,B,B-DNA
444,lineage-associated,I-DNA
444,genes,I-DNA
444,.,O
,,
445,Activation-induced,O
445,down-regulation,O
445,of,O
445,retinoid,B-protein
445,receptor,I-protein
445,RXRalpha,I-protein
445,expression,O
445,in,O
445,human,B-cell_type
445,T,I-cell_type
445,lymphocytes,I-cell_type
445,.,O
,,
446,Role,O
446,of,O
446,cell,O
446,cycle,O
446,regulation,O
446,.,O
,,
447,A,O
447,5.4-kilobase,B-RNA
447,mRNA,I-RNA
447,",",O
447,the,O
447,expression,O
447,of,O
447,which,O
447,is,O
447,down-regulated,O
447,after,O
447,treatment,O
447,of,O
447,human,B-cell_type
447,peripheral,I-cell_type
447,blood,I-cell_type
447,mononuclear,I-cell_type
447,cells,I-cell_type
447,(,O
447,PBMCs,B-cell_type
447,),O
447,with,O
447,various,O
447,T,O
447,cell-activating,O
447,agents,O
447,",",O
447,was,O
447,isolated,O
447,using,O
447,an,O
447,mRNA,O
447,differential,O
447,display,O
447,method,O
447,.,O
,,
448,Nucleotide,O
448,sequence,O
448,analysis,O
448,identified,O
448,the,O
448,5,B-RNA
448,',I-RNA
448,end,I-RNA
448,of,O
448,this,O
448,RNA,B-RNA
448,as,O
448,human,B-RNA
448,retinoid,I-RNA
448,receptor,I-RNA
448,RXRalpha,I-RNA
448,mRNA,I-RNA
448,.,O
,,
449,Here,O
449,",",O
449,we,O
449,report,O
449,the,O
449,nucleotide,O
449,sequence,O
449,of,O
449,3.6,B-DNA
449,kilobases,I-DNA
449,of,O
449,this,O
449,RNA,O
449,",",O
449,which,O
449,represents,O
449,the,O
449,3,B-RNA
449,',I-RNA
449,end,I-RNA
449,of,O
449,RXRalpha,B-RNA
449,mRNA,I-RNA
449,",",O
449,the,O
449,sequence,O
449,of,O
449,which,O
449,has,O
449,not,O
449,been,O
449,previously,O
449,described,O
449,.,O
,,
450,Activated,O
450,PBMCs,B-cell_type
450,also,O
450,expressed,O
450,lower,O
450,levels,O
450,of,O
450,RXRalpha,B-protein
450,protein,O
450,",",O
450,and,O
450,a,O
450,DNA,O
450,binding,O
450,assay,O
450,showed,O
450,that,O
450,the,O
450,activation-induced,O
450,loss,O
450,of,O
450,RXRalpha,B-RNA
450,mRNA,I-RNA
450,and,O
450,protein,O
450,expression,O
450,correlated,O
450,with,O
450,the,O
450,loss,O
450,of,O
450,DNA,O
450,binding,O
450,activity,O
450,of,O
450,this,O
450,protein,O
450,.,O
,,
451,We,O
451,present,O
451,evidence,O
451,that,O
451,the,O
451,transition,O
451,from,O
451,G0/G1,O
451,to,O
451,S,O
451,phase,O
451,of,O
451,the,O
451,cell,O
451,cycle,O
451,results,O
451,in,O
451,the,O
451,down-regulation,O
451,of,O
451,RXRalpha,B-protein
451,expression,O
451,and,O
451,that,O
451,cell,O
451,cycle,O
451,inhibitors,O
451,",",O
451,which,O
451,block,O
451,the,O
451,cells,O
451,in,O
451,G1,O
451,phase,O
451,",",O
451,prevent,O
451,this,O
451,down-regulation,O
451,.,O
,,
452,The,O
452,decrease,O
452,in,O
452,the,O
452,levels,O
452,of,O
452,RXRalpha,B-RNA
452,mRNA,I-RNA
452,was,O
452,found,O
452,to,O
452,be,O
452,regulated,O
452,at,O
452,the,O
452,post-transcriptional,O
452,level,O
452,and,O
452,involved,O
452,new,O
452,protein,O
452,synthesis,O
452,.,O
,,
453,These,O
453,observations,O
453,indicate,O
453,that,O
453,the,O
453,levels,O
453,of,O
453,RXRalpha,B-protein
453,expression,O
453,in,O
453,T,O
453,lymphocytes,O
453,are,O
453,coupled,O
453,to,O
453,cell,O
453,cycle,O
453,progression,O
453,",",O
453,and,O
453,there,O
453,is,O
453,tight,O
453,regulatory,O
453,control,O
453,of,O
453,RXRalpha,B-protein
453,expression,O
453,during,O
453,the,O
453,transition,O
453,from,O
453,G0/G1,O
453,to,O
453,S,O
453,phase,O
453,of,O
453,the,O
453,cell,O
453,cycle,O
453,.,O
,,
454,Epidemiology,O
454,and,O
454,pathogenesis,O
454,of,O
454,AIDS-related,O
454,lymphomas,O
454,.,O
,,
455,Among,O
455,patients,O
455,with,O
455,congenital,O
455,and,O
455,acquired,O
455,immunodeficiencies,O
455,",",O
455,non-Hodgkin,O
455,'s,O
455,lymphoma,O
455,(,O
455,NHLs,O
455,),O
455,are,O
455,the,O
455,most,O
455,common,O
455,tumors,O
455,of,O
455,the,O
455,immune,O
455,system,O
455,.,O
,,
456,In,O
456,the,O
456,setting,O
456,of,O
456,human,O
456,immunodeficiency,O
456,virus,O
456,(,O
456,HIV,O
456,),O
456,infection,O
456,",",O
456,as,O
456,many,O
456,as,O
456,10,O
456,%,O
456,to,O
456,20,O
456,%,O
456,of,O
456,people,O
456,ultimately,O
456,developed,O
456,NHLs,O
456,.,O
,,
457,These,O
457,tumors,O
457,are,O
457,clinically,O
457,aggressive,O
457,",",O
457,frequently,O
457,involve,O
457,extranodal,O
457,sites,O
457,",",O
457,and,O
457,often,O
457,exhibit,O
457,unique,O
457,features,O
457,that,O
457,distinguish,O
457,them,O
457,from,O
457,NHL,O
457,arising,O
457,in,O
457,individuals,O
457,with,O
457,other,O
457,forms,O
457,of,O
457,immunosuppression,O
457,.,O
,,
458,Important,O
458,in,O
458,the,O
458,development,O
458,of,O
458,HIV-associated,O
458,NHL,O
458,are,O
458,cytokines,B-protein
458,and,O
458,other,O
458,factors,O
458,that,O
458,induce,O
458,B-cell,O
458,proliferation,O
458,and,O
458,increase,O
458,the,O
458,likelihood,O
458,of,O
458,mutations,O
458,of,O
458,c-myc,B-DNA
458,",",O
458,bcl-6,B-DNA
458,",",O
458,and,O
458,other,O
458,tumor-suppressor,B-DNA
458,genes,I-DNA
458,with,O
458,carcinogenic,O
458,potential,O
458,.,O
,,
459,Specific,O
459,forms,O
459,of,O
459,HIV-associated,O
459,NHL,O
459,are,O
459,linked,O
459,to,O
459,expression,O
459,of,O
459,Epstein-Barr,B-protein
459,virus,I-protein
459,(,I-protein
459,EBV,I-protein
459,),I-protein
459,latent,I-protein
459,proteins,I-protein
459,;,O
459,the,O
459,newly,O
459,described,O
459,DNA,O
459,virus,O
459,",",O
459,Karposi,O
459,'s,O
459,sarcoma-associated,O
459,herpesvirus/human,O
459,herpesvirus-8,O
459,(,O
459,KSHV/HHV-8,O
459,),O
459,;,O
459,and,O
459,perhaps,O
459,HIV,O
459,.,O
,,
460,Elucidation,O
460,of,O
460,the,O
460,factors,O
460,that,O
460,contribute,O
460,to,O
460,the,O
460,high,O
460,incidence,O
460,of,O
460,NHL,O
460,among,O
460,patients,O
460,infected,O
460,with,O
460,HIV,O
460,provides,O
460,insights,O
460,into,O
460,important,O
460,elements,O
460,of,O
460,lymphomagenesis,O
460,.,O
,,
461,Matrix,B-protein
461,metalloproteinase,I-protein
461,expression,O
461,in,O
461,human,O
461,breast,O
461,cancer,O
461,:,O
461,an,O
461,immunohistochemical,O
461,study,O
461,including,O
461,correlation,O
461,with,O
461,cathepsin,B-protein
461,D,I-protein
461,",",O
461,type,B-protein
461,IV,I-protein
461,collagen,I-protein
461,",",O
461,laminin,B-protein
461,",",O
461,fibronectin,B-protein
461,",",O
461,EGFR,B-protein
461,",",O
461,c-erbB-2,B-protein
461,oncoprotein,I-protein
461,",",O
461,p53,B-protein
461,",",O
461,steroid,O
461,receptors,O
461,status,O
461,and,O
461,proliferative,O
461,indices,O
461,.,O
,,
462,Matrix,B-protein
462,metalloproteinase,I-protein
462,s,O
462,(,O
462,MMPs,B-protein
462,),O
462,are,O
462,a,O
462,group,O
462,of,O
462,enzymes,O
462,thought,O
462,to,O
462,be,O
462,responsible,O
462,for,O
462,both,O
462,normal,O
462,connective,O
462,tissue,O
462,matrix,O
462,remodelling,O
462,and,O
462,accelerated,O
462,breakdown,O
462,associated,O
462,with,O
462,tumour,O
462,development,O
462,.,O
,,
463,The,O
463,current,O
463,study,O
463,aimed,O
463,to,O
463,investigate,O
463,the,O
463,immunohistochemical,O
463,expression,O
463,of,O
463,matrix,B-protein
463,metalloproteinase,I-protein
463,3,I-protein
463,(,O
463,MMP-3,B-protein
463,",",O
463,stromelysin-1,B-protein
463,),O
463,in,O
463,correlation,O
463,with,O
463,the,O
463,expression,O
463,of,O
463,Basement,B-protein
463,Membrane,I-protein
463,(,I-protein
463,BM,I-protein
463,),I-protein
463,antigen,I-protein
463,(,O
463,type,B-protein
463,IV,I-protein
463,collagen,I-protein
463,",",O
463,laminin,B-protein
463,),O
463,",",O
463,fibronectin,B-protein
463,",",O
463,cathepsin,B-protein
463,D,I-protein
463,",",O
463,p53,B-protein
463,",",O
463,c-erbB-2,B-protein
463,",",O
463,proliferative,O
463,activity,O
463,(,O
463,Ki-67,B-protein
463,",",O
463,PCNA,B-protein
463,),O
463,",",O
463,steroid,O
463,receptor,O
463,content,O
463,as,O
463,well,O
463,as,O
463,to,O
463,the,O
463,other,O
463,conventional,O
463,clinicopathological,O
463,parameters,O
463,in,O
463,breast,O
463,cancer,O
463,.,O
,,
464,This,O
464,study,O
464,was,O
464,performed,O
464,on,O
464,a,O
464,series,O
464,of,O
464,frozen,O
464,and,O
464,paraffin,O
464,sections,O
464,from,O
464,84,O
464,breast,O
464,cancer,O
464,specimens,O
464,by,O
464,immunohistochemistry,O
464,using,O
464,the,O
464,monoclonal,B-protein
464,antibody,I-protein
464,MMP-3,I-protein
464,(,O
464,Ab-1,B-protein
464,),O
464,.,O
,,
465,Stromelysin-1,B-protein
465,(,O
465,ST1,B-protein
465,),O
465,was,O
465,observed,O
465,in,O
465,about,O
465,10,O
465,%,O
465,of,O
465,epithelial,B-cell_type
465,cells,I-cell_type
465,in,O
465,the,O
465,control,O
465,groups,O
465,(,O
465,cases,O
465,of,O
465,fibrocystic,O
465,and,O
465,benign,O
465,proliferative,O
465,breast,O
465,disease,O
465,),O
465,",",O
465,while,O
465,expression,O
465,(,O
465,>,O
465,10,O
465,%,O
465,of,O
465,expression,O
465,),O
465,was,O
465,detected,O
465,in,O
465,89.7,O
465,%,O
465,of,O
465,tumours,O
465,.,O
,,
466,The,O
466,expression,O
466,of,O
466,ST1,B-protein
466,in,O
466,carcinoma,O
466,cells,O
466,was,O
466,strongly,O
466,associated,O
466,with,O
466,its,O
466,presence,O
466,in,O
466,the,O
466,stroma,O
466,(,O
466,p,O
466,<,O
466,0.001,O
466,),O
466,.,O
,,
467,A,O
467,significantly,O
467,positive,O
467,correlation,O
467,was,O
467,found,O
467,between,O
467,ST1,B-protein
467,expression,O
467,",",O
467,and,O
467,p53,B-protein
467,tumour,O
467,suppressor,O
467,gene,O
467,product,O
467,(,O
467,p,O
467,=,O
467,0.004,O
467,),O
467,",",O
467,and,O
467,a,O
467,relationship,O
467,with,O
467,c-erbB-2,B-protein
467,protein,O
467,and,O
467,progesterone,O
467,receptor,O
467,status,O
467,was,O
467,also,O
467,indicated,O
467,.,O
,,
468,These,O
468,findings,O
468,suggest,O
468,that,O
468,ST1,B-protein
468,expression,O
468,in,O
468,breast,O
468,cancer,O
468,tissue,O
468,is,O
468,irrespective,O
468,of,O
468,the,O
468,expression,O
468,of,O
468,the,O
468,extracellular,O
468,matrix,O
468,component,O
468,",",O
468,the,O
468,proteolytic,B-protein
468,enzyme,I-protein
468,cathepsin,B-protein
468,D,I-protein
468,and,O
468,the,O
468,growth,O
468,fraction,O
468,of,O
468,the,O
468,tumour,O
468,",",O
468,and,O
468,that,O
468,it,O
468,could,O
468,be,O
468,a,O
468,potential,O
468,new,O
468,prognostic,O
468,marker,O
468,in,O
468,breast,O
468,cancer,O
468,.,O
,,
469,Use,O
469,of,O
469,transfected,B-cell_line
469,liver,I-cell_line
469,cells,I-cell_line
469,to,O
469,evaluate,O
469,potential,O
469,mechanisms,O
469,of,O
469,alcohol-induced,O
469,liver,O
469,injury,O
469,[,O
469,see,O
469,comments,O
469,],O
,,
470,There,O
470,is,O
470,increased,O
470,activity,O
470,of,O
470,the,O
470,proinflammatory,B-protein
470,cytokine,I-protein
470,",",O
470,tumor,B-protein
470,necrosis,I-protein
470,factor,I-protein
470,(,O
470,TNF,B-protein
470,),O
470,in,O
470,alcoholic,O
470,liver,O
470,disease,O
470,(,O
470,ALD,O
470,),O
470,.,O
,,
471,Hepatic,O
471,neutrophil,O
471,infiltration,O
471,is,O
471,a,O
471,principal,O
471,injurious,O
471,manifestation,O
471,of,O
471,ALD,O
471,.,O
,,
472,TNF,B-protein
472,can,O
472,induce,O
472,cellular,O
472,oxidative,O
472,injury,O
472,directly,O
472,",",O
472,and,O
472,indirectly,O
472,by,O
472,inducing,O
472,neutrophil,O
472,chemotactic,O
472,factor,O
472,(,O
472,IL-8,B-protein
472,),O
472,production,O
472,by,O
472,hepatocytes,O
472,.,O
,,
473,IL-8,B-protein
473,activates,O
473,and,O
473,chemotactically,O
473,attracts,O
473,neutrophils,O
473,to,O
473,the,O
473,liver,O
473,where,O
473,they,O
473,release,O
473,oxidizing,O
473,substances,O
473,.,O
,,
474,Patients,O
474,with,O
474,ALD,O
474,also,O
474,have,O
474,decreased,O
474,protective,B-protein
474,factors,I-protein
474,for,O
474,cellular,O
474,oxidative,O
474,injury,O
474,.,O
,,
475,Manganous,B-protein
475,superoxide,I-protein
475,dismutase,I-protein
475,(,O
475,MnSOD,B-protein
475,),O
475,is,O
475,an,O
475,antioxidant,B-protein
475,protective,I-protein
475,factor,I-protein
475,.,O
,,
476,The,O
476,objectives,O
476,of,O
476,these,O
476,studies,O
476,were,O
476,to,O
476,investigate,O
476,mechanisms,O
476,for,O
476,induction,O
476,of,O
476,an,O
476,injurious,B-protein
476,factor,I-protein
476,(,O
476,IL-8,B-protein
476,),O
476,and,O
476,a,O
476,protective,B-protein
476,factor,I-protein
476,(,O
476,MnSOD,B-protein
476,),O
476,in,O
476,the,O
476,HepG2,B-cell_line
476,human,I-cell_line
476,hepatoma,I-cell_line
476,cell,I-cell_line
476,line,I-cell_line
476,.,O
,,
477,In,O
477,the,O
477,first,O
477,set,O
477,of,O
477,experiments,O
477,",",O
477,IL-8,B-DNA
477,gene,I-DNA
477,reporter,I-DNA
477,constructs,I-DNA
477,were,O
477,used,O
477,to,O
477,transiently,O
477,transfect,O
477,a,O
477,derivative,O
477,(,O
477,MVh2E1-9,B-cell_line
477,),O
477,of,O
477,the,O
477,HepG2,B-cell_line
477,cell,I-cell_line
477,line,I-cell_line
477,which,O
477,expresses,O
477,P-4502E1,B-protein
477,and,O
477,metabolizes,O
477,ethanol,O
477,.,O
,,
478,Inactivation,O
478,of,O
478,the,O
478,NF-kappaB,B-DNA
478,and,I-DNA
478,3'NF-IL-6,I-DNA
478,DNA,I-DNA
478,binding,I-DNA
478,sites,I-DNA
478,decreased,O
478,IL-8,B-DNA
478,gene,I-DNA
478,transcriptional,O
478,activation,O
478,in,O
478,response,O
478,to,O
478,TNF,B-protein
478,while,O
478,inactivation,O
478,of,O
478,the,O
478,5'NF-IL-6,B-DNA
478,binding,I-DNA
478,site,I-DNA
478,increased,O
478,IL-8,B-DNA
478,gene,I-DNA
478,transcriptional,O
478,activity,O
478,in,O
478,response,O
478,to,O
478,TNF,B-protein
478,.,O
,,
479,This,O
479,system,O
479,may,O
479,be,O
479,useful,O
479,to,O
479,assess,O
479,the,O
479,effects,O
479,of,O
479,ethanol,O
479,on,O
479,TNF,B-protein
479,induced,O
479,hepatocyte,O
479,IL-8,B-protein
479,production,O
479,.,O
,,
480,In,O
480,the,O
480,second,O
480,set,O
480,of,O
480,experiments,O
480,",",O
480,HepG2,B-cell_line
480,cells,I-cell_line
480,were,O
480,cultured,O
480,in,O
480,25,O
480,to,O
480,100,O
480,mmol,O
480,concentrations,O
480,of,O
480,ethanol,O
480,.,O
,,
481,Both,O
481,TNF,B-protein
481,and,O
481,ethanol,O
481,increased,O
481,HepG2,B-cell_line
481,cell,I-cell_line
481,MnSOD,B-protein
481,activity,O
481,in,O
481,short-term,O
481,(,O
481,72,O
481,hr,O
481,),O
481,cultures,O
481,with,O
481,ethanol,O
481,.,O
,,
482,However,O
482,",",O
482,after,O
482,long-term,O
482,(,O
482,10,O
482,weeks,O
482,),O
482,culture,O
482,with,O
482,ethanol,O
482,",",O
482,there,O
482,was,O
482,no,O
482,induction,O
482,of,O
482,MnSOD,B-protein
482,by,O
482,ethanol,O
482,and,O
482,there,O
482,was,O
482,a,O
482,diminished,O
482,induction,O
482,of,O
482,MnSOD,B-protein
482,in,O
482,response,O
482,to,O
482,TNF,B-protein
482,.,O
,,
483,Further,O
483,studies,O
483,are,O
483,needed,O
483,to,O
483,assess,O
483,the,O
483,effect,O
483,of,O
483,this,O
483,diminished,O
483,induction,O
483,of,O
483,MnSOD,B-protein
483,with,O
483,chronic,O
483,ethanol,O
483,culture,O
483,on,O
483,HepG2,B-cell_line
483,cell,I-cell_line
483,susceptibility,O
483,to,O
483,TNF,B-cell_line
483,cytotoxicity,I-cell_line
483,.,O
,,
484,We,O
484,conclude,O
484,that,O
484,transfected,O
484,liver,B-cell_line
484,cell,I-cell_line
484,lines,I-cell_line
484,can,O
484,be,O
484,used,O
484,to,O
484,evaluate,O
484,mechanisms,O
484,for,O
484,increased,O
484,injurious,B-protein
484,factors,I-protein
484,and,O
484,decreased,O
484,protective,B-protein
484,factors,I-protein
484,in,O
484,alcoholic,O
484,liver,O
484,injury,O
484,.,O
,,
485,Tissue,O
485,factor,O
485,transcription,O
485,driven,O
485,by,O
485,Egr-1,B-protein
485,is,O
485,a,O
485,critical,O
485,mechanism,O
485,of,O
485,murine,B-protein
485,pulmonary,I-protein
485,fibrin,I-protein
485,deposition,O
485,in,O
485,hypoxia,O
485,.,O
,,
486,Local,O
486,hypoxemia,O
486,and,O
486,stasis,O
486,trigger,O
486,thrombosis,O
486,.,O
,,
487,We,O
487,have,O
487,demonstrated,O
487,previously,O
487,that,O
487,in,O
487,a,O
487,murine,O
487,model,O
487,of,O
487,normobaric,O
487,hypoxia,O
487,pulmonary,O
487,fibrin,B-protein
487,deposition,O
487,is,O
487,a,O
487,result,O
487,of,O
487,expression,O
487,of,O
487,tissue,B-protein
487,factor,I-protein
487,",",O
487,especially,O
487,in,O
487,oxygen-deprived,B-protein
487,mononuclear,I-protein
487,phagocytes,I-protein
487,(,O
487,MPs,B-protein
487,),O
487,.,O
,,
488,We,O
488,now,O
488,show,O
488,that,O
488,transcription,B-protein
488,factor,I-protein
488,early-growth-response,I-protein
488,gene,I-protein
488,product,I-protein
488,(,O
488,Egr-1,B-protein
488,),O
488,is,O
488,rapidly,O
488,activated,O
488,in,O
488,hypoxia,O
488,",",O
488,both,O
488,in,O
488,vitro,O
488,and,O
488,in,O
488,vivo,O
488,",",O
488,and,O
488,is,O
488,responsible,O
488,for,O
488,transcription,O
488,and,O
488,expression,O
488,of,O
488,tissue,B-protein
488,factor,I-protein
488,in,O
488,hypoxic,O
488,lung,O
488,.,O
,,
489,MPs,B-protein
489,and,O
489,HeLa,B-cell_line
489,cells,I-cell_line
489,subjected,O
489,to,O
489,hypoxia,O
489,(,O
489,pO2,O
489,approximately,O
489,13,O
489,torr,O
489,),O
489,had,O
489,increased,O
489,levels,O
489,of,O
489,tissue,B-RNA
489,factor,I-RNA
489,transcripts,I-RNA
489,(,O
489,approximately,O
489,18-fold,O
489,),O
489,and,O
489,an,O
489,increased,O
489,rate,O
489,of,O
489,transcription,O
489,(,O
489,approximately,O
489,15-fold,O
489,),O
489,",",O
489,based,O
489,on,O
489,nuclear,O
489,run-on,O
489,analysis,O
489,.,O
,,
490,Gel-shift,O
490,analysis,O
490,of,O
490,nuclear,O
490,extracts,O
490,from,O
490,hypoxic,B-protein
490,MPs,I-protein
490,and,O
490,HeLa,B-cell_line
490,cells,I-cell_line
490,demonstrated,O
490,increased,O
490,DNA-binding,O
490,activity,O
490,at,O
490,the,O
490,serum,B-DNA
490,response,I-DNA
490,region,I-DNA
490,(,O
490,SRR,O
490,;,O
490,-7.928571429,O
490,bp,O
490,),O
490,of,O
490,the,O
490,tissue,B-DNA
490,factor,I-DNA
490,promoter,I-DNA
490,at,O
490,Egr-1,B-DNA
490,motifs,I-DNA
490,.,O
,,
491,Using,O
491,32P-labeled,O
491,Egr,O
491,consensus,O
491,oligonucleotide,O
491,",",O
491,we,O
491,observed,O
491,induction,O
491,of,O
491,DNA-binding,O
491,activity,O
491,in,O
491,nuclear,O
491,extracts,O
491,from,O
491,hypoxic,O
491,lung,O
491,and,O
491,HeLa,B-cell_line
491,cells,I-cell_line
491,because,O
491,of,O
491,activation,O
491,of,O
491,Egr-1,B-protein
491,",",O
491,by,O
491,means,O
491,of,O
491,supershift,O
491,analysis,O
491,.,O
,,
492,Transient,O
492,transfection,O
492,of,O
492,HeLa,B-cell_line
492,cells,I-cell_line
492,with,O
492,chimeric,B-DNA
492,plasmids,I-DNA
492,containing,O
492,wild-type,B-protein
492,or,I-protein
492,mutant,I-protein
492,SRR,I-protein
492,from,O
492,the,O
492,tissue,B-DNA
492,factor,I-DNA
492,promoter,I-DNA
492,showed,O
492,that,O
492,intact,B-DNA
492,Sp1,I-DNA
492,sites,I-DNA
492,are,O
492,necessary,O
492,for,O
492,basal,O
492,promoter,O
492,activity,O
492,",",O
492,whereas,O
492,the,O
492,integrity,O
492,of,O
492,Egr-1,B-DNA
492,sites,I-DNA
492,was,O
492,required,O
492,for,O
492,hypoxia-enhanced,O
492,expression,O
492,.,O
,,
493,A,O
493,central,O
493,role,O
493,for,O
493,Egr-1,B-protein
493,in,O
493,hypoxia-mediated,O
493,tissue,O
493,factor,O
493,expression,O
493,was,O
493,confirmed,O
493,by,O
493,experiments,O
493,with,O
493,homozygous,O
493,Egr-1,B-protein
493,null,O
493,mice,O
493,;,O
493,wild-type,O
493,mice,O
493,subjected,O
493,to,O
493,oxygen,B-protein
493,deprivation,I-protein
493,expressed,I-protein
493,tissue,I-protein
493,factor,I-protein
493,and,O
493,showed,O
493,fibrin,B-protein
493,deposition,O
493,",",O
493,but,O
493,hypoxic,O
493,homozygous,O
493,Egr-1,B-protein
493,null,O
493,mice,O
493,displayed,O
493,neither,O
493,tissue,B-protein
493,factor,I-protein
493,nor,O
493,fibrin,B-protein
493,.,O
,,
494,These,O
494,data,O
494,delineate,O
494,a,O
494,novel,O
494,biology,O
494,for,O
494,hypoxia-induced,O
494,fibrin,B-protein
494,deposition,O
494,",",O
494,in,O
494,which,O
494,oxygen,O
494,deprivation-induced,O
494,activation,O
494,of,O
494,Egr-1,B-protein
494,",",O
494,resulting,O
494,in,O
494,expression,O
494,of,O
494,tissue,B-protein
494,factor,I-protein
494,",",O
494,has,O
494,an,O
494,unexpected,O
494,and,O
494,central,O
494,role,O
494,.,O
,,
495,Kinetics,O
495,of,O
495,cytokine,O
495,and,O
495,NFAT,O
495,gene,O
495,expression,O
495,in,O
495,human,B-cell_line
495,interleukin-2-dependent,I-cell_line
495,T,I-cell_line
495,lymphoblasts,I-cell_line
495,stimulated,O
495,via,O
495,T-cell,B-protein
495,receptor,I-protein
495,.,O
,,
496,T,B-cell_type
496,cells,I-cell_type
496,respond,O
496,to,O
496,mitogenic,O
496,or,O
496,antigenic,O
496,stimulation,O
496,by,O
496,proliferation,O
496,and,O
496,by,O
496,turning,O
496,on,O
496,cytokine,O
496,gene,O
496,expression,O
496,.,O
,,
497,Here,O
497,we,O
497,have,O
497,analysed,O
497,the,O
497,kinetics,O
497,and,O
497,nature,O
497,of,O
497,cytokine,O
497,production,O
497,in,O
497,human,B-cell_type
497,peripheral,I-cell_type
497,blood-derived,I-cell_type
497,T,I-cell_type
497,lymphoblasts,I-cell_type
497,stimulated,O
497,with,O
497,anti-CD3,B-protein
497,antibodies,I-protein
497,or,O
497,Lens,B-protein
497,culinaris,I-protein
497,lectin,I-protein
497,(,O
497,LCL,B-protein
497,),O
497,.,O
,,
498,T,B-cell_type
498,cells,I-cell_type
498,were,O
498,purified,O
498,from,O
498,peripheral,B-cell_type
498,blood,I-cell_type
498,mononuclear,I-cell_type
498,cells,I-cell_type
498,(,O
498,PBMC,B-cell_type
498,),O
498,and,O
498,primarily,O
498,activated,O
498,with,O
498,anti-CD3,B-protein
498,antibodies,I-protein
498,and,O
498,cultured,O
498,in,O
498,the,O
498,presence,O
498,of,O
498,interleukin-2,B-protein
498,(,O
498,IL-2,B-protein
498,),O
498,.,O
,,
499,Anti-CD3-restimulated,O
499,T,B-cell_type
499,cells,I-cell_type
499,(,O
499,mainly,O
499,CD8+,O
499,),O
499,produced,O
499,IL-2,B-protein
499,",",O
499,interferon-gamma,B-protein
499,(,O
499,IFN-gamma,B-protein
499,),O
499,and,O
499,tumour,B-protein
499,necrosis,I-protein
499,factor-alpha,I-protein
499,(,O
499,TNF-alpha,B-protein
499,),O
499,and,O
499,low,O
499,levels,O
499,of,O
499,IL-4,B-RNA
499,and,I-RNA
499,IL-10,I-RNA
499,transcripts,I-RNA
499,and,O
499,proteins,O
499,.,O
,,
500,No,O
500,IL-6,B-DNA
500,gene,I-DNA
500,expression,O
500,was,O
500,observed,O
500,.,O
,,
501,In,O
501,LCL-stimulated,B-cell_type
501,cells,I-cell_type
501,the,O
501,cytokine,O
501,production,O
501,pattern,O
501,was,O
501,very,O
501,similar,O
501,.,O
,,
502,Steady-state,O
502,mRNA,O
502,levels,O
502,of,O
502,IL-2,B-protein
502,",",O
502,IL-10,B-protein
502,and,O
502,IFN-gamma,B-protein
502,peaked,O
502,at,O
502,3,O
502,hr,O
502,after,O
502,anti-CD3,O
502,stimulation,O
502,and,O
502,declined,O
502,rapidly,O
502,thereafter,O
502,.,O
,,
503,The,O
503,kinetics,O
503,of,O
503,TNF-alpha,B-RNA
503,mRNA,I-RNA
503,expression,O
503,was,O
503,faster,O
503,",",O
503,being,O
503,at,O
503,its,O
503,peak,O
503,level,O
503,1,O
503,hr,O
503,after,O
503,stimulation,O
503,.,O
,,
504,Anti-CD3-stimulated,O
504,IL-2,B-DNA
504,gene,I-DNA
504,expression,O
504,was,O
504,down-regulated,O
504,by,O
504,protein,O
504,synthesis,O
504,inhibitor,O
504,",",O
504,whereas,O
504,IL-10,B-DNA
504,",",I-DNA
504,IFN-gamma,I-DNA
504,and,I-DNA
504,TNF-alpha,I-DNA
504,genes,I-DNA
504,were,O
504,readily,O
504,induced,O
504,independent,O
504,of,O
504,ongoing,O
504,protein,O
504,synthesis,O
504,.,O
,,
505,T-cell,B-protein
505,receptor,I-protein
505,stimulation,O
505,also,O
505,induced,O
505,a,O
505,very,O
505,rapid,O
505,expression,O
505,of,O
505,c-jun,B-DNA
505,",",I-DNA
505,c-fos,I-DNA
505,and,I-DNA
505,NFATc1,I-DNA
505,(,I-DNA
505,NFATc,I-DNA
505,),I-DNA
505,genes,I-DNA
505,",",O
505,the,O
505,gene,O
505,products,O
505,of,O
505,which,O
505,are,O
505,involved,O
505,in,O
505,cytokine,O
505,gene,O
505,expression,O
505,.,O
,,
506,In,O
506,conclusion,O
506,",",O
506,the,O
506,cytokines,B-protein
506,synthesized,O
506,by,O
506,IL-2-dependent,B-cell_type
506,T,I-cell_type
506,cells,I-cell_type
506,were,O
506,predominantly,O
506,IL-2,B-protein
506,",",O
506,IFN-gamma,B-protein
506,and,O
506,TNF-alpha,B-protein
506,.,O
,,
507,An,O
507,animal,O
507,model,O
507,to,O
507,study,O
507,local,O
507,oxidation,O
507,of,O
507,LDL,O
507,and,O
507,its,O
507,biological,O
507,effects,O
507,in,O
507,the,O
507,arterial,O
507,wall,O
507,.,O
,,
508,Oxidized,O
508,LDL,O
508,(,O
508,oxLDL,O
508,),O
508,is,O
508,present,O
508,in,O
508,atherosclerotic,O
508,lesions,O
508,and,O
508,is,O
508,believed,O
508,to,O
508,play,O
508,a,O
508,key,O
508,role,O
508,in,O
508,atherogenesis,O
508,.,O
,,
509,Mainly,O
509,on,O
509,the,O
509,basis,O
509,of,O
509,cell,O
509,culture,O
509,studies,O
509,",",O
509,oxLDL,O
509,has,O
509,been,O
509,shown,O
509,to,O
509,produce,O
509,many,O
509,biological,O
509,effects,O
509,that,O
509,influence,O
509,the,O
509,atherosclerotic,O
509,process,O
509,.,O
,,
510,To,O
510,study,O
510,LDL,O
510,oxidation,O
510,in,O
510,vivo,O
510,",",O
510,we,O
510,have,O
510,established,O
510,a,O
510,model,O
510,in,O
510,which,O
510,Sprague-Dawley,O
510,rats,O
510,are,O
510,given,O
510,a,O
510,single,O
510,injection,O
510,of,O
510,unmodified,O
510,human,O
510,LDL,O
510,(,O
510,>,O
510,or,O
510,=,O
510,4,O
510,mg/kg,O
510,body,O
510,weight,O
510,),O
510,.,O
,,
511,Within,O
511,6,O
511,hours,O
511,",",O
511,an,O
511,accumulation,O
511,of,O
511,apolipoprotein,O
511,B,O
511,and,O
511,epitopes,B-protein
511,present,O
511,on,O
511,oxLDL,O
511,are,O
511,detected,O
511,in,O
511,the,O
511,arterial,O
511,endothelium,O
511,and,O
511,media,O
511,.,O
,,
512,The,O
512,presence,O
512,of,O
512,oxLDL,O
512,is,O
512,associated,O
512,with,O
512,activation,O
512,of,O
512,the,O
512,transcription,B-protein
512,factor,I-protein
512,nuclear,B-protein
512,factor-kappaB,I-protein
512,in,O
512,the,O
512,endothelium,O
512,as,O
512,well,O
512,as,O
512,endothelial,O
512,expression,O
512,of,O
512,intercellular,B-protein
512,adhesion,I-protein
512,molecule-1,I-protein
512,.,O
,,
513,Injection,O
513,of,O
513,LDL,O
513,enriched,O
513,with,O
513,the,O
513,antioxidant,O
513,probucol,O
513,resulted,O
513,in,O
513,arterial,O
513,accumulation,O
513,of,O
513,apolipoprotein,O
513,B,O
513,",",O
513,but,O
513,the,O
513,expression,O
513,of,O
513,oxLDL-specific,O
513,epitopes,O
513,was,O
513,reduced,O
513,at,O
513,24,O
513,hours,O
513,.,O
,,
514,Thus,O
514,",",O
514,this,O
514,simple,O
514,model,O
514,has,O
514,the,O
514,potential,O
514,to,O
514,analyze,O
514,the,O
514,mechanisms,O
514,behind,O
514,and,O
514,biological,O
514,effects,O
514,of,O
514,LDL,O
514,oxidation,O
514,in,O
514,vivo,O
514,.,O
,,
515,Molecular,O
515,mechanisms,O
515,of,O
515,promoter,O
515,regulation,O
515,of,O
515,the,O
515,gp34,B-DNA
515,gene,I-DNA
515,that,O
515,is,O
515,trans-activated,O
515,by,O
515,an,O
515,oncoprotein,B-protein
515,Tax,I-protein
515,of,O
515,human,O
515,T,O
515,cell,O
515,leukemia,O
515,virus,O
515,type,O
515,I,O
515,.,O
,,
516,We,O
516,investigated,O
516,the,O
516,molecular,O
516,mechanism,O
516,of,O
516,transcriptional,O
516,activation,O
516,of,O
516,the,O
516,gp34,B-DNA
516,gene,I-DNA
516,by,O
516,the,O
516,Tax,B-protein
516,oncoprotein,I-protein
516,of,O
516,human,O
516,T,O
516,cell,O
516,leukemia,O
516,virus,O
516,type,O
516,I,O
516,(,O
516,HTLV-I,O
516,),O
516,.,O
,,
517,gp34,B-protein
517,is,O
517,a,O
517,type,B-protein
517,II,I-protein
517,transmembrane,I-protein
517,molecule,I-protein
517,belonging,O
517,to,O
517,the,O
517,tumor,O
517,necrosis,O
517,factor,O
517,family,O
517,and,O
517,is,O
517,constitutively,O
517,expressed,O
517,on,O
517,HTLV-I-producing,B-cell_type
517,cells,I-cell_type
517,but,O
517,not,O
517,normal,B-cell_type
517,resting,I-cell_type
517,T,I-cell_type
517,cells,I-cell_type
517,.,O
,,
518,The,O
518,transcriptional,O
518,regulatory,O
518,region,O
518,of,O
518,the,O
518,gp34,B-DNA
518,gene,I-DNA
518,was,O
518,activated,O
518,by,O
518,HTLV-I,O
518,Tax,B-protein
518,in,O
518,the,O
518,human,B-cell_line
518,T,I-cell_line
518,cell,I-cell_line
518,line,I-cell_line
518,Jurkat,I-cell_line
518,",",O
518,in,O
518,which,O
518,endogenous,O
518,gp34,B-protein
518,is,O
518,induced,O
518,by,O
518,Tax,B-protein
518,.,O
,,
519,Sequence,O
519,analysis,O
519,demonstrated,O
519,that,O
519,two,O
519,NF-kappaB-like,B-DNA
519,elements,I-DNA
519,(,O
519,1,O
519,and,O
519,2,O
519,),O
519,were,O
519,present,O
519,in,O
519,the,O
519,regulatory,B-DNA
519,region,I-DNA
519,.,O
,,
520,Both,O
520,NF-kappaB-like,B-DNA
520,elements,I-DNA
520,were,O
520,able,O
520,to,O
520,bind,O
520,to,O
520,NF-kappaB,B-protein
520,or,O
520,its,O
520,related,O
520,factor,O
520,(,O
520,s,O
520,),O
520,in,O
520,a,O
520,Tax,B-protein
520,dependent,O
520,manner,O
520,.,O
,,
521,Chloramphenicol,B-protein
521,acetyltransferase,I-protein
521,assays,O
521,indicated,O
521,that,O
521,NF-kappaB-like,B-DNA
521,element,I-DNA
521,1,I-DNA
521,was,O
521,Tax,B-protein
521,responsive,O
521,",",O
521,although,O
521,the,O
521,activity,O
521,was,O
521,lower,O
521,than,O
521,that,O
521,the,O
521,native,B-DNA
521,promoter,I-DNA
521,.,O
,,
522,NF-kappaB,B-protein
522,like,O
522,element,O
522,2,O
522,elevated,O
522,promoter,O
522,activity,O
522,when,O
522,combined,O
522,with,O
522,NF-kappaB-like,B-DNA
522,element,I-DNA
522,1,I-DNA
522,",",O
522,indicating,O
522,cooperative,O
522,function,O
522,of,O
522,the,O
522,elements,O
522,for,O
522,maximum,O
522,promoter,O
522,function,O
522,.,O
,,
523,Unlike,O
523,typical,O
523,NF-kappaB,B-DNA
523,elements,I-DNA
523,",",O
523,the,O
523,NF-kappaB-like,B-DNA
523,elements,I-DNA
523,in,O
523,gp34,B-protein
523,were,O
523,not,O
523,activated,O
523,by,O
523,treatment,O
523,of,O
523,Jurkat,B-cell_line
523,cells,I-cell_line
523,with,O
523,phorbol,O
523,ester,O
523,despite,O
523,induction,O
523,of,O
523,the,O
523,NF-kappaB,B-protein
523,like,O
523,binding,O
523,activity,O
523,.,O
,,
524,Chloramphenicol,B-protein
524,acetyltransferase,I-protein
524,reporter,O
524,assays,O
524,using,O
524,the,O
524,region,O
524,upstream,O
524,of,O
524,the,O
524,NF-kappaB-like,B-DNA
524,elements,I-DNA
524,identified,O
524,an,O
524,upstream,O
524,region,O
524,that,O
524,reduced,O
524,transcription,O
524,from,O
524,cognate,B-DNA
524,and,I-DNA
524,noncognate,I-DNA
524,core,I-DNA
524,promoters,I-DNA
524,in,O
524,a,O
524,Tax-independent,O
524,manner,O
524,.,O
,,
525,Our,O
525,results,O
525,imply,O
525,complex,O
525,regulation,O
525,of,O
525,expression,O
525,of,O
525,the,O
525,gp34,B-DNA
525,gene,I-DNA
525,and,O
525,suggest,O
525,implication,O
525,of,O
525,gp34,B-protein
525,in,O
525,proliferation,O
525,of,O
525,HTLV-I,O
525,infected,O
525,T,O
525,cells,O
525,.,O
,,
526,beta-Amyloid,B-protein
526,fibrils,I-protein
526,activate,O
526,parallel,O
526,mitogen-activated,B-protein
526,protein,I-protein
526,kinase,I-protein
526,pathways,O
526,in,O
526,microglia,B-cell_type
526,and,O
526,THP1,B-cell_line
526,monocytes,I-cell_line
526,.,O
,,
527,The,O
527,senile,O
527,plaques,O
527,of,O
527,Alzheimer,O
527,'s,O
527,disease,O
527,are,O
527,foci,O
527,of,O
527,local,O
527,inflammatory,O
527,responses,O
527,",",O
527,as,O
527,evidenced,O
527,by,O
527,the,O
527,presence,O
527,of,O
527,acute,B-protein
527,phase,I-protein
527,proteins,I-protein
527,and,O
527,oxidative,O
527,damage,O
527,.,O
,,
528,Fibrillar,B-protein
528,forms,I-protein
528,of,O
528,beta-amyloid,B-protein
528,(,O
528,Abeta,B-protein
528,),O
528,",",O
528,which,O
528,are,O
528,the,O
528,primary,O
528,constituents,O
528,of,O
528,senile,O
528,plaques,O
528,",",O
528,have,O
528,been,O
528,shown,O
528,to,O
528,activate,O
528,tyrosine,O
528,kinase-dependent,O
528,signal,O
528,transduction,O
528,cascades,O
528,",",O
528,resulting,O
528,in,O
528,inflammatory,O
528,responses,O
528,in,O
528,microglia,B-cell_type
528,.,O
,,
529,However,O
529,",",O
529,the,O
529,downstream,O
529,signaling,O
529,pathways,O
529,mediating,O
529,Abeta,B-protein
529,induced,O
529,inflammatory,O
529,events,O
529,are,O
529,not,O
529,well,O
529,characterized,O
529,.,O
,,
530,We,O
530,report,O
530,that,O
530,exposure,O
530,of,O
530,primary,B-cell_type
530,rat,I-cell_type
530,microglia,I-cell_type
530,and,O
530,human,B-cell_line
530,THP1,I-cell_line
530,monocytes,I-cell_line
530,to,O
530,fibrillar,B-protein
530,Abeta,I-protein
530,results,O
530,in,O
530,the,O
530,tyrosine,B-protein
530,kinase,I-protein
530,dependent,O
530,activation,O
530,of,O
530,two,O
530,parallel,O
530,signal,O
530,transduction,O
530,cascades,O
530,involving,O
530,members,O
530,of,O
530,the,O
530,mitogen-activated,B-protein
530,protein,I-protein
530,kinase,I-protein
530,(,I-protein
530,MAPK,I-protein
530,),I-protein
530,superfamily,I-protein
530,.,O
,,
531,Abeta,B-protein
531,stimulated,O
531,the,O
531,rapid,O
531,",",O
531,transient,O
531,activation,O
531,of,O
531,extracellular,B-protein
531,signal-regulated,I-protein
531,kinase,I-protein
531,1,I-protein
531,(,O
531,ERK1,B-protein
531,),O
531,and,O
531,ERK2,B-protein
531,in,O
531,microglia,B-cell_type
531,and,O
531,ERK2,B-protein
531,in,O
531,THP1,B-cell_line
531,monocytes,I-cell_line
531,.,O
,,
532,A,O
532,second,O
532,superfamily,B-protein
532,member,I-protein
532,",",O
532,p38,B-protein
532,MAPK,I-protein
532,",",O
532,was,O
532,also,O
532,activated,O
532,with,O
532,similar,O
532,kinetics,O
532,.,O
,,
533,Scavenger,B-protein
533,receptor,I-protein
533,and,O
533,receptor,B-protein
533,for,I-protein
533,advanced,I-protein
533,glycated,I-protein
533,end,I-protein
533,products,I-protein
533,(,O
533,RAGE,B-protein
533,),O
533,ligands,O
533,failed,O
533,to,O
533,activate,O
533,ERK,B-protein
533,and,O
533,p38,B-protein
533,MAPK,I-protein
533,in,O
533,the,O
533,absence,O
533,of,O
533,significant,O
533,increases,O
533,in,O
533,protein,O
533,tyrosine,O
533,phosphorylation,O
533,",",O
533,demonstrating,O
533,that,O
533,scavenger,B-protein
533,receptors,I-protein
533,and,O
533,RAGE,B-protein
533,are,O
533,not,O
533,linked,O
533,to,O
533,these,O
533,pathways,O
533,.,O
,,
534,Importantly,O
534,",",O
534,the,O
534,stress-activated,B-protein
534,protein,I-protein
534,kinases,I-protein
534,(,O
534,SAPKs,B-protein
534,),O
534,were,O
534,not,O
534,significantly,O
534,activated,O
534,in,O
534,response,O
534,to,O
534,Abeta,B-protein
534,.,O
,,
535,Downstream,O
535,effectors,O
535,of,O
535,the,O
535,MAPK,O
535,signal,O
535,transduction,O
535,cascades,O
535,include,O
535,MAPKAP,B-protein
535,kinases,I-protein
535,",",O
535,such,O
535,as,O
535,RSK1,B-protein
535,and,O
535,RSK2,B-protein
535,",",O
535,as,O
535,well,O
535,as,O
535,transcription,B-protein
535,factors,I-protein
535,.,O
,,
536,Exposure,O
536,of,O
536,microglia,B-cell_type
536,and,O
536,THP1,B-cell_line
536,monocytes,I-cell_line
536,to,O
536,Abeta,B-protein
536,resulted,O
536,in,O
536,the,O
536,activation,O
536,of,O
536,RSK1,B-protein
536,and,O
536,RSK2,B-protein
536,and,O
536,phosphorylation,O
536,of,O
536,cAMP,B-protein
536,response,I-protein
536,element-binding,I-protein
536,protein,I-protein
536,at,O
536,Ser133,O
536,",",O
536,providing,O
536,a,O
536,mechanism,O
536,for,O
536,Abeta,B-protein
536,induced,O
536,changes,O
536,in,O
536,gene,O
536,expression,O
,,
537,Regulation,O
537,of,O
537,cellular,B-protein
537,retinoic,I-protein
537,acid,I-protein
537,binding,I-protein
537,protein,I-protein
537,(,O
537,CRABP,B-protein
537,II,I-protein
537,),O
537,during,O
537,human,B-cell_type
537,monocyte,I-cell_type
537,differentiation,O
537,in,O
537,vitro,O
537,.,O
,,
538,Cellular,B-protein
538,retinoic,I-protein
538,acid,I-protein
538,binding,I-protein
538,proteins,I-protein
538,(,O
538,CRABP,B-protein
538,),O
538,are,O
538,low,B-protein
538,molecular,I-protein
538,weight,I-protein
538,proteins,I-protein
538,whose,O
538,precise,O
538,function,O
538,remains,O
538,unknown,O
538,.,O
,,
539,They,O
539,bind,O
539,retinoids,O
539,and,O
539,may,O
539,thereby,O
539,modulate,O
539,the,O
539,intracellular,O
539,steady-state,O
539,concentration,O
539,of,O
539,retinoids,O
539,.,O
,,
540,Whereas,O
540,CRABP,B-protein
540,I,I-protein
540,is,O
540,ubiquitously,O
540,expressed,O
540,",",O
540,CRABP,B-protein
540,II,I-protein
540,is,O
540,mainly,O
540,detected,O
540,in,O
540,various,O
540,cell,O
540,types,O
540,of,O
540,the,O
540,skin,O
540,.,O
,,
541,By,O
541,representative,O
541,difference,O
541,analysis,O
541,we,O
541,found,O
541,that,O
541,CRABP,B-protein
541,II,I-protein
541,is,O
541,also,O
541,strongly,O
541,expressed,O
541,in,O
541,human,B-cell_type
541,monocyte-derived,I-cell_type
541,macrophages,I-cell_type
541,(,O
541,MAC,B-cell_type
541,),O
541,but,O
541,not,O
541,in,O
541,freshly,B-cell_type
541,isolated,I-cell_type
541,monocytes,I-cell_type
541,(,O
541,MO,B-cell_type
541,),O
541,.,O
,,
542,The,O
542,CRABP,B-RNA
542,II,I-RNA
542,mRNA,I-RNA
542,was,O
542,gradually,O
542,upregulated,O
542,during,O
542,differentiation,O
542,from,O
542,MO,B-cell_type
542,to,O
542,MAC,B-cell_type
542,in,O
542,the,O
542,presence,O
542,of,O
542,2,O
542,%,O
542,serum,O
542,.,O
,,
543,Adherence,O
543,",",O
543,which,O
543,is,O
543,important,O
543,for,O
543,MO,B-cell_type
543,differentiation,O
543,",",O
543,induced,O
543,CRABP,B-protein
543,II,I-protein
543,expression,O
543,",",O
543,but,O
543,the,O
543,addition,O
543,of,O
543,10,O
543,(,O
543,-7,O
543,),O
543,M,O
543,retinoic,O
543,acid,O
543,inhibited,O
543,the,O
543,upregulation,O
543,of,O
543,CRABP,B-protein
543,II,I-protein
543,expression,O
543,during,O
543,MO/MAC,O
543,differentiation,O
543,.,O
,,
544,As,O
544,MO,B-cell_type
544,can,O
544,differentiate,O
544,along,O
544,the,O
544,classical,O
544,pathway,O
544,not,O
544,only,O
544,to,O
544,MAC,B-cell_type
544,but,O
544,also,O
544,to,O
544,dendritic,O
544,cells,O
544,we,O
544,analyzed,O
544,the,O
544,expression,O
544,of,O
544,CRABP,B-protein
544,II,I-protein
544,in,O
544,MO-derived,B-cell_type
544,dendritic,I-cell_type
544,cells,I-cell_type
544,cultured,O
544,with,O
544,10,O
544,%,O
544,FCS,B-protein
544,",",O
544,IL-4,B-protein
544,",",O
544,and,O
544,GM-CSF,B-protein
544,.,O
,,
545,In,O
545,contrast,O
545,to,O
545,MAC,B-cell_type
545,",",O
545,MO-derived,B-cell_type
545,dendritic,I-cell_type
545,cells,I-cell_type
545,showed,O
545,an,O
545,extremely,O
545,low,O
545,expression,O
545,of,O
545,CRABP,B-protein
545,II,I-protein
545,.,O
,,
546,From,O
546,these,O
546,results,O
546,we,O
546,conclude,O
546,(,O
546,1,O
546,),O
546,that,O
546,the,O
546,availability,O
546,and,O
546,the,O
546,metabolism,O
546,of,O
546,retinoids,O
546,may,O
546,be,O
546,different,O
546,in,O
546,MAC,B-cell_type
546,compared,O
546,to,O
546,MO,B-cell_type
546,and,O
546,dendritic,B-cell_type
546,cells,I-cell_type
546,and,O
546,(,O
546,2,O
546,),O
546,that,O
546,this,O
546,may,O
546,influence,O
546,differentiation,O
546,and,O
546,activation,O
546,of,O
546,those,O
546,cells,O
546,.,O
,,
547,Transcription,B-protein
547,factor,I-protein
547,B-cell-specific,I-protein
547,activator,I-protein
547,protein,I-protein
547,(,O
547,BSAP,B-protein
547,),O
547,is,O
547,differentially,O
547,expressed,O
547,in,O
547,B,B-cell_type
547,cells,I-cell_type
547,and,O
547,in,O
547,subsets,O
547,of,O
547,B-cell,O
547,lymphomas,O
547,.,O
,,
548,The,O
548,paired,B-DNA
548,box,I-DNA
548,containing,I-DNA
548,gene,I-DNA
548,PAX-5,B-DNA
548,encodes,O
548,the,O
548,transcription,B-protein
548,factor,I-protein
548,BSAP,B-protein
548,(,O
548,B-cell-specific,B-protein
548,activator,I-protein
548,protein,I-protein
548,),O
548,",",O
548,which,O
548,plays,O
548,a,O
548,key,O
548,role,O
548,in,O
548,B-lymphocyte,O
548,development,O
548,.,O
,,
549,Despite,O
549,its,O
549,known,O
549,involvement,O
549,in,O
549,a,O
549,rare,O
549,subtype,O
549,of,O
549,non-Hodgkin,O
549,'s,O
549,lymphoma,O
549,(,O
549,NHL,O
549,),O
549,",",O
549,a,O
549,detailed,O
549,examination,O
549,of,O
549,BSAP,B-protein
549,expression,O
549,in,O
549,NHL,O
549,has,O
549,not,O
549,been,O
549,previously,O
549,reported,O
549,.,O
,,
550,In,O
550,this,O
550,study,O
550,",",O
550,we,O
550,analyzed,O
550,normal,O
550,and,O
550,malignant,O
550,lymphoid,O
550,tissues,O
550,and,O
550,cell,B-cell_line
550,lines,I-cell_line
550,",",O
550,including,O
550,102,O
550,cases,O
550,of,O
550,B-cell,O
550,NHL,O
550,",",O
550,23,O
550,cases,O
550,of,O
550,T-,O
550,and,O
550,null-cell,O
550,NHL,O
550,",",O
550,and,O
550,18,O
550,cases,O
550,of,O
550,Hodgkin,O
550,'s,O
550,disease,O
550,.,O
,,
551,Normal,O
551,lymphoid,O
551,tissues,O
551,showed,O
551,strong,O
551,nuclear,O
551,BSAP,B-protein
551,expression,O
551,in,O
551,mantle,B-cell_type
551,zone,I-cell_type
551,B,I-cell_type
551,cells,I-cell_type
551,",",O
551,less,O
551,intense,O
551,reactivity,O
551,in,O
551,follicular,B-cell_type
551,center,I-cell_type
551,B,I-cell_type
551,cells,I-cell_type
551,",",O
551,and,O
551,no,O
551,expression,O
551,in,O
551,cells,O
551,of,O
551,the,O
551,T-cell-rich,O
551,zones,O
551,.,O
,,
552,Monocytoid,B-cell_type
552,B,I-cell_type
552,cells,I-cell_type
552,showed,O
552,weak,O
552,expression,O
552,",",O
552,whereas,O
552,plasma,B-cell_type
552,cells,I-cell_type
552,and,O
552,extrafollicular,B-cell_type
552,large,I-cell_type
552,transformed,I-cell_type
552,B,I-cell_type
552,cells,I-cell_type
552,were,O
552,negative,O
552,.,O
,,
553,Of,O
553,the,O
553,102,O
553,B-cell,O
553,NHLs,O
553,",",O
553,83,O
553,(,O
553,81,O
553,%,O
553,),O
553,demonstrated,O
553,BSAP,B-protein
553,expression,O
553,.,O
,,
554,All,O
554,of,O
554,the,O
554,13,O
554,(,O
554,100,O
554,%,O
554,),O
554,B-cell,O
554,chronic,O
554,lymphocytic,O
554,leukemias,O
554,(,O
554,B-CLLs,O
554,),O
554,",",O
554,21,O
554,of,O
554,(,O
554,100,O
554,%,O
554,),O
554,mantle,B-cell_type
554,cells,I-cell_type
554,(,O
554,MCLs,B-cell_type
554,),O
554,",",O
554,and,O
554,20,O
554,of,O
554,21,O
554,(,O
554,95,O
554,%,O
554,),O
554,follicular,O
554,lymphomas,O
554,(,O
554,FLs,O
554,),O
554,were,O
554,positive,O
554,.,O
,,
555,Moderate,O
555,staining,O
555,intensities,O
555,were,O
555,found,O
555,in,O
555,most,O
555,B-CLL,O
555,and,O
555,FL,O
555,cases,O
555,",",O
555,whereas,O
555,most,O
555,MCLs,B-cell_type
555,showed,O
555,strong,O
555,reactions,O
555,",",O
555,paralleling,O
555,the,O
555,strong,O
555,reactivity,O
555,of,O
555,nonmalignant,B-cell_type
555,mantle,I-cell_type
555,cells,I-cell_type
555,.,O
,,
556,Eight,O
556,of,O
556,12,O
556,(,O
556,67,O
556,%,O
556,),O
556,marginal,O
556,zone,O
556,lymphoma,O
556,cases,O
556,showed,O
556,negative,O
556,or,O
556,low,O
556,BSAP,B-protein
556,levels,O
556,",",O
556,and,O
556,17,O
556,of,O
556,24,O
556,(,O
556,71,O
556,%,O
556,),O
556,large,O
556,B-cell,O
556,lymphomas,O
556,displayed,O
556,moderate,O
556,to,O
556,strong,O
556,expression,O
556,.,O
,,
557,None,O
557,of,O
557,the,O
557,23,O
557,T-,O
557,and,O
557,null-cell,O
557,lymphomas,O
557,reacted,O
557,with,O
557,the,O
557,BSAP,B-protein
557,antisera,O
557,",",O
557,whereas,O
557,in,O
557,Hodgkin,O
557,'s,O
557,disease,O
557,",",O
557,2,O
557,of,O
557,4,O
557,(,O
557,50,O
557,%,O
557,),O
557,nodular,O
557,lymphocytic,O
557,predominance,O
557,and,O
557,5,O
557,of,O
557,14,O
557,(,O
557,36,O
557,%,O
557,),O
557,classical,O
557,cases,O
557,showed,O
557,weak,O
557,nuclear,O
557,or,O
557,nucleolar,O
557,BSAP,B-protein
557,reactions,O
557,in,O
557,a,O
557,fraction,O
557,of,O
557,the,O
557,tumor,B-cell_type
557,cells,I-cell_type
557,.,O
,,
558,Western,O
558,blot,O
558,analysis,O
558,showed,O
558,a,O
558,52-kD,O
558,BSAP,B-protein
558,band,O
558,in,O
558,B-cell,B-cell_line
558,lines,I-cell_line
558,",",O
558,but,O
558,not,O
558,in,O
558,non-B-cell,B-cell_line
558,or,I-cell_line
558,plasma,I-cell_line
558,cell,I-cell_line
558,lines,I-cell_line
558,.,O
,,
559,We,O
559,conclude,O
559,that,O
559,BSAP,B-protein
559,expression,O
559,is,O
559,largely,O
559,restricted,O
559,to,O
559,lymphomas,O
559,of,O
559,B-cell,B-cell_type
559,lineage,I-cell_type
559,and,O
559,that,O
559,BSAP,B-protein
559,expression,O
559,varies,O
559,in,O
559,B-cell,B-cell_type
559,subsets,I-cell_type
559,and,O
559,subtypes,O
559,of,O
559,B-cell,O
559,NHL,O
559,.,O